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Abstract 
African trypanosomes, the causative agent of sleeping sickness in humans, and 
nagana in cattle, are typically transmitted by the bite of an infected tsetse fly. 
The nature of the mammalian innate immune response during and immediately 
after the bite of an infected tsetse fly remains poorly understood. Previous 
studies characterising the events occurring in the skin post-infected tsetse fly 
bite have mainly focussed on the development of the chancre, which occurs 
from day 5 post-infection. Additionally, most immunopathological studies on 
trypanosomes have used intravenous or intraperitoneal injections of blood stage 
parasites, therefore bypassing relevant inoculation routes (tsetse fly), site 
(skin), and parasite life cycle stages (metacyclics). It is known that following 
tsetse fly bites, trypanosomes leave the skin via the host lymphatic system in 
order to initiate a blood stage infection. However, how the host responds to this 
challenge and how the parasite negotiates the anatomy of the host immune 
system remains unclear. In the present study, I have built on existing intravital 
microscopy tools to visualise T. b. brucei infections in the dermis and lymphatics 
of an infected mouse ear after transmission. I have also characterised by flow 
cytometry, taqman low density arrays and depletion studies the magnitude and 
kinetics of the early innate immune response in the skin, as well as the 
functional role of neutrophils, by examining infections in the context of the 
natural route of infection- the bite of a tsetse fly. Neutrophils were identified to 
be the predominant responders at the bite site, the neutrophil response was 
rapid, and they were recruited independent of the infection status of the tsetse 
flies. Taqman low-density arrays, which measured expression levels of 
inflammation-associated genes, suggested that neutrophil recruitment was 
mediated by CXCL1/CXCL2 release in the skin following mechanical trauma by 
the tsetse fly, in addition to the release of pro-inflammatory cytokines- IL-1β 
and IL-6. Following the identification of neutrophils by flow cytometry, I then 
applied intravital microscopy to visualise influx of neutrophils, which was rapid, 
directed at the bite site, and did not form dynamic clusters. To further test the 
functional role of neutrophils very early in infection, neutrophils were depleted 
using a monoclonal antibody and mice infected via tsetse fly bites. Neutrophil 
depleted mice had no effect on pathogenesis in vivo. Using Prox-1 mOrange 
reporter mice, I also examined the interaction of bloodstream trypanosomes 
with lymphatic vessels in the skin in the period immediately following 
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inoculation using intravital imaging. I imaged metacyclic trypanosomes in situ 
and demonstrated that they had significantly higher velocity in the extravascular 
matrix compared to bloodstream forms. Additionally, my data showed 
bloodstream parasites actively migrating towards lymphatic vessels, and intra-
lymphatic T. b. brucei were also observed, enabling comparison of trypanosome 
motility in the extravascular matrix and lymphatic vessels; in lymph vessels 
trypanosomes were moving in a more directional and rapid manner. This work 
revealed the early cellular and molecular responses to T. b. brucei infection and 
investigated interactions of parasites with the anatomy and cells of the host 
immune system. These studies demonstrate that furthering our understanding of 
the very early events in trypanosome infections is essential to understand how a 
systemic trypanosome infection is established.  
 
  
4 
 
Table of Contents 
Abstract…………………………………………………………………………………...2 
Table of Contents………………………………………………………………………..4 
List	  of	  Tables	  ................................................................................................................................	  7	  
List	  of	  Figures	  ..............................................................................................................................	  8	  
Acknowledgements	  .................................................................................................................	  11	  
Author’s	  Declaration	  ...............................................................................................................	  13	  
Abbreviations	  ............................................................................................................................	  14	  
1	   General	  Introduction	  .......................................................................................................	  16	  
1.1	   Introduction	  to	  African	  trypanosomes	  ...................................................................................	  17	  
1.1.1	   Life	  cycle	  of	  Trypanosoma	  brucei	  ....................................................................................	  17	  
1.2	   Clinical	  features	  of	  Trypanosomiasis	  ......................................................................................	  20	  
1.2.1	   Animal	  African	  Trypanosomiasis	  .....................................................................................	  20	  
1.2.2	   Human	  African	  Trypanosomiasis	  .....................................................................................	  21	  
1.2.3	   Diagnosis	  .........................................................................................................................	  22	  
1.3	   Prevention	  and	  control	  of	  Animal	  and	  Human	  African	  Trypanosomiasis	  ..............................	  24	  
1.3.1	   Host	  .................................................................................................................................	  24	  
1.3.2	   Vector	  ..............................................................................................................................	  25	  
1.3.3	   Parasite	  ...........................................................................................................................	  26	  
1.3.4	   Drugs	  for	  treatment	  of	  Human	  African	  Trypanosomiasis	  ...............................................	  26	  
1.3.5	   Drugs	  used	  for	  Animal	  African	  trypanosomiasis	  (AAT)	  ....................................................	  28	  
1.3.6	   Drug	  resistance	  ................................................................................................................	  28	  
1.4	   The	  Tsetse	  fly:	  Vector	  of	  African	  trypanosomes	  ....................................................................	  29	  
1.4.1	   Distribution	  of	  Tsetses	  .....................................................................................................	  29	  
1.5	   The	  skin	  ..................................................................................................................................	  31	  
1.6	   The	  Innate	  Immune	  system	  ....................................................................................................	  31	  
1.6.1	   Pattern	  recognition	  receptors	  (PRRs)	  ..............................................................................	  32	  
1.6.2	   Complement	  ....................................................................................................................	  34	  
1.7	   Immunity	  in	  the	  skin	  ...............................................................................................................	  36	  
1.7.1	   Skin	  resident	  immune	  cells	  ..............................................................................................	  38	  
1.8	   Cytokines	  in	  inflammation	  .....................................................................................................	  40	  
1.9	   Chemokines	  and	  their	  receptors	  ............................................................................................	  42	  
1.9.1	   Nomenclature	  and	  classification	  of	  chemokines	  .............................................................	  42	  
1.9.2	   Homeostatic	  and	  Inflammatory	  chemokines	  ..................................................................	  43	  
1.10	   Cell	  recruitment	  during	  inflammation	  .................................................................................	  44	  
1.10.1	   Neutrophils	  ....................................................................................................................	  46	  
1.10.2	   Monocytes	  .....................................................................................................................	  48	  
1.11	   Host	  parasite	  interactions	  in	  the	  skin	  ..................................................................................	  50	  
1.11.1	   Current	  knowledge	  about	  events	  in	  the	  skin	  following	  	  African	  trypanosome	  deposition
	   51	  
1.11.2	   How	  do	  African	  trypanosomes	  get	  into	  the	  	  bloodstream?	  ...........................................	  52	  
1.12	   Lymphatic	  system	  ................................................................................................................	  52	  
1.12.1	   How	  the	  structure	  of	  lymphatic	  capillaries	  relates	  to	  	  its	  function	  ................................	  53	  
1.12.2	   Leukocyte	  migration	  through	  lymphatic	  vessels	  ...........................................................	  54	  
1.13	   Host-­‐	  trypanosome	  interactions	  ..........................................................................................	  55	  
1.13.1	   Variant	  Surface	  Glycoprotein	  Coat	  ................................................................................	  56	  
1.13.2	   Immune	  suppression	  in	  African	  trypanosomes	  .............................................................	  56	  
1.14	   African	  Trypanosomes	  are	  highly	  motile	  .............................................................................	  57	  
5 
 
1.14.1	   The	  role	  of	  motility	  in	  African	  Trypanosomes	  	  pathogenesis	  ........................................	  58	  
1.14.2	   Flagellar	  pocket	  and	  host-­‐parasite	  interactions	  ............................................................	  59	  
1.15	   Imaging	  host-­‐parasite	  interactions	  in	  vivo	  ...........................................................................	  60	  
1.15.1	   Bioluminescence	  imaging	  ..............................................................................................	  60	  
1.15.2	   Fluorescence	  microscopy	  ...............................................................................................	  61	  
1.15.3	   Epi-­‐fluorescent	  microscopy	  ...........................................................................................	  61	  
1.15.4	   Confocal	  microscopy	  .....................................................................................................	  61	  
1.15.5	   Multiphoton	  laser	  scanning	  microscopy	  (MPLSM)	  ........................................................	  62	  
1.16	   Project	  aims	  .........................................................................................................................	  63	  
2	   Materials	  and	  Methods	  ....................................................................................................	  64	  
2.1	   Mice	  .......................................................................................................................................	  65	  
2.2	   Trypanosome	  strains	  and	  culture	  ...........................................................................................	  65	  
2.2.1	   Trypanosome	  strains	  .......................................................................................................	  65	  
2.2.2	   Culturing	  bloodstream	  (BSF)	  T.	  b.	  brucei	  .........................................................................	  65	  
2.2.3	   Trypanosome	  stabilate	  preparation	  ................................................................................	  66	  
2.3	   Maintenance	  and	  infection	  of	  Tsetse	  flies	  .............................................................................	  66	  
2.3.1	   Tsetse	  Flies	  (Glossina	  morsitans	  morsitans)	  ....................................................................	  66	  
2.3.2	   Membrane	  feeding	  of	  tsetse	  flies	  ....................................................................................	  67	  
2.3.3	   Maintenance	  of	  tsetse	  flies	  .............................................................................................	  67	  
2.3.4	   Screening	  tsetse	  flies	  for	  Trypanosome	  infections	  ..........................................................	  70	  
2.4	   Infection	  of	  mice	  with	  Trypanosomes	  ....................................................................................	  70	  
2.4.1	   Inoculation	  and	  monitoring	  mice	  infections	  ....................................................................	  70	  
2.4.2	   Enumeration	  of	  parasite	  burden	  .....................................................................................	  71	  
2.4.3	   Preparation	  of	  tsetse	  fly	  feeds	  from	  mice	  .......................................................................	  71	  
2.5	   Nucleic	  acid	  analysis	  ...............................................................................................................	  71	  
2.5.1	   DNA	  extraction	  from	  trypanosome	  culture	  .....................................................................	  71	  
2.5.2	   Isolation	  of	  genomic	  DNA	  from	  tissue	  .............................................................................	  72	  
2.5.3	   RNA	  Isolation	  ...................................................................................................................	  72	  
2.6	   Taqman	  low-­‐density	  array	  (TLDA)	  ..........................................................................................	  74	  
2.7	   Parasite	  quantitation	  ..............................................................................................................	  75	  
2.7.1	   Polymerase	  chain	  reaction	  (PCR)	  of	  tsetse	  fly	  bite	  site	  tissue	  .........................................	  75	  
2.7.2	   PFR2	  primers	  and	  probe	  ..................................................................................................	  75	  
2.7.3	   Preparation	  of	  dilutions	  for	  standard	  curve	  ....................................................................	  76	  
2.7.4	   Quantitation	  of	  parasites	  in	  the	  skin	  and	  draining	  lymph	  node	  by	  QPCR	  .......................	  77	  
2.8	   Flow	  cytometry	  ......................................................................................................................	  78	  
2.8.1	   Infecting	  mice	  ears	  ..........................................................................................................	  78	  
2.8.2	   Ear	  tissue	  preparation	  .....................................................................................................	  79	  
2.8.3	   Flow	  cytometry	  analysis	  of	  samples	  ................................................................................	  79	  
2.9	   Neutrophil	  depletion	  in	  vivo	  ..................................................................................................	  80	  
2.10	   Imaging	  the	  ear	  using	  the	  multiphoton	  microscope	  ............................................................	  80	  
2.10.1	   Mouse	  preparation	  .......................................................................................................	  80	  
2.10.2	   Injection	  of	  mCherry	  T.	  b.	  brucei	  ...................................................................................	  81	  
2.10.3	   Exogenous	  fluorescent	  labels	  ........................................................................................	  82	  
2.10.4	   Placing	  the	  mouse	  under	  the	  microscope	  ......................................................................	  82	  
2.11	   Hematoxylin	  and	  Eosin	  staining	  ...........................................................................................	  83	  
2.12	   Transmigration	  assay	  ...........................................................................................................	  84	  
3	   Development	  of	  an	  experimental	  tsetse	  fly	  infection	  system	  ............................	  85	  
3.1	   Introduction	  ...........................................................................................................................	  86	  
3.2	   Experimental	  infections	  of	  Glossina	  spp.	  ...............................................................................	  89	  
3.2.1	   Tsetse	  Fly	  infections	  ........................................................................................................	  89	  
3.3	   Does	  infected	  tsetse	  bites	  result	  in	  patency	  via	  the	  ear	  pinna	  of	  mice?	  ................................	  93	  
3.4	   Quantifying	  T.	  b.	  brucei	  in	  mice	  ..............................................................................................	  94	  
3.5	   General	  summary	  ...................................................................................................................	  95	  
3.6	   Discussion	  ...............................................................................................................................	  96	  
6 
 
3.6.1	   Infection	  rates	  .................................................................................................................	  96	  
3.6.2	   The	  ear	  pinna	  is	  a	  valid	  route	  of	  infection	  .......................................................................	  99	  
3.6.3	   T.	  b.	  brucei	  kinetics	  ........................................................................................................	  101	  
4	   Characterising	  the	  skin	  immune	  response	  to	  the	  bite	  of	  trypanosome	  
infected	  tsetse	  fly	  ..................................................................................................................	  103	  
4.1	   Introduction	  .........................................................................................................................	  104	  
4.2	   Kinetics	  of	  cellular	  recruitment	  in	  the	  skin	  following	  tsetse	  fly	  bite	  ....................................	  106	  
4.2.1	   Cells	  were	  recruited	  to	  the	  bite	  site	  following	  tsetse	  exposure	  .....................................	  106	  
4.2.2	   Flow	  cytometry	  for	  identification	  of	  recruited	  leukocytes	  .............................................	  108	  
4.2.3	   CD45+	  cells	  were	  identified	  post	  tsetse	  exposure	  by	  flow	  cytometry	  .............................	  110	  
4.2.4	   Neutrophils	  were	  recruited	  within	  the	  first	  24	  hrs	  post	  tsetse	  exposure	  .......................	  113	  
4.2.5	   Macrophage	  numbers	  in	  the	  ear	  skin	  do	  not	  change	  following	  tsetse	  exposure	  ..........	  115	  
4.2.6	   Inflammatory	  monocytes	  do	  not	  appear	  within	  24	  hrs	  post	  tsetse	  exposure.	  ..............	  118	  
4.2.7	   Activation	  of	  macrophages	  in	  the	  skin	  post	  tsetse	  exposure	  .........................................	  120	  
4.2.8	   Characterisation	  of	  the	  inflammatory	  profile	  in	  the	  ear	  ...............................................	  122	  
4.2.9	   Summary	  of	  gene	  upregulation	  in	  the	  skin	  post	  tsetse	  exposure	  ..................................	  132	  
4.2.10	   Inflammatory	  profile	  of	  the	  lymph	  node	  post	  tsetse	  	  exposure	  ...................................	  134	  
4.2.11	   Summary	  of	  gene	  upregulation	  in	  the	  draining	  LN	  post	  	  tsetse	  exposure	  ...................	  136	  
4.2.12	   Depletion	  of	  neutrophils	  ..............................................................................................	  137	  
4.3	   General	  summary	  .................................................................................................................	  139	  
4.4	   Discussion	  of	  the	  molecular	  and	  cellular	  events	  in	  the	  skin	  post	  tsetse	  bites	  .....................	  141	  
5	   Imaging	  African	  trypanosomes	  and	  host	  interactions	  ......................................	  147	  
5.1	   Introduction	  .........................................................................................................................	  148	  
5.2	   Metacyclic	  stage	  T.	  b.	  brucei	  can	  be	  visualised	  in	  the	  skin	  ...................................................	  150	  
5.3	   Neutrophils	  can	  be	  imaged	  in	  the	  skin	  following	  infected	  tsetse	  fly	  bites	  and	  do	  not	  form	  
clusters	  ..........................................................................................................................................	  156	  
5.4	   African	  trypanosomes	  may	  demonstrate	  tropism	  for	  lymphatic	  vessels	  .............................	  158	  
5.5	   General	  summary	  .................................................................................................................	  163	  
5.6	   Discussion	  .............................................................................................................................	  164	  
6	   General	  Discussion	  ........................................................................................................	  172	  
6.1	   Introduction	  .........................................................................................................................	  173	  
6.2	   Tsetse	  fly	  infections	  and	  T.	  b.	  brucei	  egress	  from	  the	  skin	  to	  the	  lymph	  node	  ....................	  174	  
6.3	   Identification	  of	  the	  molecular	  and	  cellular	  events	  in	  the	  skin	  post	  tsetse	  fly	  bites	  ............	  175	  
6.4	   Proposed	  mechanism	  for	  T.	  b.	  brucei	  dissemination	  through	  the	  lymphatics	  .....................	  177	  
6.5	   Conclusions	  ..........................................................................................................................	  178	  
6.6	   Future	  work	  ..........................................................................................................................	  179	  
Appendices	  ..............................................................................................................................	  180	  
List	  of	  References	  ..................................................................................................................	  183	  
 
  
7 
 
List of Tables 
Table 1.1. PRRs, their ligands and pathogens that express them 
Table 1.2. Leukocyte adhesion receptors and their ligands on activated  
  endothelial cells 
Table 1.3. Monocyte subsets in Mouse and human blood 
Table 1.4. The role of monocytes during protozoan infections  
Table 2.1. cDNA synthesis mix 
Table 2.2. Oligonucleotide sequences used for quantification of T. b.  
  brucei 
Table 3.1. Developmental sites of African trypanosomes in Glossina spp.  
Table 3.2. Factors reported to affect successful trypanosome infection  
  rates in the laboratory using experimentally infected tsetse flies 
Table 3.3.  Summary of tsetse fly infections using different strains of T. b. 
  brucei 
Table 4.1.  Summary of the results of bar graphs presented for genes  
  analysed at 2 and 12 hrs 
 
 
 
 
 
 
  
8 
 
List of Figures 
Figure 1.1. Life cycle of Trypanosoma brucei 
Figure 1.2. Human African Trypanosomiasis 
Figure 1.3. Photomicrograph of a Giemsa stained Trypanosoma   
  brucei 
Figure 1.4. Photomicrograph of a tsetse fly 
Figure 1.5.  Tsetse fly distribution in Africa 
Figure 1.6. The Complement pathway 
Figure 1.7.  Mouse skin resident immune cells 
Figure 1.8.  The role of chemokines in innate cell recruitment in the   
  skin 
Figure 1.9.  Comparison of the structure and function of lymphatic   
  vessels 
Figure 2.1.  Tsetse fly facility 
Figure 2.2.  Tsetse fly feeds 
Figure 2.3.  Tsetse fly screening for infection 
Figure 2.4.  Standard curve for quantitation of T. b.     
  brucei 
Figure 2.5.  Tsetse probe on mouse ear 
Figure 2.6.  Mouse ear post tsetse exposure 
Figure 2.7.  Setup required for imaging mouse ears 
Figure 2.8.  A mouse already prepared for imaging 
Figure 3.1.  Screening for metacyclic trypanosomes 
Figure 3.2.  mCherry expressing metacyclic T. b. brucei 
Figure 3.3.  Kinetics of parasitemia in C57Bl/6 mice infected with T. b.  
  brucei post tsetse  exposure to ear pinna of mice 
Figure 3.4.  T. b. brucei kinetics in the skin  
Figure 3.5.  T. b. brucei kinetics in the draining lymph node 
Figure 4.1. Infected and uninfected tsetse exposure caused recruitment  
  of cells to the bite site 
Figure 4.2. Flow cytometry-gating strategy for identification of   
  leukocytes in the ear skin 
Figure 4.3. Total leukocyte populations in the ear skin post tsetse   
  exposure 
9 
 
Figure 4.4. Estimation of the kinetics of neutrophil recruitment in the ear  
  post tsetse exposure 
Figure 4.5. Kinetics of macrophage numbers following tsetse  exposure 
Figure 4.6. Kinetics of resident monocytes in the skin post tsetse   
  bites 
Figure 4.7. Upregulation of MHCII on macrophages in the ear skin post  
  tsetse exposure 
Figure 4.8. Assessment of RNA quality isolated from mouse ear skin and  
  draining lymph node tissues isolated post tsetse exposure 
Figure 4.9. CC-chemokine expression did not differ at 2 and 12 hrs in  
  infected and uninfected samples post tsetse exposure to the ear 
  skin 
Figure 4.10. CXC-chemokine expression did not differ at 2 and 12 hrs in  
  infected and uninfected samples post tsetse exposure to the ear 
  skin 
Figure 4.11. CX3CL1 expression in the ear skin at 12 hrs post tsetse   
  exposure 
Figure 4.12. Inflammatory cytokine expression at 2 and 12 hrs in the ear skin 
  post tsetse exposure 
Figure 4.13. Summary of total genes analysed by Taqman Low Density  
  Arrays at 2 and 12  hrs in the ear skin post tsetse exposure 
Figure 4.14. CC and CXC-chemokine upregulation at 12 hrs in the   
  draining lymph node post tsetse exposure 
Figure 4.15. Setting up the neutrophil depletion study 
Figure 4.16. Depletion of neutrophils causes an early appearance of   
  parasitemia 
Figure 4.17. Summary of the earliest events in the skin and draining lymph  
  node at the molecular and cellular level post tsetse exposure 
Figure 5.1. Visualising metacyclic T. b. brucei in the skin 
Figure 5.2. Metacyclic T. b. brucei parasites do not enter skin blood  
  vessels 
Figure 5.3 Bloodstream form T. b. brucei parasites do not enter skin blood 
  vessels 
Figure 5.4.  Metacyclic T. b. brucei migrate faster than blood stream   
  forms 
10 
 
Figure 5.5 Neutrophils do not swarm following inoculation of   
  metacyclic T. b. brucei 
Figure 5.6. Visualising lymphatic vessels in Prox-1 mOrange mice 
Figure 5.7. T. b. brucei demonstrate tropism for lymphatic vessels 
Figure 5.8. There is no chemotaxis of T. b. brucei towards CCL21 
 
 
 
 
 
  
11 
 
Acknowledgements 
I would like to appreciate my supervisor Prof Jim Brewer, for being very patient 
with me during my thesis writing and your invaluable inputs during the 
experimental phase of my project. Also, my secondary supervisor Dr. Liam 
Morrison you have been an immense source of support especially during the 
parasitology aspects of this project, your help with the in vitro and in vivo 
aspects of my work, your critiquing of my ideas and writing have made me 
better. I also want to thank Prof Paul Garside for challenging me to learn and 
read more about immunology, those one to one meetings challenged me and 
would not be forgotten. Special thanks also goes to Prof Dave Barry for accepting 
me into his lab, and starting this project with me before his retirement. I am 
very grateful to the Wellcome Trust for funding my research, there is no way on 
earth I would have been able to afford it! To the Wellcome Trust 4 yr PhD 
program directors- Darren Monckton and Olwyn Byron, you guys are amazing! 
 
I also want to say a special and big thank you to uncle Bob, I never would have 
been able to perform any of the immunology experiments without your help at 
the start of my PhD, your patience and understanding will always remain with 
me. Thank you also for the time you spared to chat me up about my project and 
make me think critically about it, for finding time to attend my meetings, I am 
very grateful. I also want to appreciate every member of the GBM group and 
students in the level 5 office, for their love and support towards my family. 
 
I am grateful to staff at the JRF- David Gormal, Colin Chapman, you amaze me 
with your keen interest to help even when its not convenient for you. Thanks to 
Craig Lapsley, for your help with the pupae orders, tsetse infections and Anne 
Donachie for teaching me how to carry out injections in mice and stabilate 
preparation. 
 
To every worker in my church, RCCG FOL Glasgow, I say thank you. Special 
thanks to Pastor and Pastor (Mrs) Makun for all your prayers that have been 
answered in my life, Pastor Segun Ibigbemi, his wife my HOD, and son Seyi, for 
their concern, care, and love towards my progress and support towards my 
12 
 
family. Also, I want to appreciate Pastor Bola Owati for his prayers and constant 
love towards me, and my family-thank you sir. 
 
Finally, I want to appreciate, my late father-Caleb Olufisayo Ajibola, that taught 
me the meaning of hard work through his life style, you left at the start of my 
PhD but I know you will be proud of me now, my mother (Mama Voma) without 
your prayers, I know I won’t be where I am today, my parents-in-love for their 
support and prayers, my siblings- late Mrs. Omolola Adesina, Kemi, Biodun and 
my siblings-in-love. Thanks to Mummy Arewa, Yinka Arewa and his siblings, Bode 
Bankole and his family, Akinbami Adenugba for the prayer meetings and 
discussions, you have all been a great source of strength to my family during all 
the trying times we went through in the last 4 years- only God can reward you. 
To my inestimable jewel, my wife, you have been very patient with me during 
the thesis-writing period, I am very grateful and I love you. To my daughter 
Oluwadamilola Esther Jesutofunmi, you came into our world at the best time, 
and you are part of the wonderful history we have made as a family, I love you 
and thank you. 
  
Above all, I say thank you to the one that promises and fulfils, the God of 
Abraham, Isaac and Jacob- thank you for the fulfilment of your Word in my life.  
 
 
 
To God alone be all the glory.  
 
  
13 
 
Author’s Declaration 
I declare that this thesis and the results in it are the outcome of my own work 
except where otherwise stated. No part of this thesis has been previously 
submitted at any university for the award of a degree.  
 
 
 
 
 
 
 
 
 
 
Olumide Ajibola 
 
  
14 
 
Abbreviations 
AAT   Animal African Trypanosomiasis  
APC   Antigen presenting cells 
CATT   Card agglutination test for trypanosomes 
CCCD  Cooled charge-coupled device 
CD  Cluster of differentiation 
CNS   Central nervous system 
DAMP   Danger associated molecular patterns 
DC   Dendritic cells 
DDC   Dermal dendritic cells 
dLN   Draining lymph node 
DNA   Deoxyribonucleic acid 
EpCAM  Epithelial adhesion molecules 
ESAG   Expression site associated gene 
GFP   Green fluorescent protein 
GPI-PLC  Glycophosphatidyl inositol phospholipase C 
HAT   Human African Trypanosomiasis 
H & E   Hematoxylin and Eosin 
HEV   High endothelial venules 
IFN   Interferon 
Ig   Immunoglobulin 
IL   Interleukin 
iNOS   Inducible nitric oxide synthase 
i.p.   Intraperitoneal 
i.v.   Intravenous 
LN   Lymph node 
LPS  Lipopolysaccharide 
LTB4   Leukotriene B4 
MFI   Mean fluorescent intensity 
MHC   Major histocompatibility complex 
MPLSM  Multiphoton laser scanning microscopy 
MVSG   Metacyclic variant surface glycoprotein 
NAG   N-acetyl glucosamine 
NET   Neutrophil extracellular trap 
15 
 
NLR   NOD like receptor 
NO   Nitric oxide 
PAMP   Pathogen associated molecular pattern 
PBS  Phosphate buffered saline 
PCR   Polymerase chain reaction 
PFR   Paraflagellar rod 
PRR   Pattern recognition receptors 
RIN   RNA integrity number 
RLR   Retinoic- acid-inducible gene-I-like receptors 
RNA   Ribonucleic acid 
Th   T helper 
TLDA   Taqman low density array 
TLR   Toll like receptor 
TNF   Tumor necrosis factor 
VSG   Variant surface glycoprotein 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 General Introduction
Chapter 1  17 
 
1.1 Introduction to African trypanosomes 
African trypanosomes belong to the family Trypanosomatidae, order 
Kinetoplastida, they live and multiply extracellularly in the blood and tissue 
fluids of mammals [1, 2]. The main species of African trypanosomes that cause 
human and animal disease are Trypanosoma congolense, Trypanosoma vivax, and 
Trypanosoma brucei. T. congolense and T. vivax infect a range of livestock in 
which they cause nagana or African Animal Trypanosomiasis (AAT). Other 
pathogenic species of African trypanosomes of agricultural importance are T. 
equiperdum and T. evansi. Two subspecies of T. brucei, T. b. gambiense and T. 
b. rhodesiense, also infect humans and cause Human African Trypanosomiasis 
(HAT), also known as sleeping sickness [3, 4]. AAT and HAT are transmitted by 
the bite of infected tsetse flies. Consequently, the distribution of tsetse flies 
across much of sub-Saharan Africa renders swathes of land unavailable for the 
productive raising of cattle, and a large human population vulnerable to 
infection.  
AAT is endemic to 37 sub-Saharan countries with over 46 million cattle at risk, 
over an estimated 8.7 million km2 [5, 6]. Currently, it is estimated that fewer 
than 12 000 HAT cases are reported per year. HAT is a disease of the poor, 
affecting remote and poor parts of Africa. Disease is transmitted in areas of 
Africa where the people thrive on farming, hunting, fishing, or live and carry out 
their activities near streams [3]. Direct economic losses from AAT in cattle has 
been estimated to be approximately US $2.5 billion in east Africa alone [7]. 
Further studies estimated that the economic cost of trypanosomiasis in Africa 
was about US $4.5 billion. In addition to economic losses from contracting AAT, 
it also has indirect impact on crop agriculture, human welfare and economic 
development in afflicted areas [6].  
1.1.1  Life cycle of Trypanosoma brucei  
African trypanosomes have a complex digenetic lifecycle (Figure 1.1), occurring 
in mammalian and tsetse fly hosts [8]. In each host, T. brucei undergoes specific 
developmental stages, involving proliferation, expression of specific proteins on 
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their surface, and distinct morphologies in order to adapt to different 
environments.  
 
Figure 1-1 Life cycle of Trypanosoma brucei. 
The different life cycle stages of T. brucei in the tsetse fly and mammalian hosts are shown by 
scanning electron micrographs. The circular arrows indicate the stages that are capable of cell 
division. Mammalian hosts are infected through the deposition of metacyclic stage trypanosomes in 
the skin. Metacyclic stage parasites differentiate into long slender forms also known as 
bloodstream stage. For tsetse fly transmission to occur, the blood stream form parasites 
differentiate into stumpy forms, which are then taken up during a tsetse fly feed. Figure adapted 
from [9].   
 
The T. brucei lifecycle in mammals starts through the bite of its vector, the 
tsetse fly, which deposits metacyclic stage trypanosomes in the skin [10]. In 
cattle and humans, deposition of trypanosomes in the skin is followed by the 
development of a skin lesion called the chancre at the site of inoculation, its 
diameter varying in size from a few millimetres to several centimeters appearing 
as from day 5 post infection [11]. The chancre is characterised by an intense 
host inflammatory reaction, more frequent in T. b. rhodesiense HAT and 
disappearing within two to three weeks [12]. However, chancre appears to be 
absent in rodents challenged with infected tsetse flies [13]. The chancre was 
also found to serve as a site for proliferation and establishment of trypanosomes 
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in the skin, and also represents the parasitic invasion phase of the lymphatic 
organs in stage 1 HAT. Following the deposition of the metacyclic stage 
trypanosomes, they differentiate into the bloodstream forms, that swim freely in 
the blood and tissue fluids of mammals [14]. Bloodstream trypanosomes express 
variant surface glycoproteins (VSG) on their cell surface in order to survive the 
host immune assault and continue to thrive in its host (see section 1.12.1 for 
further details) [9, 15, 16]. At peak parasitemia, most of the surviving 
trypanosomes undergo terminal differentiation to a stage of the parasite that 
can survive in the tsetse fly when it takes a blood meal. These terminally 
differentiated trypanosomes are described as short stumpy form trypanosomes, 
which are adapted for survival in the tsetse fly [17]. Some of the changes 
include a switch in the parasites metabolic requirement from a glucose rich 
environment in the bloodstream of mammals, to the proline rich environment in 
the tsetse fly midgut [18], other biochemical and morphological changes also 
occur in the parasites [2, 19]. Despite the changes the bloodstream form 
parasites undergo in order to survive in the tsetse fly, about 99% of the ingested 
parasites do not survive the initial phase of development, including stumpy 
forms [20], although pre-adapted for life in the tsetse fly [18].  
Once the parasites arrive in the midgut of the tsetse, the stumpy trypanosomes 
differentiate into procyclic trypanosomes. The procyclic trypanosomes change 
expression of their surface coat from the VSG to a less dense coat comprised of 
the surface antigens, EP (characterised by an internal repeat of glutamic acid E 
and proline P) and GPEET (characterised by an internal repeat of glycine G, 
proline P, glutamic acid E, and Threonine T) procyclin [21]. Colonization of the 
midgut of the tsetse fly is accompanied by an expansion of procyclic 
trypanosomes in the ectoperitrophic space of the midgut and parasite 
elongation, progressing from the posterior to the anterior ends. Long 
trypomastigote forms found in the anterior position of the midgut, in the 
ectoperitrophic space of the tsetse fly near the proventriculus, are called the 
mesocyclic forms [18]. The mesocyclic forms have undergone a cell cycle arrest 
and are at the G0/G1 phase of development, which represents the endpoint in 
parasite establishment in the midgut. The transformation into mesocylic stage 
parasites is also crucial for migration into the lumen of the proventriculus, and 
subsequently to travel into the foregut and proboscis, where they undergo the 
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next stage of differentiation into epimastigote forms. The incoming mesocyclic 
cells produce two types of morphologically identical epimastigote forms during 
asymmetric division; long and short epimastigotes, and both types have diploid 
DNA contents [22]. The short epimastigote forms have reduced motility due to a 
short flagellum, and heteronuclear kinetoplast, resembling the attached 
epimastigote stage in the salivary gland. In order for the parasites to swim from 
the proboscis through the hypopharynx and reach the salivary glands, only the 
highly asymmetrical, highly motile and dividing epimastigote parasites succeed 
in migrating [20]. Once they succeed in migrating, the short epimastigote forms 
are now in a convenient location for attachment with their flagellum. The series 
of differentiation the parasites undergo at this phase are irreversible. In the 
salivary gland of the tsetse fly, the parasites attach to epithelial surfaces as 
epimastigote forms [23]. The epimastigote forms are proliferative and eventually 
generate the non-proliferative metacyclic trypanosomes, which have reacquired 
the VSG coat, which can then be transmitted into its new mammalian host 
during a tsetse feed/probe [18, 19, 23, 24]. The post-mesocyclic forms 
represents an essential bridge between the procyclic and metacyclic production 
phase in the salivary glands [20].   
1.2 Clinical features of Trypanosomiasis 
1.2.1  Animal African Trypanosomiasis 
Livestock affected by AAT show extensive immune mediated pathology, cardiac 
involvement and severe anemia [25], and are weak and unproductive particularly 
in the chronic stage of disease. Animals show intermittent fever, weight loss and 
lymphadenopathy. They also exhibit reduced milk production, herd size, growth 
and work output. Deaths are common in chronically infected animals, and 
animals that recover may relapse when stressed. This loss in animal productivity 
has important socio economic implications for people whose livelihood depends 
on these animals [26]. Anemia is a consistent observation in HAT patients [27] 
and AAT affected animals [28]. Anemia is present in the acute and chronic stages 
of infection in animals. During the acute phase of infection, anemia has been 
associated with the immune response of the host, due to binding of immune 
complexes to erythrocytes [25]. While during the chronic phase when the 
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animals are immunosuppressed multiple factors are involved such as 
splenomegaly, sensitisation of erythrocytes by immune complexes, and 
haemodilution [25].   
1.2.2  Human African Trypanosomiasis 
HAT or sleeping sickness is caused by two subspecies of T. brucei, T. b. 
rhodesiense and T. b. gambiense (Figure 1.2 for distribution).  
 
Figure 1-2 Human African Trypanosomiasis 
Diagram adapted from http://www.who.int/csr/resources/publications/CSR_ISR_2000_1tryps/en/. 
The map of Africa depicting the cases of HAT in Africa and areas of Africa that are free from HAT. 
Cases of HAT above 100 persons are predominantly located in West Africa. 
 
The course of infection of HAT is dependent on the sub-species infecting 
humans. T. b. rhodesiense is found in eastern and southern parts of Africa and 
results in an acute form of infection (weeks-months) whereas T. b. gambiense, 
found in west and central Africa, causes more chronic infections (months-years).  
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1.2.2.1 Clinical features 
HAT appears in two stages, the first is the haemolymphatic stage, characterised 
by restriction of the parasites to the blood and lymph, and Stage 2, the 
meningoencephalitic stage characterised by the invasion of the central nervous 
system (CNS). Trypanosomes are thought to penetrate the blood brain barrier 
and enter the CNS in an active manner, at or near intracellular junctions of the 
endothelia [29]. The resulting encephalitis from Stage 2 disease produces the 
symptoms of sleeping sickness and is the major cause of death in patients 
infected with both sub-species of T. brucei. Death from T. b. rhodesiense usually 
occurs within weeks or months of infection due to its acute nature [30]. 
During infection with T. b. rhodesiense there can be the appearance of a 
chancre at the tsetse fly bite site, which is a persistent swelling found in about 
19% of patients and disappears in about two to three weeks [12], whereas 
chancres are rarely seen in T. b. gambiense infections [3]. In addition, clinical 
signs associated with Stage 1 HAT include chronic and intermittent fever, 
headache, lymphadenopathy, joint pains and itching. Fevers in stage 1 HAT may 
last from a day to a week, separated by intervals of a few days to a month or 
longer, and are rarely present in Stage 2 disease [31, 32].  
The leading symptom of stage 2 of disease is the sleep disorder experienced by 
patients. At this stage, infection causes a dysregulation of the circadian rhythm 
controlling the host’s sleep/wake cycle, and consequently fragmentation of the 
sleep pattern. The degree of disruption of the 24 hrs sleep/wake cycle of 
patients is proportional to the severity of clinical symptoms. Patients also 
experience neurological symptoms such as tremor, general motor weakness, 
hemiparesis, limb paralysis, abnormal movements and ultimately death if 
untreated [33, 34].  
1.2.3  Diagnosis 
Different approaches are used in diagnosis of T. b. gambiense and T. b. 
rhodesiense infection. The reasons for these differences are that firstly, there is 
no serological test available for T. b. rhodesiense. Secondly, there is the 
presence of permanent parasitemia in T. b. rhodesiense compared to T. b. 
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gambiense where there are few parasites in peripheral circulation, except at 
periods of chronic disease [35]. Therefore, thin or thick blood smears are usually 
sufficient to diagnose T. b. rhodesiense (Figure 1.3). 
 
Figure 1-3 Photomicrograph of a Giemsa stained Trypanosoma brucei 
Diagram adapted from http://www.cdc.gov/parasites/sleepingsickness/epi.html. A thin blood smear 
(x1000 magnification) of Trypanosoma brucei spp. Image approved for reproduction by the Centres 
for Disease Control and Prevention. 
 
Currently, the card agglutination test for trypanosomes (CATT) which can be 
performed on serum, blood from impregnated filter papers, or blood obtained 
from finger pricks using a blood lancet is commonly used in T. b. gambiense 
diagnosis [20, 36, 37]. The CATT test is a rapid test that can be used to screen 
hundreds of individuals daily, and is the most efficient screening method 
available to date. CATT has also been reported to have a sensitivity of about 87-
98% and specificity of 93-95% [38, 39]. In non-endemic countries, other 
serological tests such as immunofluorescence assay, or enzyme linked 
immunosorbent assays detecting parasite-specific IgG subclasses (IgG1 and IgG3) 
and IgM isotypes in serum and cerebrospinal fluid of individuals with suggestive 
clinical features of HAT are carried out [39-43]. Serological tests are not 100% 
sensitive in the detection of HAT, because of the high capacity for the parasite 
to switch its VSGs, which are the antigens used in serological tests [44, 45]. 
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Consequently, microscopic examination is still employed in addition to other 
diagnostic methods to search for trypanosomes in individuals that have chancre 
or symptoms of HAT [39, 40]. Microscopic confirmation of parasites in lymph 
node aspirates, cerebrospinal fluid (CSF) or blood remains the gold standard for 
parasitological confirmation [3].  
 
Staging of HAT patients is important because of substantial differences in the 
drugs administered in the two stages of HAT. According to the World Health 
Organisation (WHO) recommendations, the presence of more than five white 
blood cells per µl in the CSF or increased protein content (>370 mg/L) confirms 
the second stage of the disease [37, 46, 47]. Some researchers have suggested 
that there may be an intermediate stage of infection with a CSF WBC of < 20/µl, 
where the parasites penetrate the blood brain barrier and are treated with early 
stage drugs. The notion of an intermediate stage requires caution in its approach 
[35, 48]. Research is currently on-going through the organisation, Foundation for 
Innovative New Diagnostics (FIND) to improve the diagnosis and staging of HAT, 
including using recombinant trypanosome native antigens for development of 
rapid diagnostic tests [49]. These new diagnostic tests could be used for 
screening populations that are at risk of infection. Improved methods of 
confirming cases of HAT, using a LED fluorescence microscope and evaluation of 
a molecular test based on Loop-Mediated Isothermal Amplification of DNA 
(LAMP) are also in development [50].   
1.3  Prevention and control of Animal and Human African 
Trypanosomiasis 
The prevalence of animal and human African trypanosomiasis could be controlled 
via approaches targeted at the vector, parasite and the host described below.  
1.3.1  Host 
Genetic resistance to African trypanosomes has been identified in certain breeds 
of livestock, and these animals are described as trypanotolerant. Exploiting the 
inherent genetic properties of the host to control disease has been applied in 
AAT, where some breeds of cattle such as N’dama and Muturu remain infected 
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with trypanosomes, but do not suffer the severe clinical signs of susceptible 
counterparts [51]. The ability of N’dama cattle to limit anemia has been linked 
to the presence of hematopoietic tissue of trypanotolerant origin. T cells and 
antibodies were described not to contribute to trypanotolerance, hence a role 
for erythropoiesis was proposed [52]. In some trypanosome endemic areas, it has 
been advised to selectively breed from trypanotolerant cattle in order to 
maintain productivity in the face of infection [53, 54]. In the past, wild game 
that served as reservoirs for trypanosomes, have also been targeted by culling, 
in order to reduce the overall prevalence of the parasite and reduce the ratio of 
infected tsetse flies in such areas. This approach is no longer considered 
acceptable and no longer in practice. More recently, the expression of a 
trypanosome resistance gene, APOL1, in transgenic livestock is currently been 
investigated with the aim of reducing susceptibility of animal reservoirs. The 
presence of the primate APOL1 is sufficient to confer resistance in these 
animals, as observed in transgenic mice expressing human APOL1 [55]. So it is 
expected that expression of baboon APOL1 in transgenic cattle would also confer 
resistance against T. b. brucei and T. b. rhodesiense. These studies are currently 
ongoing and it is hoped that these would provide a new avenue to control 
African trypanosomes [56]. 
1.3.2  Vector 
Approaches targeted at the vector are aimed either at indirectly reducing the 
available habitat for the tsetse fly to thrive, or directly by reducing the tsetse 
population in such areas. Traditional methods employed include bush clearing 
and application of insecticides. However, insecticides are clearly indiscriminate 
and kill both the tsetse fly and other insects in the ecosystem, in addition to 
other undesirable effects the insecticides may have. Currently, the use of traps 
is more acceptable because its more environmentally friendly and does not kill 
other insects in the population. The pan African Tsetse and Trypanosomiasis 
Eradication Campaign (PATTEC), has in addition to the use of traditional 
methods of control of tsetse flies, also included the use of sterile insect 
technique in tsetse fly control. The sterile insect technique involves the release 
of sterile males, which mate unproductively with females, and has been 
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effective in contributing to the elimination of Glossina austeni from the island of 
Unguja in Zanzibar [57, 58].  
1.3.3  Parasite 
The sole method of control available at the parasite level currently is limited to 
chemotherapy. The drugs for treatment of both AAT and HAT are currently 
limited and few new drugs have been formulated over recent decades, largely 
because of a combination of the cost of developing new drugs and the fact that 
trypanosomiasis occurs in a region of the world that does not represent a 
sufficiently profitable market [59]. The drugs currently in use for treatment of 
HAT are donated by pharmaceutical companies to the World Health 
Organisation.  
1.3.4  Drugs for treatment of Human African Trypanosomiasis 
For Stage 1 or the haemolymphatic stage of HAT, there are only two licensed 
drugs, pentamidine and suramin for treatment of T. b. gambiense and T. b. 
rhodesiense infections, respectively. For Stage 2 disease, melarsorprol and 
difluoromethlyornithine, Ornidyl ® (DFMO), and nifurtimox-eflornithine 
combination therapy (NECT) are the drugs currently in use [60-63]. In addition to 
the drugs currently in use, new drug candidates are also been investigated in the 
treatment of HAT. One of such novel drugs with great potential is 
nitroimidazole, an analogue of fexinidazole rediscovered by Drugs for Neglected 
Diseases Initiative (DNDi) [64]. This drug has been shown to have potential 
against both strains of HAT in the two stages, and it is administered orally. Other 
promising candidates in development include the oxaboroles [65] administered 
orally, and DB75 (Furamidine), a diamidine analogue of pentamidine [59]. Some 
other trypanocidal drugs currently used in anti-cancer therapies are also been 
tested but are yet to undergo full scale clinical trials, and examples include 
cordycepin, deoxycoformycin and lodamine, a known oral anti-cancer agent 
[65]. The main drugs currently in use are described below. 
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1.3.4.1  Pentamidine 
Pentamidine is the drug of choice for treatment of T. b. gambiense for patients 
in the first stage of disease. Resistance to pentamidine has been unreported 
since the introduction of the drug in 1940 and it has remained the first line 
treatment drug for T. b. gambiense sleeping sickness for more than 60 years. 
Treatment failures from pentamidine are uncommon, and believed to be due to 
misdiagnosis of the stage of disease. The mode of action of pentamidine has 
been linked to the high accumulation of the drug by the parasite, while its likely 
mode of resistance based on work carried out on laboratory selected isolates is 
linked to efflux of the drug or decreased uptake [66].  
1.3.4.2  Suramin 
Suramin can also be used for treatment of Stage 1 T. b. rhodesiense and 
gambiense, although it is not used against T. b. gambiense in western and 
central Africa. Suramin is not used in second stage treatment of HAT because it 
does not cross the blood-brain barrier. The use of suramin in west and central 
Africa is avoided due to the presence of Onchocerca spp. in these areas, as the 
activity of suramin against Onchocerca spp. can increase the risk of allergic 
reactions. Suramin presents with toxic side effects such as nephrotoxicity, 
peripheral neuropathy, bone marrow toxicity with agranulocytosis and 
thrombocytopenia. Suramin is a large polyanion and exerts inhibitory properties 
on a wide spectrum of enzymes such as fumarase, dihydrofolate reductase, 
hexokinase, thymidine kinase, trypsin and dehydrogenase [67, 68]. 
1.3.4.3  Melarsoprol 
Melarsorprol was introduced in 1950 to replace earlier organo-arsenics that were 
ineffective. This remains the drug of choice in the treatment of second stage 
HAT caused by T. b. gambiense, especially in poor countries where eflornithine 
is not available. Second stage HAT caused by T. b. rhodesiense is only treated 
with melarsorprol. Adverse reaction to melarsoprol is frequent and is often life 
threatening, with between 4% and 12% of patients who receive melarsoprol dying 
from side effects associated with the drug [69, 70]. Treatment failures and 
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resistance to melarsorprol have also been on the increase in the last decade in 
endemic areas such as southern Sudan, Congo and Angola [3, 71]. 
1.3.4.4  Eflornithine 
In the last 50 yrs, Eflornithine also known as DFMO is the only new molecule that 
has been introduced for the treatment of HAT. Eflornithine has been 
demonstrated to show reduced mortality in the treatment of second stage HAT 
more than melarsoprol. Eflornithine is recommended as first line drug in the 
treatment of T. b. gambiense disease, but is not recommended in the treatment 
of T. b. rhodesiense, which is less innately susceptible to eflornithine [72, 73]. 
1.3.5  Drugs used for Animal African trypanosomiasis (AAT) 
Chemotherapy of AAT faces similar challenges to those in treatment of HAT. 
These challenges include the limited availability of drugs due to reluctance of 
the pharmaceutical companies to invest in research and development of new 
drugs for a neglected disease, in addition to resistance development against the 
drugs by the parasite. The drugs currently used in the treatment of AAT in 
cattle; diminazene aceturate (Berenil®), ethidium bromide and isometamidium 
chloride (Samorin®, Trypamidium®), while cymelarsan is used for treating T. 
evansi infection in camels. Diminazene aceturate and isometamidium chloride 
have been widely used as therapeutic and prophylactic trypanocides, 
respectively. However, cases of resistance by trypanosomes against these drugs 
have been reported [74-77]. 
1.3.6  Drug resistance 
The control of human and animal African trypanosomiasis principally relies on 
chemotherapy, owing to the absence of vaccines and effective vector control 
strategies. Resistance to commonly used animal trypanocides such as suramin, 
the preferred drug for treatment of camel trypanosomiasis, diminazene 
aceturate, cymelarsan, homidium and isometamidium chloride has been 
reported in the field [78, 79]. More recently, mutations in T. b. gambiense 
aquaglyceroporin gene in field isolates were demonstrated to be responsible for 
resistance to melarsoprol and pentamidine [80]. Also, some researchers have 
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recently carried out genome scale RNA interference target sequencing (RIT-seq) 
screens on all five known HAT drugs to identify transporters, metabolic pathways 
and enzymes in T. brucei that function to enable antitrypanosomal drug action. 
Furthermore the use of RIT-seq analysis also revealed over 50 genes that 
enhance drug susceptibility. This study further corroborated the role of 
aquaglyceroporin in pentamidine and melarsoprol cross resistance [81]  
1.4  The Tsetse fly: Vector of African trypanosomes 
The tsetse fly (Figure 1.4) belongs to the genus Glossina, family Glossinidae and 
order Diptera; there are 22 different species currently recognised, and their 
distribution is restricted to sub-Saharan Africa. Tsetse flies are classified into 
three main groups, the Morsitans, the Palpalis and the Fusca groups. Both male 
and female tsetse flies are capable of transmitting trypanosomes.   
 
Figure 1-4 Photomicrograph of a tsetse fly 
Diagram adapted from http://www.cdc.gov/parasites/sleepingsickness/epi.html. A recently fed 
tsetsefly with an engorged abdomen.. 
 
1.4.1  Distribution of Tsetses 
The three main groups of tsetse differ in their distribution according to the 
availability of their preferred type of vegetation. The distribution of tsetse flies 
in Africa is described using the map below (Figure 1.5). 
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Figure 1-5 Tsetse fly distribution in Africa 
Image from http://www.genomics.liv.ac.uk/tryps/images/africamap3.gif. The distribution of tsetse 
flies and cattle in Africa, and areas that are susceptible to cattle infection by tsetse flies are shown 
in the map. 
 
 
1.4.1.1  Morsitans group 
Morsitans group species are found in the savannah regions of Africa, and are not 
present in rain forests or swampy areas. The distribution of Morsitans species is 
also limited by colder climatic conditions in southern Africa, hot and dry 
conditions in the north-west and central Africa. In this group, G. morsitans 
morsitans is the most widespread; other members of importance to transmitting 
trypanosomes include G. m. centralis, G. pallidipes, G. longipalis. 
 
1.4.1.2  Palpalis group 
This group of tsetse flies are present in humid areas of Africa, including 
mangrove swamps, rain forest, lakeshores and along rivers. Members of this 
group important in transmitting trypanosomes include G. palpalis, G. fuscipes, 
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G. tachinoides, G. caliginea and G. pallicera. G. caliginea and G. pallicera, and 
are mainly limited to areas of West Africa. 
1.4.1.3  Fusca group 
There are three main types of the Fusca group, which differ in their distribution. 
Glossina longipennis is found in rather dry countries such as Sudan (south east 
corner), Ethiopia (southern border), Somalia, Kenya, and northeastern Tanzania. 
The second group Glossina brevipalpalis is scattered through the eastern parts of 
Africa e.g. Ethiopia and Somalia. The last group is limited to more thickly 
forested areas of Africa, with similar distribution to G. papalis/G. fuscipes.  
1.5 The skin  
The skin is a highly complex organ composed of the epidermis, dermis and 
subcutaneous fatty layers. These layers accommodate various structures such as 
hair follicles, sweat glands in humans (absent in mice), blood vessels and 
lymphatics. The layers of the skin are populated by cells involved in immune 
surveillance and innate immune responses to infection. The skin serves as 
protective interface against environmental toxins, and physical stresses [82]. 
The cellular components of the skin, the layers that cells are present are 
described in section 1.7, and the description of the lymphatic system is given in 
section 1.12. 
1.6  The Innate Immune system 
Skin and mucosal surfaces provide a barrier function to protect the host from 
infection through contact with pathogens. However on breach of this barrier, the 
ability to fight these pathogens relies on the efficacy of the immune system. The 
immune system can be divided into the innate and adaptive arms. The adaptive 
arm of immunity is specific and slow to develop on first encounter with 
pathogens. The innate arm of immunity on the other hand is very critical during 
the first few hours of pathogen encounter, and plays an important role in 
initiating and shaping the subsequent adaptive immune response that provides 
long lasting immunity.  
Chapter 1  32 
 
Innate immune responses are relatively non-specific for pathogens, and rely on 
germ-line encoded receptors expressed on immune cells that recognise certain 
Pathogen Associated Molecular Patterns (PAMPs). The innate arm of immunity 
can also be triggered by various physical or metabolic insults, which produce 
soluble mediators of inflammation known as Danger Associated Molecular 
Patterns (DAMPs). The inflammatory responses produced mostly resolve once the 
source of inflammation has been eliminated, though in some instances this can 
persist or there can be aberrant resolution of the inflammatory response [83, 
84]. Preformed, soluble components of the innate immune system include the 
complement system, the coagulant and fibrinolytic cascades and antimicrobial 
peptides [85, 86]. Innate immune cells include resident cells, such as 
macrophages, dermal dendritic cells, mast cells and Langerhans cells, and also 
recruited cells, such as eosinophils, basophils, neutrophils and monocytes. These 
innate immune cells respond to PAMPs as well as host derived DAMPS, and 
products of the complement cascade [87]. This activates innate cells with the 
concomitant release of pro-inflammatory cytokines/chemokines, which initiate 
inflammation and recruitment of immune cells to the site of injury. The skin also 
serves as the main interface for encounter with pathogens, through Pattern 
Recognition Receptors (PRRs). The crucial role PRRs play in recognition of PAMPs 
and DAMPs, activation/recruitment of cells in the skin, and the complement 
system has been detailed.  
1.6.1 Pattern recognition receptors (PRRs) 
PRRs are germ-line encoded and play a crucial role in sensing the presence of 
foreign objects via PAMPs and also endogenous molecules released from 
damaged cells (DAMPS) in the body. There are four families of PRRs that have 
been identified to date. These families include transmembrane proteins like 
Toll-like receptors (TLRs) and C-type lectin receptors (CLRs), cytoplasmic 
proteins such as retinoic acid-inducible gene (RIG)-I-like receptors (RLRs) and 
the NOD-like receptors (NLRs). PRRs are expressed on professional (macrophages 
and dendritic cells) and non-professional immune cells such as epithelial cells, 
fibroblasts and endothelial cells [84]. The sensing of PAMPs by PRRs results in 
the upregulation of gene transcripts involved in inflammation.  
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Table 1-1 PRRs, their ligands and pathogens that express them 
PRRs Localisation Origin of the 
Ligand 
TLR   
TLR1 Plasma membrane Bacterial triacyl 
lipoprotein 
TLR2 Plasma membrane Lipoprotein e.g. 
bacteria, parasites, 
viruses 
TLR3 Endolysosome Viral dsRNA 
TLR4 Plasma membrane LPS e.g. bacteria 
TLR5 Plasma membrane Bacterial flagellin 
TLR6 Plasma membrane Bacteria and viral 
diacyl lipoprotein 
TLR7 Endolysosome ssRNA e.g. virus and 
bacteria 
TLR9 Endolysosome CpG DNA e.g. 
protozoa, and 
bacteria  
TLR10 Endolysosome Unknown 
TLR11 Plasma membrane Protozoa profilin-like 
molecule 
 
RLR 
RIG-I Cytoplasm Short dsRNA e.g. RNA viruses 
MDA5 Cytoplasm Long dsRNA e.g. RNA viruses 
LGP2 Cytoplasm RNA viruses, ligands unknown 
 
NLR 
NOD1 Cytoplasm iE-DAP from bacteria 
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NOD2 Cytoplasm MDP from bacteria 
 
CLR 
Dectin-1 Plasma membrane β-Glucan e.g. Fungi 
Dectin-2 Plasma membrane β-Glucan e.g. Fungi 
MINCLE Plasma membrane SAP130 e.g. Fungi 
 
TLRs are the most studied PRRs and are involved in the sensing of pathogens 
outside the cell, and in the intracellular endosomes and lysosomes of 
phagocytes. They have a vital role in triggering innate immunity and 
orchestrating the adaptive immune response. Table 1.1 gives a summary of the 
families of PRRs and the PAMP ligands they recognise. 
1.6.2  Complement 
In addition to the cells of the innate response, the complement system is one of 
the major effector mechanisms of the innate immune system [88]. Its name was 
derived by its ability to ‘complement’ the antibacterial properties of antibodies 
in the heat stable fraction of the serum. Complement is made up of more than 
30 proteins that constitute approximately 15% of the globular fraction of plasma 
and can respond efficiently, and produce tightly regulated inflammatory and 
cytolytic immune responses to pathogens. Activation of the complement system 
occurs via three main pathways; classical, lectin and alternative pathways [85, 
86]. The initiation, activation and termination of the three main pathways is 
summarised in figure 1.6. Although the proteins involved in the initiation of 
complement activation are different, the three pathways converge with the 
generation of C3 convertase. The classical pathway is immunoglobulin 
dependent as it involves the binding of the C1 complex (C1q in complex with C1r 
and C1s serine proteases) to the Fc region of complement fixing antibodies [88]. 
The lectin pathway, though similar to the classical pathway, is immunoglobulin 
independent in its mechanism of action. 
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Figure 1-6  The Complement pathway 
Complement can be activated through three ways: classical, lectin and alternative pathways. 
Complement activation through the classical pathway is initiated when C1q binds to antibody 
attached to an antigen, which then activates C1r and C1s, which then cleaves C4 and C2. In the 
lectin pathway, activation begins when mannose- binding lectin (MBL) comes in contact with 
conserved pathogenic motifs, which then proceeds through C4 and C2 which produce activated 
complement proteins further down the cascade. In contrast to the classical pathway, the lectin 
pathway does not recognize antibody bound to antigen. The alternative pathway is activated 
through spontaneous hydrolysis of C3, which forms the initial products of the alternate pathway, C3 
convertase, (C3(H20)Bb. Formation of C3 convertase allows the binding of plasma proteins Factor 
B and Factor D, to cleave to Ba and Bb and formation of C3bBb and C5 convertase C3bBbC3b. 
The three complement pathways ultimately result in the formation of convertases, which generate 
the major effectors of the complement system such as anaphylatoxins, the membrane attack 
complex (MAC), and opsonins. Figure adapted from [88]. 
 
The lectin pathway employs PRRs, mannose binding lectin (MBL) and ficolins, for 
nonself recognition. The lectin pathways uses these PRRs to recognise PAMPs 
associated with microorganisms [89, 90]. The alternative pathway on the other 
hand is distinct from both the classical and lectin pathways. It is initiated by 
spontaneous hydrolysis of C3, which is abundant in blood plasma. Hydrolysis of 
C3 to the C3b analog, C3(H2O) enables binding to Factor B, in turn allowing 
cleavage of Factor B into its two components Bb and Ba by factor D. This forms 
the initial alternative pathway C3 convertase, which then forms the basis of the 
amplification loop at later stages of the cascade. In summary, irrespective of the 
pathway of complement activation, it basically serves to carry out the following 
broad effector functions; These functions include the direct lysis of targeted 
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surfaces, generating a potent proinflammatory reaction through anaphylatoxins, 
opsonisation and phagocytosis of targeted surfaces through the engagement of 
complement receptors on phagocytic cells such as macrophages and neutrophils 
[85, 86, 88]. 
1.7  Immunity in the skin 
The skin is arguably the largest organ of the human body, composed of 1.8 m2 of 
diverse habitats, consisting of folds, invaginations and specific niches that 
support a wide range of microorganisms. The skin serves as a physical barrier to 
protect the human body from the assault of foreign organisms or toxic 
substances. The skin also serves as an interface between the body and the 
outside environment. It is therefore very important in interactions involving 
pathogenic organisms that rely on the skin as a route of entry for establishment 
and dissemination throughout the body. Pathogenic protozoa that enter via the 
skin include the vector-borne protozoa T. brucei, Plasmodium spp., and 
Leishmania spp. The skin also consists of a plethora of cell types that are 
resident, together with other structures, such as sweat glands (absent in mice), 
nerves, blood vessels, and lymphatics [82]. These small organs contribute to 
functions such as temperature regulation, barrier maintenance and immunity. 
The skin is composed of the epidermis and the dermis (Figure 1.7). The 
epidermis is attached to the basement membrane, beneath which lie the dermis 
and a subcutaneous fatty region. Structurally, the epidermis comprises several 
layers of keratinocytes. During physical damage to the skin such as vector bite, 
or needle, keratinocytes can become activated via the TLR pathway where they 
release IL-1α [91, 92].  
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Figure 1-7 Mouse skin resident immune cells 
The epidermis is made up of Langerhans cells, and resident memory CD8+ T cells.  The dermis 
comprises CD4+ T cells (effector and memory), γδ T cells, NKT cells, dermal DCs and 
macrophages. Figure adapted from [82]. 
 
As well as responding to physical trauma, the ability of keratinocytes to 
recognise various pathogen molecules and activate the TLR pathway makes them 
a formidable force for frontline protection against pathogen invasions. 
Keratinocytes may also produce cytokines such as interleukin 22 (IL-22), IL-1α 
and IL-1β, IL-6, IL-10, IL-18 and IL-33, chemokines including CXCL9, 10, 11 and 
CCL20, or antimicrobial peptides such as β-defensins [93, 94]. The epidermis 
also contains Langerhans cells (epidermal dendritic cells), and CD8+ T cells.  
Beneath the epidermis is the dermis composed of elastin fibres, collagen and 
other extracellular matrix proteins produced by fibroblasts. The dermis also 
contains blood vessels, and draining lymphatics begin in the dermis and 
penetrate deeper into the skin to access the lymph nodes. Immunologically 
important cells of the dermis include the mast cells, dermal DCs (DDCs), 
macrophages, γδT cells, and NK cells. DDCs are evenly dispersed across the 
dermis and can be distinguished from Langerhans cells through lack of expression 
of epithelial cell adhesion molecule (EpCAM) [95]. A certain group of T cells 
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referred to as unconventional or innate like T cells (γδT and NK cells) are also 
present in the epidermis and dermis, and perform immunosurveillance roles.  
1.7.1  Skin resident immune cells 
1.7.1.1  Dendritic cells  
Langerhans cells are positioned in the epidermis above the basal keratinocytes 
and are found in both humans and mice. The role of Langerhans cells has been 
extensively studied, and recent evidence suggests that they contribute to 
priming adaptive immunity to skin pathogens such as Candida albicans, and 
bacteria such as Staphylococcus aureus [96, 97]. During infection or topical 
application of allergens, LCs can transit from the epidermis via afferent 
lymphatics to the LN, and can be distinguished from other cutaneous DCs based 
on high surface expression of EpCAM [98]. Langerhans cells can also sample 
bacterial toxins in order to generate humoral immunity, and have also been 
demonstrated to possess immunosuppressive effects, either through induction of 
T cell deletion or activation of regulatory T cells that dampen skin responses 
[99, 100].  
CD103+ dermal DCs have a well-defined role in immunity, particularly in anti-
viral immunity [98, 101, 102]. CD103+ dermal DCs have also been shown to 
efficiently cross present self-antigens to CD8+ T cells, which suggest a potential 
role in self-tolerance in the steady state. CD11b+ DCs are also present in the skin 
and represent a highly heterogeneous group of DCs. CD11b+ migratory DCs in the 
mouse skin have been linked to TH17 cell-mediated immunity [103]. In addition, 
intradermal injection of Leishmania spp. has revealed an important role for 
CD11b+ DCs in antigen presentation [104]. 
1.7.1.2  Macrophages  
Macrophages are a highly plastic and heterogeneous population of professional 
phagocytes involved in tissue homeostasis through clearance of senescent cells 
and tissue repair after inflammation [105, 106]. Macrophages are present in the 
normal skin at a low density of 1-2 per mm2. Tissue resident macrophages are 
well known for their role as immune sentinels, and also for being amongst the 
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cells that participate early in the immune response. They engulf apoptotic cells 
and pathogens and release immune effector molecules, and can also present 
antigens. Resident tissue macrophages have been implicated to have a role in 
tissue repair and remodelling [107]. Resident skin macrophages are thought to 
scan the skin and participate in the early detection of, and response to 
pathogens entering the body through the skin. After an initial recognition of 
microbial challenge, resident macrophages, alongside other resident cells, 
release inflammatory mediators to drive recruitment of innate cells, initially 
neutrophils within a few minutes, followed by monocytes as early as six hours.  
During tissue repair following an insult, the tissue formation phase, which is the 
mid stage in the restoration of skin integrity and homeostasis post injury, 
requires the presence of macrophages. The other two stages involved in wound 
repair are inflammation and maturation phases. Depletion of macrophages 
during the tissue formation phase leads to haemorrhage, failure of wound 
closure, and transition to the tissue maturation phase [106, 108-113]. The pro-
inflammatory role of resident macrophages has been described in studies in 
which depletion of macrophages impacted chemokine production and neutrophil 
influx [114-116]. Depletion of resident macrophages through clodronate 
liposomes led to a reduction in host protection to infection, loss of inflammatory 
mediators such as chemokines, cytokines and altered inflammatory cell 
recruitment [115-117].  
In summary, dermal macrophages lack migratory capabilities to the draining 
lymph node, poor antigen presentation properties, involved in maintaining tissue 
homeostasis, repair and might have an immunosurveillance role in the skin in 
sensing foreign invaders [106].  
1.7.1.3  Skin resident T cells 
The normal human skin contains more than 2 x 1010 skin-resident T cells, which 
is more than twice the total number of T cells in the blood [118]. In the 
epidermis, T cells are mostly CD8+ αβ T cells that are distributed in the basal and 
suprabasal keratinocyte layer, in close proximity to Langerhans cells. In the 
dermis, T cells are often clustered around postcapillary venules and the 
proportion of CD4+ and CD8+ T cells are almost the same, with most of the T 
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cells displaying a memory phenotype and expressing cutaneous lymphocyte 
associated antigen (CLA), CCR4 and CCR6 skin homing addressins that interact 
with E-selectin [118]. Specifically, CLA is thought to be a ligand for E-selectin, 
while other vascular addressins CCR4 and CCR6 contribute to selective 
trafficking from circulation into the skin. Most of the skin resident T cells have a 
Th1 effector memory phenotype, although T regulatory and central memory cells 
are also present [118]. T cells present in the skin (~80%), lacked expression of 
CCR7 and CCR4, while those that were present in the skin and expressed CCR7 
and L-selectin, but also had expression of CLA have been identified as an 
intermediate phenotype capable of accessing the skin and secondary lymphoid 
organs [118]. Most of the CLA+ T cells (~80%) are resident in the skin even in the 
absence of inflammation.  
Until recently skin resident T cells have received less attention than those T 
cells that migrate between the skin draining lymph node and the peripheral 
tissue. The preferential accumulation of CLA+ effector memory T cells in the skin 
highlights their importance in cutaneous immunosurveillance in the skin, and 
also in responding immediately to antigenic challenges. Skin resident T cells 
form a large pool of cells capable of interacting with dermal DCs for prompt 
response against microbial invasion, although it could contribute to the 
perpetuation of inflammatory diseases [119]. 
In addition to the presence of conventional T cells resident in the skin, there is 
also another group of T cells described as unconventional or innate-like T cells 
[120, 121]. Invariant NKT cells (iNKT) in the skin have been demonstrated to 
recognise bacterial glycolipids, hence play a protective role as antimicrobial 
immune sentinels [121]. In summary, T cells in the skin have a diverse 
repertoire, are Th1 biased, comprised primarily of effector memory cells, and 
subpopulations of central memory and T regulatory cells are also present. 
1.8 Cytokines in inflammation 
Cytokines are small-secreted proteins that have specific effects on interactions 
and communication of cells of the immune system. The name cytokine is a 
general name, which includes lymphokine (cytokines made by lymphocytes), 
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monokine (cytokines made by monocytes), chemokines (cytokines with 
chemotactic activities, described in section 1.9), interleukins (cytokines made 
by one leukocyte acting on other leukocytes). Cytokines carry out their action by 
acting directly on cells that secrete them (autocrine), on nearby cells 
(paracrine), or at cells at a distance from where they are released (endocrine) 
[122, 123]. Cytokines exhibit redundancy in their activity, that is one or more 
cytokines may carry out the same function, and they may act synergistically or 
antagonistically. Cytokines are mostly produced by helper T cells (Th) and 
macrophages, although other cell populations may also produce cytokines. 
During inflammation, cytokines released may play a pro or anti-inflammatory 
role in tissues [122]. 
Proinflammatory cytokines are produced by activated macrophages, and other 
immune cells such as fibroblasts and endothelial cells during tissue injury, 
infection, invasion and inflammation. This class of cytokines include IL-1β, Il-6, 
TNF-α, IL-15, and Il-18. Their classification as proinflammatory is based on the 
observation that this class of molecules are upregulated during inflammation 
[123]. For example during inflammation, IL-1 and TNF-α are upregulated, which 
are inducers of endothelial adhesion molecules, which is essential for leukocyte 
adhesion to endothelial surfaces prior to extravasation into tissues [123]. In the 
intracellular parasite Trypanosoma cruzi that is capable of replicating in a 
variety of host cells including macrophages, efficient control of T. cruzi during 
the first few weeks of infection was found to depend on macrophage activation 
by cytokines. In vitro data available suggests that treatment of macrophages 
with IFN-γ [124, 125] and/or TNF-α [126, 127], resulted in more efficient 
parasite killing. In vivo experiments further suggested that injection of IFN-γ 
into mice resulted in increased resistance [128], consistent with in vitro data. In 
malaria, studies in mice suggested that mice treated with anti-TNF-α, took 
longer to clear infection, suggesting that TNF-α was important early in infection 
[129]. Similar results have also been obtained when P. chaubaudi chaubaudi was 
injected into mice to investigate the role of IFN-γ, suggesting their importance 
in protection during infection [130]. In humans and animal trypanosomiasis, 
studies in mouse models have revealed that TNF-α was found to be crucial for 
parasite control through its trypanolytic effects on T. b. brucei and T. b. 
gambiense [131]. In T. b. rhodesiense and T. congolense, a role has been 
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proposed for TNF-α to carry out its trypanolytic activity in conjunction with IFNγ 
and NO. Studies in IFNγ knock out (KO) mice has also revealed a role for this 
cytokine in clearing infection, with these KO mice infected with T. brucei 
experiencing early mortality due to excessive parasitemia. Hence, TNF-α and 
IFNγ have been described to be involved in controlling parasitemia early in 
infection, but also involved in infection associated inflammatory complications 
[132].  
1.9 Chemokines and their receptors 
Chemokines, also known as chemotactic cytokines, are a group of over 50 
proteins with a molecular weight of about 8-10 kDa. Chemokines play a principal 
role in the recruitment and guidance of cells in development, homeostasis and 
inflammation. This group of proteins have about 20-70% homology at the amino 
acid sequence level, and are subdivided into four families based on the relative 
position of their cysteine residues. The cysteine residues in chemokines are 
important for maintaining their structural integrity.  
1.9.1  Nomenclature and classification of chemokines 
The chemokine sequences are characterized by having four conserved cysteine 
residues, and are classified based on the position of the first two cysteines. They 
are divided into four subfamilies; α (CXC), β (CC), γ (C), CX3C (δ). Chemokines 
bind to their receptors, which are G-coupled seven transmembrane domain 
receptors. Chemokine receptors have been named based on the chemokine class 
i.e. CXCR1, 2, 3, 4, and 5 (bind CXC chemokines); CCR1-9 (bind CC chemokines), 
XCR1 (binds C chemokine), and CX3CR1 (binds CX3C chemokine, fractalkine) 
[133, 134]. When chemokines are secreted, cells respond in a rapid and transient 
manner. Some chemokines do not partake in the recruitment of cells, for 
example the promiscuous chemokine receptor D6 and the duffy antigen-related 
chemokine receptor (DARC) but rather scavenge chemokines [135]. 
Chapter 1  43 
 
1.9.2  Homeostatic and Inflammatory chemokines 
 Chemokines, in addition to being classified based on structure, can also be 
classified based on function. A group of chemokines known as inflammatory 
chemokines control the recruitment of effector leucocytes in infection, 
inflammation, tissue injury, and tumours. Inflammatory chemokines have a 
broad spectrum of activity and play a significant role in the innate immune 
system, through attraction of neutrophils, monocytes, macrophages, dendritic 
cells and natural killer cells [136]. A second group of chemokines that has been 
described are the homeostatic chemokines that help navigate leukocytes during 
hematopoiesis in the bone marrow, thymus, and during the initiation of an 
adaptive immune responses in secondary lymphoid organs such as the spleen and 
lymph nodes. Homeostatic chemokines are also involved in immune surveillance 
functions of healthy peripheral tissues [135].  
1.9.2.1  Homeostatic chemokines 
Homeostatic chemokines also known as constitutively expressed chemokines are 
also important for migration of antigen presenting cells (APCs) and lymphocytes 
to lymphoid organs, and can also be expressed under inflammatory conditions 
[137, 138]. For example, CCL17 and 27 are involved in skin homing, while CCL21 
which is expressed on the luminal side of high endothelial venules is involved in 
homing of T and B cells to the lymphoid organs. However, under inflammatory 
stimuli, CCL21 could be induced in the afferent lymphatics, hence boosting the 
numbers of DCs that arrive at the lymph node [139]. Homeostatic chemokines 
are important for regulation of basal leukocyte trafficking and regulate immune 
surveillance processes in the tissues such as homing of DC to the draining lymph 
node (dLN) [140-142]. In sum, homeostatic chemokines have a more 
monogamous receptor usage compared to inflammatory chemokines. 
1.9.2.2  Inflammatory chemokines in innate immunity 
Initiation of the innate immune system through the recognition of PAMPS or 
DAMPS by PRR results in production of inflammatory cytokines such as IL-1, 
interferons, IL-4, 5, 6, 13, 17 and chemokines. [143, 144]. Phagocytic cells such 
as neutrophils, monocyte/macrophages are recruited in the inflammatory 
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response through expression of chemokine receptors and respond to different 
chemoattractants (Figure 1.8). 
 
 
Figure 1-8 The role of chemokines in innate cell recruitment in the skin 
Chemokines orchestrate events that impact on cellular recruitment during the early phase of a 
microbial challenge or trauma to the skin. This results in the release of inflammatory cytokines or 
chemokines, which activates the endothelium, followed by the recruitment and activation of 
leukocytes critical for the innate immune responses such as neutrophils, monocytes, DCs, and NK 
cells. Some chemokines may also act directly on the pathogens as antimicrobial peptides e.g. 
CCL20, CXCL9, 11. Figure adapted from [144]. 
 
Neutrophils, which are the cells that arrive first at inflammation sites, respond 
to CXC ligands such as CXCL1, 5 and 8 via their expression of CXCR1 and CXCR2 
receptors. On the other hand, monocytes and other mononuclear cells express 
CCR1, CCR2, and CCR5 receptors and respond to their chemokine ligands CCL2, 3 
and 5 and arrive at sites of inflammation at later time points [137]. 
1.10  Cell recruitment during inflammation 
During tissue damage and inflammation, leukocytes are recruited from the 
blood, by mechanisms that involve selective leukocyte endothelial cell 
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recognition. This process is highly specific for the inflammatory stimuli, the 
stage of the inflammatory response and the tissue site involved. Examples 
include the specific recruitment of neutrophils during acute inflammation, and 
tissue selective interaction of lymphocyte subsets with high endothelial venules. 
Hence, activation of the endothelium plays an important role during leukocyte 
recruitment. This process has been demonstrated to occur both in vivo and in 
vitro [145], and in mouse models leukocyte accumulation is influenced by the 
endothelial stimulus [146]. Activation of the endothelium occurs through signals, 
delivered by receptors that recognize inflammatory, traumatic stimuli or 
oxidants. The vascular endothelium is diversified at different levels, consisting 
of large vessels, which differ from small vessels and capillaries, while the 
venular endothelium also differs from the arterial endothelium [147]. Leukocytes 
preferentially migrate through postcapillary venules due to lower shear stress, 
which is more favourable for leukocyte attachment than in capillaries or 
arterioles. Also the abundance of selectins such as P –selectin, induction of E-
selectin and vascular adhesion molecule-1 (VCAM-1), which are much more 
expressed during inflammation on postcapillary venules makes them preferred 
by leukocytes [148, 149]. The display of these selectins following activation of 
the endothelium mediates the other stages of leukocyte extravasation; capture, 
tethering and rolling.  
A summary of some of the leukocyte adhesion receptors and the ligands they 
bind to on activated endothelial cells are provided in table 1.2. The subsequent 
sections then give a description of the cells that are recruited in inflammation 
and their functions. 
Table 1-2 Leukocyte adhesion receptors and their ligands on activated 
endothelial cells 
Leukocyte adhesion 
receptor 
Endothelial ligand Function(s) 
PSGL-1 P-selectin Capture, Rolling 
L-selectin P-selectin, E-selectin,  Capture 
Chapter 1  46 
 
α4β7 (unactivated) MadCAM-1 Rolling 
α4β7 (activated) VCAM-1/MAdCAM-1 Firm adhesion 
α4β1 (unactivated) VCAM-1 Rolling 
PECAM-1 PECAM-1 Emigration 
CD11a/CD18 (LFA-1) ICAM-1, ICAM-2 Firm adhesion, 
Emigration 
 
1.10.1 Neutrophils 
Neutrophils are the first line of defense and play a key role in the elimination of 
pathogens [150]. In addition to their microbicidal role, neutrophils are also 
crucial in wound healing and tissue repair [151, 152]. As a key component of the 
inflammatory response, neutrophils play an important role in recruitment, 
activation and interaction with APCs. Neutrophils also release chemotactic 
signals to attract monocytes and DCs, and influence the differentiation of 
macrophages either to a pro or anti-inflammatory state. Neutrophils follow 
chemotactic gradients produced by host (IL-8) and pathogens (e.g. fMLP; N-
Formylmethionyl leucyl-phenylalanine) in order to reach sites of infection [151]. 
Neutrophils have also been implicated in immune regulation, as a source of 
cytokines, such as IL-12, IL-10, IFNg and TNF-α, suggesting that they help bridge 
the innate and adaptive immune system [153]. Neutrophils are known to express 
PRRs e.g. FPR1 (Formyl peptide receptor 1), which is a seven transmembrane G-
coupled receptor that helps in neutrophil chemotaxis to sites of tissue damage 
and recognition of microbial moieties. Other PRRs expressed by neutrophils 
include all members of the TLR family, excluding TLR3, C-type lectin receptors 
dectin 1 (CLEC7A), CLEC2 (absent in mouse neutrophils), and cytoplasmic sensors 
of ribonucleic acids (RIG-1 and MDA5). These PRRs expressed by neutrophils are 
essential together with other lymphoid cell-derived signals to sense tissue 
damage and pathogens, which then activates the effector functions of 
neutrophils.  
Chapter 1  47 
 
Neutrophils carry out their killing functions either through intra or extracellular 
means. When neutrophils encounter pathogens, they can phagocytose them, and 
the pathogens become encapsulated in the phagosomes. Following 
encapsulation, the pathogens are then killed using reactive oxygen species or 
antibacterial proteins such as cathepsins, defensins, lactoferrin and lysozyme 
[154, 155]. These antibacterial proteins are released from neutrophil granules 
either into phagosomes or the extracellular milieu. Hence, they can act both on 
intracellular or extracellular pathogens. In some infections, neutrophils can 
become highly activated and eliminate extracellular microorganisms through the 
formation of neutrophil extracellular traps (NETs) [156]. NETs are composed of 
core DNA elements bound to histones, proteins and enzymes such as 
myeloperoxidase and neutrophil elastase. NETs can trap pathogens, preventing 
their spread and subsequently exact a direct killing effect through antimicrobial 
histones and proteases [157]. NETs have been described to be formed in 
Staphylococcus aureus [158], Candida albicans [159], and Leishmania infections 
[160]. 
In addition to their innate immune functions, individuals with insufficient 
neutrophils (neutropenia) have been shown to have wounds that heal poorly or 
with lethal outcomes [161], and total absence of neutrophils could lead to 
death. Inherited neutrophil defects such as severe congenital neutropenia (SCN), 
chronic granulomatous disease (CGD) and myeloperoxidase (MPO) deficiency 
exemplify the importance of neutrophils in various infectious and non-infectious 
conditions. For example in CGD caused by mutations in the genes encoding the 
subunits of NADPH oxidase complex, has an incidence around 1/200, 000 [162]. 
These individuals have phagocytes that are fail to kill ingested pathogens, due to 
inability to effectively produce superoxide, leading to severe infections mainly 
by Aspergillus and Staphylococcus species [162, 163]. CGD patients also exhibit a 
state of chronic immune activation, making them more prone to autoimmune 
disorders such as rheumatoid arthritis, and systemic lupus erythematous [163, 
164].  
In intracellular parasitic infections such as Leishmania major in mouse models, 
neutrophils recruited to sites of infection have been described to enhance 
pathogenesis. Depletion of neutrophils in vivo using a monoclonal antibody (anti-
Ly6G), appeared to decrease the parasitemia in mouse models of Leishmania 
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major infections [165, 166]. This suggested that despite the fact that the 
primary role of neutrophils was killing foreign substances, and they were the 
first cells to be recruited during tissue injury, inflammation, or infection, some 
parasites have evolved mechanisms to by-pass neutrophil killing functions and 
use them to thrive in its host. 
1.10.2  Monocytes 
Monocytes are mononuclear leukocytes with a bilobed nucleus, which are bone 
marrow derived and along with other cells such as neutrophils, eosinophils, mast 
cells and natural killer cells, are part of the innate immune system. In addition 
to the bone marrow, the spleen also serves as an important reservoir of 
monocytes, and in myocardial infarctions, the spleen and not the bone marrow is 
the source of monocytes [167-170]. Monocytes can also migrate to other tissues 
of the body such as the lungs, spleen, lymph nodes, liver, subcutaneous tissue 
and peritoneal cavity [168, 171]. Recruited, inflammatory monocytes may also 
support dendritic cells in the transport of antigens to the draining lymph nodes 
[172]. In mice, monocytes express the lineage markers CD11b, F4/80 and in 
humans CD11b, CD14, and CD11c [167]. Monocytes express MHC class I and II and 
can also present antigen to T cells in infection [170]. The plasticity of monocytes 
has been shown by their ability to produce different subsets of inflammatory DCs 
such as Tumour necrosis factor and Inducible nitric oxide synthase (iNOS)-
Producing (Tip)-DCs, and Ly6Chi DCs [171]. Two monocyte subsets have been 
characterized in mice using adoptive transfer technology, based on their 
expression of the lineage marker GR1 (Ly6C and Ly6G), CCR2 and the fractalkine 
receptor (CX3CR1). These two classes of monocytes in mice were similar to those 
identified in human blood, and are summarised in table 1.3 with the phenotypic 
markers they express. Inflammatory monocytes in mice, which home to sites to 
injury, have the classical expression Ly6Chi CCR2+ CX3CR1lo, which is similar to 
CD14+ monocytes in humans.  
Table 1-3 Monocyte subsets in Mouse and human blood 
 Mouse monocyte subsets Human monocyte 
subsets 
Subsets   
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Inflammatory 
Resident/ patrolling 
CD11b+Ly6Chi CCR2+ 
CX3CR1- 
CD11b+Ly6Clo CCR2- 
CX3CR1+ 
CD14++ CD16- 
CD14dim CD16+ 
Percentage of cells 
Inflammatory 
monocytes 
Resident monocytes 
 
50% 
 
50% 
 
90% 
 
10% 
Morphology and size 
Inflammatory 
monocytes 
Resident monocytes 
 
Granular, 10-14 µm 
 
Less granular, 8-12 µm 
 
Granular, ~18 µm 
 
Less granular,~14µm 
 
Non-classical or resident murine monocytes have the expression Ly6Clo CCR2- 
CX3CR1hi, similar to CD14dim CD16+ human monocytes. Patrolling or non-classical 
monocytes are involved in tissue surveillance roles in the absence of 
inflammation, and they detect infection or injury [173]. In protozoan infections 
such as orally transmitted toxoplasmosis, rapid influx of inflammatory monocytes 
to the gastrointestinal tract acts as the first line of defence in infection (see 
table 1.4 for summary). Mice that were CCR2- deficient were more susceptible to 
infection by T. gondii, which further supports the evidence that CCR2 was 
crucial for emigration of inflammatory monocytes to sites of infection [174]. In 
African trypanosomiasis, inflammatory monocytes appeared to have a pathogenic 
role. Inflammatory monocytes were observed to accumulate in the liver, spleen, 
and lymph nodes of infected mice [175].  
Table 1-4 The role of monocytes during protozoan infections 
Protozoan 
parasite 
Localisation 
in host cells 
Disease caused Site of 
infection 
Role of 
monocytes 
T. Extracellula African Liver Tip-DCs 
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brucei[176] r trypanosomiasis 
P. 
chaubaudi 
[177] 
Intracellular Malaria  Spleen TNF and iNOS 
producing 
monocytes 
L. major[178] Intracellular Cutaneous 
leishmaniasis 
Skin Effector 
monocytes/ 
iNOS 
producing 
DCs 
Toxoplasma 
gondii[179] 
Intracellular Oral 
toxoplasmosis 
Peritoneum Inflammatory 
macrophages 
and DCs, TNF 
and iNOS 
producing 
monocytes 
 Adapted from [175-180] 
During trypanosomiasis, the presence of Tip DCs in the liver caused necrosis and 
apoptosis, which resulted in the exacerbation of disease and reduced survival of 
infected mice. In the absence of CCR2, there was reduced pathology in infected 
mice, due to lower numbers of Tip DCs, which was related to an increase in the 
number of inflammatory monocytes in the bone marrow and decrease in the 
liver [181]. The role of inflammatory monocytes in other parasitic infections 
such as, Plasmodium chaubaudi, visceral, and cutaneous leishmaniasis have also 
been studied in vivo using mice models [177, 182]. 
1.11  Host parasite interactions in the skin  
Studies with a number of pathogen models have identified that pathogenesis is 
critically influenced by the earliest interactions between host and pathogen. 
This has been particularly true in experimental Plasmodium infections, where 
analysis of the initiation of infection and the associated host response has 
provided novel and fundamental biological insights challenging existing dogma. 
Imaging mosquito delivered, Plasmodium berghei infections in mice has revealed 
that sporozoites are initially deposited in skin and subsequently find and invade 
blood vessels through their ‘gliding’ behaviour [183]. These studies also reveal 
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the surprising quantity of sporozoites that progress to the lymphatic system 
where they can undergo extra-hepatic transformation to merozoites [184], and 
have identified the skin draining lymph node as the site where the host’s 
adaptive immune response is initiated [185].  
1.11.1  Current knowledge about events in the skin following 
 African trypanosome deposition 
In African trypanosomes, very little is known about the key events at the bite 
site following the bite of an infected tsetse fly. Most research on trypanosome 
infections have used intravenous or intraperitoneal injections of the bloodstream 
stage of the parasite into mice, which is not the route of infection in nature, and 
also not the appropriate infective stage of the parasite. These studies have also 
focussed on what happens when the parasite is in the blood, hence information 
that we have in abundance about the immune response is mostly on adaptive 
immunity.  
 Following the bite of an infected tsetse fly, metacyclic stage trypanosomes are 
released into the dermis of the skin, along with the saliva of the tsetse fly that 
contains immunomodulatory factors and anticoagulants, which are important in 
tsetse feeding and infection of its host [186, 187]. Data suggests that the tsetse 
saliva biases the host immune system towards a Th2 associated cytokine 
response (IL-4, and IL-10), inhibiting proinflammatory cytokines (TNF-α, IL-6, IL-
12) that have trypanocidal effects in vivo [188]. While the infective metacyclic 
trypanosomes are in the dermis of the skin, they proliferate and become 
established. A local skin reaction about 2-3 mm in diameter, described as a 
chancre develops within 5-7 days following infected tsetse bites in humans and 
ruminants. The chancre also serves as a focal point for interactions between 
trypanosomes and host immune cells, as evidenced by the presence of 
neutrophils, macrophages, lymphocytes and trypanosomes in the chancre of 
infected mammals [13].  
Previous reports on the cellular infiltrate in the skin following infected tsetse 
bite have observed the cellular events in the skin after the onset of the chancre 
(from day 5). In experiments that have been carried out in large animals such as 
Chapter 1  52 
 
goats, T. congolense was still present in the dermis of the skin at day 8 post 
tsetse bite, with parasites occasionally found between hair follicles [189]. During 
day 8 post infected tsetse bite, histological characterisation reveals the cellular 
infiltrate in the skin to comprise of small lymphocytes, numerous neutrophils, 
but few macrophages and very few trypanosomes. At day 11 post infection, 
aspirates taken reveal the presence of predominantly large lymphocytes, 
lymphoblasts, numerous macrophages, trypanosomes and few neutrophils [11, 
190]. To date, the information we have on the events in the skin following 
interactions of the parasite with the host mostly relates to events that coincide 
with the appearance of the parasites in the blood. Therefore information is 
lacking on the very initial interactions of parasites, and host cells at the bite 
site. 
1.11.2  How do African trypanosomes get into the 
 bloodstream? 
Following the deposition of the metacyclic trypanosomes in the skin and 
proliferation in the skin, trypanosomes begin to appear in large numbers in the 
lymph, 2-3 days before detectable parasitemia. Cannulation of afferent and 
efferent lymphatics in large animals such as goats has been able to establish the 
importance of the lymphatics in parasite dissemination into the blood stream 
from the site of inoculation. These observations of parasites in the lymph before 
detection in the blood have been demonstrated using T. congolense and T. b. 
brucei infected tsetse flies [11, 189, 191, 192]. Hence, the lymphatic system has 
been postulated to be a principal route of parasite entry into the bloodstream 
when establishing infections with cyclically transmitted parasites. 
1.12  Lymphatic system 
The lymphatic system is a uni-directional system of conduits that helps in 
draining excess fluids in the interstitial, and also serves immunological 
functions. The draining function of the lymphatic system helps to regulate tissue 
fluid balance, which then complements the functions of the blood vascular 
system. Although there is an interdependence of the blood and lymphatic 
vasculatures for maintenance of tissue homeostasis, they are structurally and 
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functionally distinct entities. Lymphatic vessels help direct leukocytes and 
antigens in tissues to the lymph nodes, which is critical for the initiation of an 
immune response [193]. However, we now know that the diverse structure of 
lymphatic capillaries may explain some of the differences observed between the 
migratory patterns of cells. 
1.12.1  How the structure of lymphatic capillaries relates to 
 its function 
Lymphatic capillaries are blind ended vessels, bounded by an endothelial cell 
layer and optimised for uptake of fluid, macromolecules, and cells [194]. 
Compared with blood capillaries, lymphatic capillaries have a more irregular 
morphology with a very narrow endothelium (Figure 1.9), and an incomplete 
basement membrane with sparsely populated pericytes. A distinguishing trait of 
lymphatic capillaries is their overlapping junctions or button-like junctions, 
formed by the superimposition of adjacent lymphatic endothelial cells.  
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Figure 1-9 Comparison of the structure and function of lymphatic vessels 
Comparison of the structure of the blood vessel to the lymphatic vessel reveals that the basement 
membrane (BM) of lymphatics is incomplete with few pericytes (P). APC, antigen presenting cell; T, 
T cell; D, dendritic cell, AF; anchoring filaments. Adapted from [194]. 
 
These button-like junctions can open due to increases in interstitial fluid, 
thereby permitting the passage of fluid and particles into the vessels. Once fluid 
enters the vessels, the pressure in the vessel decreases, the junctions close and 
this prevents a back flow of the fluid into the interstitium [195, 196]. 
1.12.2  Leukocyte migration through lymphatic vessels 
The cells that migrate through the lymphatics to the lymph node include T cells 
and myeloid cells [197-199], the majority of which are DCs. Due to their 
importance in the initiation of adaptive immunity, DC trafficking towards the 
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lymph node has been extensively studied [200]. Under steady state, epidermal 
resident CD206+ Langerhans cells, as well as dermal resident DCs continuously 
migrate to the LN at modest intensities.  
During inflammation, migration of DCs to lymphatics is significantly increased in 
response to chemotactic signals induced by the products of inflammation [201]. 
The migration of DCs to the lymphatic vessels is largely driven by CCR7, and the 
expression of its ligand, CCL21 on lymphatic vessels is strongly upregulated in 
the presence of pro-inflammatory cytokines such as TNF-α [202]. There is also 
experimental evidence to suggest that as lymph flow increases during 
inflammation, there is also a concomitant increase in CCL21 expression [202]. 
The ingress of DCs into the lymphatic vessels occurs through the basement 
membrane of initial lymphatics in close proximity to CCL21 depots. Inside the 
lymphatics, DCs crawl directionally on the luminal side of the capillary [203]. 
These data provide a strong correlation with DC migration along areas of dense 
CCL21 depots on lymphatic vessels [204]. 
1.13 Host- trypanosome interactions 
African trypanosomes spend a large part of their life in the mammalian 
bloodstream [205], being extracellular parasites and interact with the host 
immune system. In HAT caused by T. b. rhodesiense and T. b. gambiense, the 
parasites are able to evade lysis by human serum apolipoprotein (APOL1), which 
is crucial in innate immunity against African trypanosomes. APOL1 resides in two 
fractions, trypanolytic factors 1 (TLF-1) and 2 (TLF-2) [206]. APOL1 kills 
trypanosomes after insertion into lysosomal membrane. TLF-1 binds to the 
parasite through interaction with the haptoglobin-related protein (HPR) and the 
haptoglobin haemoglobin receptor (HpHbR) in the flagellar pocket of the 
parasite, while TLF-2 interacts with HpHbR through an alternative route [207, 
208]. T. b. rhodesiense evades killing in human serum through interaction of 
serum resistance associated gene (SRA) with APOL1 in the lysosome preventing 
lysis [60]. While in T. b. gambiense, resistance to TLFs is via a hydrophobic β 
sheet of the T. b. gambiense specific glycoprotein (TgsGP), which prevents 
APOL1 toxicity and induces the stiffening of the membranes [209]. In AAT caused 
by T. b. brucei and most trypanosomes, these paraistes are susceptible to serum 
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killing by APOL1. The section below highlights some of the mechanisms 
employed by T. brucei in evading the immune response.  
1.13.1 Variant Surface Glycoprotein Coat 
As a result of being exposed, a trypanosome’s cell surface serves as the primary 
target against immune responses from the host. African trypanosomes are 
completely covered with a monomolecular layer of a single species of a 
glycoprotein coat [210]. Trypanosomes are able to persist in the bloodstream of 
mammals by replacing this monolayer of VSG coat that shields it from the 
immune effectors of the host [211, 212]. The switching of their VSG coat is a 
mechanism that has been employed in order to thrive for long-lasting periods, 
enhancing transmission to the tsetse fly, although also resulting in pathological 
manifestations. Trypanosomes undergo VSG switching, up to 10-3 switches per 
cell division, allowing it to produce unique VSGs that the immune system cannot 
recognise when antibodies against the currently expressed VSGs are produced 
[213]. The high switch rate of the VSG coat has also made it difficult to develop 
effective vaccines against human and African animal trypanosomiasis. 
1.13.2  Immune suppression in African trypanosomes 
Immunosuppression has been observed in humans and mammals, although most 
of our understanding of immunosuppression comes from experimental data in 
mice. African trypanosomiasis, whether in humans or experimental inoculations 
in animals, presents with numerous alterations in the normal functioning of T 
and B cells. Immune suppression in African trypanosome infected livestock 
results in a reduced ability to mount an effective humoral response against non-
trypanosome antigens, depressed T cell proliferation, reduced cytokine 
production, most notably IL-2 and phenotypic changes to monocyte effector 
functions [214, 215]. Also, immune suppression in African trypanosome infected 
mice is also responsible for the inefficacy of other administered vaccines such as 
diphtheria, tetanus and pertussis. Failure to control parasitemia levels and 
ineffective vaccination regimes against other infections are hallmarks of immune 
suppression in African animal trypanosomiasis [216].  
Chapter 1  57 
 
1.14  African Trypanosomes are highly motile 
African trypanosomes derived the name of their genus Trypanosoma from two 
Greek words Trypanon and soma, meaning auger and body, respectively. The 
name was based on the observation of their corkscrew motion in mammalian 
blood. Trypanosomes have an undulating membrane, which is the flagellum and 
their motility has been the subject of interest over the years [19, 217-219]. The 
flagellum of T. brucei has the canonical ‘9+2’ axoneme, which serves as the 
platform for the assembly of dynein motors that regulate the flagellar beat 
[220]. Motility of African trypanosomes is driven by the flagellar wave that is 
initiated at the tip of the flagella towards the base of the flagellum [221]. The 
importance of motility for parasite transmission has also been recently 
demonstrated in T. brucei, where the propulsive motility of the parasite is 
essential for infection of the tsetse fly [22]. Owing to the fact that the flagellum 
is an essential organelle, which has also been directly linked to parasite 
pathogenesis, chemotherapeutic approaches have also begun to investigate the 
possibility of the flagellum as a drug target [220, 222-224]. Trypanosomes move 
through the propagation of the flagellar wave along the cell, allowing the cell to 
move in the surrounding fluid through the beat propagation of the flagellum in 
the opposite direction. Thus, three classic descriptions of trypanosome motility 
have been described, which presumably confer advantages to the parasite in 
particular scenarios. However the exact mechanisms guiding motility has yet to 
be understood. In the first model, using state of the art high-speed microscopy 
imaging, analyses of the movement of bloodstream form T. brucei parasites 
were carried out in liquid cultures, and by simulating the bloodstream 
environment. In their experiments, it was shown that the tip of the flagellum 
moves faster than the posterior of the cell [225, 226]. In the second model, 
mathematical models were used to propose a plane rotational model of motility 
in African trypanosomes. This was based on the observation that the cell body 
rotates as it moves forward, with the rotation of the cell body occurring 
uniformly in an anticlockwise direction. The plane rotational model suggests that 
the flagellum beats in a planar fashion, and the beats become helical as it moves 
forward due to physical constraints from the attached cell body [227]. This 
proposition of a planar model contrasts previous reports of a helical model for T. 
brucei and other flagellated protists [226]. The third model for trypanosome 
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motility was described as a bihelical model. In this model, the flagellar 
waveform alternates between left-handed and right-handed helical waves, 
which cause the trypanosome body to alternate in anti-clockwise, and clockwise 
directions [226]. Bihelical motility has also been observed in the bacterium 
Spiroplasma melliferum and Plasmodium berghei [228, 229].  
1.14.1 The role of motility in African Trypanosomes 
 pathogenesis 
In the tsetse fly, trypanosomes have to traverse between different 
environments, e.g. from the midgut to the salivary gland [18]. In order to arrive 
at the salivary gland from the alimentary canal, parasites travel a distance that 
is estimated to equal the entire body length of the tsetse fly, and must 
penetrate the proventriculus and peritrophic membranes. Available data 
suggests that some of the crossing events in the tsetse fly require active parasite 
motility [230]. In the mammalian host, following the deposition of motile 
metacyclic parasites into the skin, the parasites need to navigate their way 
through the crowded environment of the skin [226, 231]. The role of the 
flagellum very early on is yet unclear, but might be crucial for entry into the 
lymphatic vessels. Despite the potential role of the flagellum in pathogenesis, 
only one study to date has directly investigated the contribution of motility 
mutants in establishing infection [232].  
One major challenge in studying the role of motility mutants in trypanosome 
infections has been the inability to generate viable mutants. However, using loss 
of function point mutants, instead of depleting proteins through RNAi, a mutant 
with a defect in motility was generated. This technique allowed the generation 
of bloodstream form mutants that had its outer dynein structure intact and 
viable. Using this mutant, it was demonstrated that mutants that had their 
motility fundamentally altered, showed no difference in patency, gross 
pathology, and lethality between motility mutants and wild type blood stream 
form T. b. brucei 427 strain. However, a major limitation of this study was that 
infection was carried out using the intraperitoneal route of injection; secondly 
the mutants still retained some residual motility, which may be sufficient for the 
parasites to establish infection [232]. Despite these findings, trypanosome 
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motility is generally agreed to be essential for penetration of the blood brain 
barrier, and invasion of the central nervous system (CNS) [233-237]. Also, 
parasite uptake by the tsetse fly may require motility, in addition to migration 
through the tsetse fly in order to establish mature infections in the salivary 
gland [22, 238, 239].  
In addition, through the flagellar pocket and endosomal system, T. brucei has 
optimised endocytosis and recycling of VSGs as an adaptation to its unique 
lifestyle. During infection in the blood stream, anti-VSG antibodies bind the 
surface of the parasite, which can effectively kill the parasite via complement-
mediated lysis. Parasites can use the hydrodynamic forces generated by the 
flagella to sweep anti-VSG antibodies to the posterior of the cell into the 
flagellar pocket where they are endocytosed [240]. Anti-VSG complexes are then 
degraded and intact VSGs recycled back to the surface via RAB11b recycling 
endosomes [241, 242]. In bloodstream form T. brucei, the parasites are able to 
turn over back to the parasite’s surface the entire VSG pool in approximately 12. 
5 mins [243]. 
1.14.2 Flagellar pocket and host-parasite interactions 
The flagellar pocket is the site of exchange of macromolecules between the 
parasite and its environment. For example, the parasite takes up host transferrin 
as a source of iron, but can also take up trypanolytic factors that are present in 
the host serum [207, 244, 245]. The flagellum also releases proteins that 
modulate virulence in the mammalian host. For example, 
glycophosphatidylinositol-phospholipase C (GPI-PLC) is required for virulence in 
pleomorphic trypanosomes (parasites that can differentiate from the 
bloodstream form and complete its life cycle in the tsetse fly). The role of GPI-
PLC in virulence was demonstrated in mice infected with parasites lacking GPI-
PLC, which survived longer and gave lower parasitemia [246]. GPI-PLC also 
facilitates differentiation of parasites from blood stream form to the tsetse 
procyclic stage [247]. Other flagellar proteins, which also serve as virulence 
factors, such as calflagins, metacaspase 4, and the expression site associated 
gene 4 (ESAG4) have further shed light on flagellar and host-parasite interactions 
[248-250]. 
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1.15  Imaging host-parasite interactions in vivo 
Advances in molecular biology through the use of fluorescent protein reporter 
genes coupled with advances in microscopy, have facilitated further 
understanding of parasite behaviour in vivo and in vitro. The availability of 
transgenic mice expressing cell specific fluorescent reporters have also helped in 
understanding the interaction of parasites with host cells in vivo [251]. These 
approaches are important in identifying new strategies to solve the disease 
burden posed by protozoan parasites such as Leishmania spp., Plasmodium spp., 
and Trypanosoma spp. Conventional approaches for immunological studies, such 
as immunohistochemistry and flow cytometry, only give a snap shot of the 
events that occur and are unable to give exact spatiotemporal information. 
Microscopy provides tools to enable dynamic analysis of the cellular events that 
take place; in the case of a vector bite, specifically providing the ability to 
analyse aspects such as parasite entry into the skin and egress from the bite 
site, and similarly, location and dynamics of interactions with host immune cell 
populations.  
1.15.1 Bioluminescence imaging 
Bioluminescent imaging has been applied in testing drug efficacy and drug 
discovery for African trypanosomiasis and Leishmaniasis. Introducing firefly 
luciferase into protozoan parasites has made it possible to assess their 
localisation in their hosts, their proliferation over time and clearance when 
drugs are administered. The reaction of the luciferase enzyme with its substrate 
luciferin culminates in the release of photons, which is then detected by a high 
sensitivity cooled charge-coupled device (CCCD) camera. This approach is 
sensitive enough to allow whole body imaging of mice and localisation of the 
signal in specific tissues and organs. For example, testing efficacy of drugs in 
models of Stage 2 African trypanosomiasis takes approximately 180 days, but 
with in vivo bioluminescent imaging, the time can be reduced to 30 days [252]. 
In addition, novel information has been gained through these approaches on the 
dissemination of African trypanosomes and the location and dynamics of 
recrudescence after incomplete drug therapy [237, 252, 253]. In vivo 
fluorescence imaging has also been applied in similar ways to perform drug 
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screening, using GFP expressing L. major or L. donovani, and EGFP expressing L. 
amazonensis [254, 255]. Bioluminescent imaging has also been applied in 
understanding the development of Leishmania through its sand fly host using 
RFP-expressing L. major parasites [256, 257]. The introduction of red-shifted 
luciferase and fluorescent proteins has also helped in reducing loss of signal due 
to tissue absorption [258, 259]. The inability to image deeper into tissues with 
this technique, and the lack of resolution to visualise interactions at the cellular 
level, means that to address both of these issues necessitates the use of an 
optimised fluorescent microscopy approach such as multiphoton laser scanning 
microscopy (MPLSM).  
1.15.2 Fluorescence microscopy 
In order to overcome the challenges posed using bioluminescent approaches in 
imaging, fluorescence microscopy has provided a viable alternative. In contrast 
to bioluminescence approaches that require the availability of a substrate to 
execute the enzymatic reaction resulting in photon emission, fluorescent 
microscopy uses a single wavelength to excite a fluorescent molecule, and then 
as the excited electrons decay back to their ground state, detects emitted 
photons at a specific wavelength.  
1.15.3 Epi-fluorescent microscopy 
Epifluorescence microscopy allows the visualisation of cells or parasites using a 
broad excitation and detection system to capture fluorescence emission from 
samples. However this approach also collects out of focus light emitted above 
and below the focal plane, making quantitative cell tracking impossible. While 
software deconvolution does allow some correction for out of focus light this is 
very difficult to apply in complex 3- dimensional (D) specimens and is prone to 
artefact generation [260, 261]. This limits its use for investigating in vivo 
parasite host interactions for immunological studies. 
1.15.4 Confocal microscopy 
Confocal microscopy allows the visualisation of interactions both in 3 and 4 
dimensions, that is, in space and time. This approach relies on high power (laser) 
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illumination of the specimen, and uses a pinhole to reject out of focus light 
emitted from the sample [262]. While laser scanning microscopy and 
subsequently high-speed spinning disk confocal microscopy have been used for in 
vivo imaging of host/parasite interactions [183], the high energy excitation light 
required due to the low efficiency recovery of light due to the pinhole causes 
cell damage and is limited in depth to 50 microns below the tissue surface [262].  
1.15.5 Multiphoton laser scanning microscopy (MPLSM)  
The development of MPLSM has been an important tool, which allows long term 
in vivo imaging, at deeper penetration depths, without the issue of phototoxicity 
associated with other single photon imaging approaches. MPLSM employs the 
physical property of a fluorochrome to be excited by near simultaneous 
absorption of two lower energy, longer wavelength photons [263]. The only 
place that the sample photon density is sufficient to achieve this process is at 
the focal point of the objective lens. This allows the MPLSM to recover all of the 
emitted light from the sample, with the knowledge that it was emitted from a 
single point in space, negating the requirement for a pinhole. Furthermore, 
longer wavelength, infra red light penetrates tissue more effectively allowing 
imaging depths of hundreds of microns into tissue, with minimal tissue damage 
[264]. As with other in vivo microscopy approaches, MPLSM also requires surgical 
exposure of the tissue of interest. MPLSM has helped in understanding of the 
anatomy and architecture of the immune system, and the role that the immune 
architecture may play in infectious diseases. MPLSM has been applied in 
visualising cellular interactions in Leishmania, Plasmodium, as well as viral and 
bacterial infections. Conventional techniques such as flow cytometry and 
immunohistochemistry have revealed the identity of inflammatory cells, but 
MPLSM has been able to reveal the spatial and temporal nature of single cells in 
vivo. For example, MPLSM studies in Leishmania have demonstrated that 
neutrophils were rapidly recruited to the bite site, where they formed a plug to 
close the sand fly bite, irrespective of the infection status of the sand fly, [165, 
265]. With the MPLSM, the role of LCs and DDCs were investigated in a bacteria 
model of infection in the skin, using CD11cYFP transgenic mice. It was 
demonstrated that LCs were static, but carry out immunosurveillance functions 
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with their dendrites, and that DDCs migrate and respond to infection through its 
tissue surveillance activities [266].  
1.16  Project aims 
As already discussed, the very early immunological events following tsetse 
deposition of trypanosomes in skin have yet to be investigated in detail. In 
addition, the host parasite interactions that occur in the skin and cell to cell 
interactions/migration of the parasites through the lymphatic vessels as a result 
of the deposition of trypanosomes remains unknown. Understanding these 
interactions/events is important in designing new therapeutic approaches and 
also gaining an in-depth understanding of how trypanosomes disseminate into 
the bloodstream. In order to illuminate these grey areas, I hypothesised that 
‘mammals mount a potentially effective innate immune response against 
trypanosomes at the site of tsetse bite, and understanding these events would 
help promote our understanding of parasite dissemination. To test this 
hypothesis, the following aims were set out: 
1. To establish a model for infecting tsetse in vitro and demonstrate that the 
ear pinna is a valid route of infection in mouse models. Following the 
establishment of the model, I set out to quantify parasite dissemination 
from the bite site to the draining lymph node prior to systemic infection. 
The results from these experiments are discussed in chapter 3. 
2. To evaluate the inflammatory profile in the skin, characterising the 
mediators of inflammation and the cells that are recruited following 
tsetse fly bites. The results are described in chapter 4. 
3. To visualise the parasites in the skin, examine their interactions with 
lymphatic vessels to attempt to understand the mechanisms of entry into 
the lymphatics in vivo. The results are described in chapter 5. 
4. To reveal functional importance of the cells identified in aim 2 through 
depletion studies. The results are described in chapter 4. 
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2 Materials and Methods 
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2.1 Mice 
For all immunological studies, female C57Bl/6 6-10 weeks old mice were 
obtained from Harlan laboratories (Bicester, UK). For obtaining infected mouse 
blood for tsetse fly feeds, female ICR or BALB/c mice aged 6-10 weeks 
purchased from Harlan were used. Mice were given one week to acclimatise in 
either the Joint Research Facility or Central Research Facility of the University 
of Glasgow and kept in conventional cages. LysM-GFP [267] and Prox-1 mOrange 
mice [268, 269] used for intravital microscopy were bred in house. Transgenic 
mice (Prox-1 mOrange, and LysM-GFP) used in these study had constitutive 
expression of the fluorescent reporters. All procedures were carried out in 
accordance with the United Kingdom Home Office regulations under the 
authority of the appropriate project and personal licenses. This study complied 
with the Animal Research: Reporting of In vivo Experiments (ARRIVE) guidelines 
[270]   
 
2.2 Trypanosome strains and culture 
2.2.1 Trypanosome strains  
Pleomorphic T. b. brucei strains STIB247 (hereafter referred to as ‘STIB247’), 
isolated in 1971 in the Serengeti national park (Tanzania) from a hartebeest 
(Alcelaphus buselaphus), and GVR35 were both used in this study [271, 272]. 
GVR35 was isolated from a wildebeest also in Serengetei in 1966, and this 
stabilate produces chronic infection in mice, and has been used to test the 
trypanocidal effects of drugs on trypanosomes in the CNS [272, 273]. Transgenic 
247 and GVR35 expressing mCherry [234, 252] were supplied as a kind gift from 
Dr Elmarie Myburgh and Prof Jeremy Mottram, Wellcome Trust Centre for 
Molecular Parasitology (WTCMP), University of Glasgow.  
 
2.2.2 Culturing bloodstream (BSF) T. b. brucei 
In vitro culture of bloodstream form T. b. brucei 247 was carried out at 37 °C in 
a humidified 5% CO2 incubator using modified HMI-9 medium [274] (see appendix 
I for details of media and general solutions) supplemented with 20% Serum Plus 
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(Sigma-Aldrich, Dorset, UK), 20% FBS gold (PAA Laboratories, Buckinghamshire, 
UK), and T. b. brucei 247 mCherry were maintained in culture media in the 
presence of puromycin (0.15 µg/ml). Parasites were allowed to grow to a cell 
density of 1-2 x 106, at which point the parasites were sub-passaged by adding 1-
2 x 105 trypanosomes to 5 ml of fresh culture media. Blood stream form (BSF) 
cell density was determined microscopically using a bright line haemocytometer 
(Hausser Scientific, Horsham, USA). The number of parasites in a 10 µl aliquot of 
culture was determined by counting the parasites under a 1 mm square area and 
multiplying by 104 to obtain the number of cells per ml.  
 
2.2.3 Trypanosome stabilate preparation 
For long-term storage of trypanosomes, stabilates were prepared by addition of 
10% w/v sterile glycerol to culture with a cell density of approximately 2 x 106 
cells /ml. One ml aliquots were then placed in 1.2 ml cryotubes (Nunc, Paisley, 
UK), wrapped in cotton wool, frozen at -80 °C overnight and then transferred to 
liquid nitrogen. Records were entered with the appropriate stabilate numbers in 
the stabilate database. For stabilate retrieval from liquid nitrogen, frozen cells 
were defrosted at 37 °C, and placed in 5 ml modified HMI-9 culture media for 3-
4 days before continuous passage as described above.  
 
2.3 Maintenance and infection of Tsetse flies 
2.3.1 Tsetse Flies (Glossina morsitans morsitans) 
Tsetse fly- Glossina morsitans morsitans pupae were purchased from the 
Institute of Zoology, Slovak Academy of sciences, Slovakia (the contact person 
was Dr Peter Takac; Peter.Takac@savba.sk). Pupae were dispatched wrapped in 
cotton wool and placed in a sealed petri dish with holes on the lid to allow 
breathing. When pupae arrived, usually in batches of 400, approximately 50 
pupae per meshed cage were kept at 25 °C and 70% relative humidity until 
eclosion. Newly emerged tsetse flies were then fed with blood meals (uninfected 
or infected with T. b. brucei). 
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2.3.2 Membrane feeding of tsetse flies 
The membrane feeding system for tsetse flies used in this project has been 
previously described [275] (Figure 2.2). Newly hatched flies were fed within 24-
48 hrs with the first infected blood meal. Two – three ml of fresh infected blood 
or thawed cryostabilates containing a majority of short stumpy stage 
trypanosomes was mixed with 18 ml of defibrinated horse blood (TCS 
Biosciences, Buckingham, UK) to feed 6 cages containing 50 tsetse flies each. 
Trypanosome infected blood meals were repeated thrice at one-day intervals, 
using a mixture of fresh infected blood and frozen fly feeds.  
 
2.3.3 Maintenance of tsetse flies 
The tsetse fly room (Figure 2.1) was maintained at a temperature of 25 °C, 
relative humidity 65%. The lights in the room are on 12 hours on/12 hours off 
cycle. Following the T. b. brucei infected feeds, tsetse flies were then 
maintained on defibrinated sterile horse blood by feeding 3 times a week 
(Mondays, Wednesdays and Fridays). This was carried out by pouring the 
defibrinated horse blood on a pre-sterilised metal tray on a hot plate pre-heated 
to 37 °C, covering with a silicone membrane, and tsetse flies in meshed drum 
cages were then fed [276]. 
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Figure 2-1 Tsetse fly facility 
Tsetse flies are kept in meshed drum cages, and placed in trays within a confined room at 65% 
relative humidity, 25 °C. 
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Figure 2-2 Tsetse fly feeds. 
In order to feed the tsetse flies routinely post infected blood feeds, a hot plate was pre-heated to 37 
°C, trays sterilised, and 20 ml defibrinated horse blood poured on each tray, covered with silicone 
membrane and tsetse flies in drum cages placed on the trays for feeds. 
 
 
 
Figure 2-3 Tsetse fly screening for infection 
Following 27 days post-infected feeds, tsetse flies were separated into universal tubes by cooling 
down at 4 °C for 5 mins in a refrigerator, and tsetses allowed to recover in the universal tubes at 
room temperature. Tsetse flies were then fed the day after separation into universal tubes with 
defibrinated horse blood. Two days post separation, tsetses were made to probe for approximately 
10 mins on a warm glass slide, on a hot plate pre-heated to 37 °C, so that tsetse flies may extrude 
their saliva on the glass slide. Saliva containing extruded saliva was then viewed under the 
brightfield microscope. 
 
Tsetse flies were maintained for 27 days for infections to mature before 
screening commenced. Once the 27 day period of maturation of parasites was 
over, tsetse flies were fed a day before, then cooled at 4 °C for 5 mins, and 
separated into universal tubes using forceps. Twenty-four hours post separation 
into universal tubes, tsetse flies were fed again with sterile defibrinated horse 
blood, and feeding of tsetse flies was increased to daily intervals, because tsetse 
flies were inclined to feed less when in individual tubes. Additionally, leaving 
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the tsetse flies in individual tubes for at least 10 mins on the hot plate greatly 
increased the number of tsetse flies that successfully fed as opposed to leaving 
for a shorter period of 5 mins.  
 
2.3.4 Screening tsetse flies for Trypanosome infections 
On days 28-30 the tsetses were induced to probe on microscope slides warmed 
on a hot plate pre-heated to 37 °C (Figure 2.3). The saliva that was expelled 
onto the slides was checked under a brightfield microscope at x20 magnification 
for the presence of metacyclic trypanosomes. Some of the tsetse flies also 
regurgitated the proventicular (PV) stage in the saliva when screened. These PV 
trypanosomes are recognisably morphologically distinct from metacyclics, being 
significantly longer. For tsetse flies infected with mCherry-expressing 
trypanosomes, warm modified HMI9 culturing media (100 µl) was added to warm 
slides, and after tsetse flies made to probe, a coverslip was sealed over the area 
and examined under the Zeiss Axioskope using epifluorescent illumination for 
identification of fluorescent trypanosomes under the x63 oil immersion objective 
excitation/emission at 450nm and 550 nm respectively. Pictures were taken 
using a x63 oil immersion objective. 
 
2.4 Infection of mice with Trypanosomes 
2.4.1 Inoculation and monitoring mice infections 
Mice were inoculated through the intraperitoneal route using blood straw 
stabilates resuspended in 200 µl phosphate buffered saline (PBS) (Sigma-Aldrich, 
Dorset, UK). Mice infections were maintained until they reached about 108 
parasites within 10 days using the matching method [276], and then euthanised 
and blood collected by cardiac puncture method in a syringe containing 100 µl 
CBSS/heparin. Blood collected was used for either tsetse fly feeds or for 
preparation of blood straw stabilates. 
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2.4.2 Enumeration of parasite burden 
To determine parasitemia for preparation of tsetse feeds, tail tips of mice were 
pricked with blood lancets and blood was collected using a 100 µl pipette 
(Gilson, Bedfordshire, UK). A drop of blood was then transferred to glass slides 
and sealed with a cover slip to estimate parasitemia using the matching method 
[276]. The matching method approach was used during preparation of tsetse 
feeds, and blood stabilate preparation. For a more precise determination of 
parasite burden post infected tsetse exposure, ten microliter of blood was lysed 
in equal volume of 0.8% ammonium chloride in PBS, and parasites counted using 
a haemocytometer (Hausser scientific, Pensylvannia, USA) as described in 
section 2.2.2.  
 
2.4.3 Preparation of tsetse fly feeds from mice 
Female ICR or BALB/c mice were infected with the STIB247 T. b. brucei to be 
used to infect the tsetse flies approximately 10 days before the estimated hatch 
date of the tsetse flies. Mice were inoculated and parasitaemia was measured as 
described in sections 2.4.1 and 2.4.2. In the cases where the parasitemia of the 
mice became patent and there were sufficient short stumpy T. b. brucei to make 
tsetse fly feeds (approximately 70%), but the tsetse flies were yet to hatch, 
cryostabilates were made by adding 10% glycerol to the volume of infected blood 
that could be extracted from the mouse after euthanasia and cryostabilated as 
described in section 2.2.3.  
 
2.5 Nucleic acid analysis 
2.5.1 DNA extraction from trypanosome culture 
Trypanosome cultures at approximately 1 x 106 cells/ml was centrifuged at 1, 
000 x g for 10 mins, supernatant removed and discarded, and pellets 
resuspended in RLT buffer provided in the kit for extraction of genomic DNA 
from blood and tissue (Qiagen, 7104, Manchester, UK). The samples were then 
processed following the manufacturer’s instructions. 
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2.5.2 Isolation of genomic DNA from ear tissue and cervical 
lymph nodes 
Mouse ear and cervical lymph node samples draining the ear inoculation site 
were processed following Qiagen kit extraction protocol, except for a slight 
modification when extracting from ear tissue, of doubling the concentration of 
proteinase K added for overnight digestion to allow complete lysis and removal 
of any tissue clumps. All other steps were carried out according to the 
manufacturer’s instructions (Qiagen, 7104, Manchester, UK). To collect cervical 
draining lymph nodes, mice were euthanased post tsetse exposure at the 
respective time points. Mice were dissected with scissors, and forceps used to 
harvest the cervical draining lymph node and placed in PBS prior to DNA 
extraction. While mice ears were collected by euthanasing mice with a schedule 
1 procedure and ears removed with a pair of scissors. 
 
2.5.3 RNA Isolation  
Ear or cervical lymph node tissues for RNA isolation were removed at the 
appropriate time points and transferred to sterile DNase/RNase free 
microcentrifuge tubes containing 500 µl RNAlater (Qiagen, 74104, Manchester, 
UK). For ear samples, the tissue was fragmented using a sterile scalpel blade 
prior to placing in the microcentrifuge, to allow RNAlater to more efficiently 
diffuse into the tissue. Samples were then transferred into M-tubes (Miltenyi, 
Surrey, UK) containing 600 µl RLT buffer + β-mercaptoethanol. The tube was 
then spun on a gentleMACS dissociator (Miltenyi) using a 40s spin. Following the 
homogenisation of the tissue, subsequent steps were then carried out using the 
RNeasy mini kit according to the manufacturer’s instructions (Qiagen, 74104, 
Manchester, UK). RNA samples were quantified using a nanodrop and frozen at -
80 °C until needed for use. 
 
2.5.3.1  Measuring concentration of nucleic acids 
Nucleic acid (DNA or RNA) concentration was measured photospectrometrically 
using a NanoDrop 2000 spectrophotometer (ThermoScientific, Paisley, UK). 
Chapter 2  73 
 
DNA/RNA samples were quantified using 1.2 µl volume of samples, and elution 
buffer as blank control. 
 
2.5.3.2  Agarose gel electrophoresis 
DNA separations were performed on 1.5-2% agarose gels (Invitrogen), made with 
1 x TAE buffer (40mM Tris, 19 mM acetic acid, 1 mM EDTA), and SYBRSafe 
(Invitrogen). DNA/ RNA samples were electrophoresed in 1 x TAE buffer at 100 V 
for 1 hr. A 100 bp ladder (NEB, Herts, UK) was used as molecular base pair size 
marker. DNA samples were then visualised on a GelDoc system (BioRad) using 
ultraviolet light. 
2.5.3.3  Measurement of RNA quality 
The quality of RNA extracted from tissue was determined using the Agilent 2100 
Bioanalyser (Agilent Technologies, Edinburgh, UK), using approximately 100-200 
ng/µl of sample. The RNA concentration was determined and RNA integrity 
number (RIN) calculated [277]. RIN values of (<5) were considered to be 
degraded RNA and RIN values >8 were considered to be very good quality RNA 
suitable for other experimental purposes.  
 
2.5.3.4  Complementary DNA (cDNA) synthesis for Taqman low density 
arrays 
For cDNA synthesis, 1 µg RNA was reverse transcribed using the Precision™ 
nanoscript reverse transcription kit (Primer design). RNase free water, oligo-dT 
and random nonamer primers were combined in a master mix to a final volume 
of 10 µl (Table 1.1). 
 
Table 2-1 CDNA synthesis mix 
Nanoscript 10X buffer 2 µl 
 
dNTP mix 10 mM each 1 µl 
 
DTT 100 mM 2 µl 
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Nanoscript enzyme 1 µl 
 
RNase free water 4 µl 
 
 
1 µg RNA was made up to a volume of 10 µl with RNase free water, denatured in 
a hot water bath at 65 °C for 5 mins, and immediately transferred on ice. Ten 
microlitres master mix was added to the RNA, to make up a total volume of 20 
µl. Reverse transcription was carried out using a PCR machine at the following 
conditions: 25 °C for 5 mins, 55 °C for 20 mins and then 75 °C for 15 mins for 
heat inactivation.  
2.6 Taqman low-density array (TLDA) 
Taqman® low-density array microfluidic cards (Applied Biosystems) were 
designed using two different formats: 32 and 64 genes of interest. The TLDA 
microfluidic cards with 32 genes were used for the analysing the ear tissue 
samples and contained probes for chemokines, and inflammatory chemokines. 
The 64 gene microfluidic card contained murine probes for all murine 
chemokines with the exclusion of CCL10, CXCL4, CXCL7 and CXCL11. The 
microfluidic card also contained probes for 9 inflammatory cytokines, 4 pattern 
recognition receptors, 2 transcription factors and 8 interferon inducible genes. 
The microfluidic card consisted of 384 wells, which were already customised 
with the probes and primers for each gene. Two samples were analysed per 32 
well card, and four samples per 64 well card respectively. The samples were 
loaded through the wells present in the microfluidic cards. Each loaded well-
contained 100 µl of the reaction mix, prepared in 200 µl volume consisting of 20 
µl of RNase free water and cDNA (1 µg total RNA equivalent), and 160 µl of 
Taqman Universal PCR master mix (Applied Biosystems, Paisley, UK). The 
Taqman array cards were run on a 7900HT fast real time machine (Applied 
Biosystems) according to the cycling conditions below:  
 
95 °C 2 mins 
95 °C 15 s 
65 °C 60 s 
40 cycles  
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Data was analysed using SDS 2.2 software and RQ manager version 1.2.2 (Applied 
Biosystems), following the manufacturer’s instructions. The relative amount of 
each target gene was normalised against the chosen endogenous reference gene 
(18S) in untreated ear or lymph node samples. For lymph node analysis, cervical 
lymph nodes proximal to the ear skin were collected for processing. Results were 
reported as fold changes that gives an indication of how much more or less a 
gene in the experimental group is expressed compared to its expression in the 
calibrator group or control. 
 
2.7 Parasite quantitation 
2.7.1 Polymerase chain reaction (PCR) of tsetse fly bite site tissue 
PCR was performed on DNA extracted from tissue following infected tsetse fly 
bites. Primers were designed that targeted the paraflagellar rod 2 gene, because 
it is expressed in all the lifecycle stages of T. b. brucei [252]. PCR was 
performed using 100-200 ng template DNA from infected tissue or T. b. brucei 
DNA added to 14.5 µl reddymix PCR master mix with 1.5 mM MgCl2 
(Thermoscientific, Paisley, UK), 0.5 µl each of forward and reverse primers (100 
mM), and made up with distilled water in a 25 µl reaction volume. The cycling 
conditions used were an initial 95°C for 15 mins, followed by 45 cycles of 94°C 
for 15 s, 60°C for 30 s and 72°C for 1 min 30 s, with a final incubation of 72°C 
for 10 mins. PCR products were routinely stored at -20°C. 
 
2.7.2 PFR2 primers and probe 
Gene sequences were downloaded from TriTrypDB Kinetoplastid genomics 
(www.tritrypDB.org). Primers for qRT-PCR designed using the Applied Biosystems 
qRT-PCR primer design software and supplied as a kind gift by Dr. Jean Rodgers 
[252]. PFR2 probe was tagged with FAM and TAMRA at its 5’ and 3’ ends. 
Oligonucleotides were then synthesised by Eurofins MWG Operon 
(www.eurofinsdna.com) as listed in table 2.2. Primers were stored as stock 
solutions (100 pmol/µl) at -20°C and diluted to a working concentration of 10 
pmol/µl when needed. 
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Table 2-2 Oligonucleotide sequences used for quantification of T. b. brucei 
Oligonucleotide name Sequence 
PFR2 primers Forward: AAGTGCTTTCCCATCGCAACT 
Reverse: GACGCACTAAACCCCTCCAA 
PFR2 probe FAM-CGGTTCGGTGTGTGGCGCC 
 
2.7.3 Preparation of dilutions for standard curve 
A plasmid kindly provided by Dr Jean Rodgers was used as standard to estimate 
the number of copies of PFR2 present in the tissue samples at the different time 
points quantified [252]. The standard containing 107 copies/ 5 µl of the PFR2 
gene was serially diluted with sterile DNase/RNase free water to give dilutions 
ranging from 106 to 101 copies per 10 µl. All standard dilutions were prepared 
fresh for each PCR reaction, and used immediately. An example of a standard 
curve is given in figure 2.4. 
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Figure 2-4 Standard curve for quantitation of T. b. brucei.  
Plasmids were diluted from 106 to 101 copies and loaded on 384 well PCR wells for analysis on a 
7900HT Fast Real-Time machine. Red squares indicate the plasmid dilutions.  
 
 
2.7.4 Quantitation of parasites in the skin and draining lymph 
node by QPCR 
In order to quantify parasites in the ear skin and cervical draining lymph node 
(dLN), a taqman semi-quantitative PCR approach was used which was based on 
designing a taqman probe that relies on the 5’-3’ exonuclease activity of Taq 
polymerase to cleave the PFR2 probe when it binds to its complementary 
sequence. The QPCR reaction consisted of 12.5 µl Taqman Brilliant II master 
mix, 0.05 pmol/µl (final concentration) of each primer, 0.1 pmol/µl of the probe 
(final concentration), 300 ng template DNA, and made up to the final volume of 
a 25 µl reaction with sterile DNase/RNase fee water. Each sample was analysed 
in duplicates. The QPCR reaction was performed in an Applied Biosystem, 7900 
HT thermocycler. After an initial denaturation step at 95°C for 10 mins, followed 
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by 95°C for 15 s, 60°C for 1 min for annealing to occur, and finally temperature 
raised to 72°C for 0.1 s. The reaction consisted of a total of 45 cycles. 
2.8 Flow cytometry 
2.8.1 Infecting mice ears 
Mice to be used for flow cytometry analysis were anesthetized using 
Hypnorm/Hypnovel injectable anesthesia (10 mL/Kg of a mix of 
fentanyl/fluanisone/midazolam/H20 at 1:1:2 by volume) administered 
intraperitoneally, and placed in a hot box to maintain the body temperature at 
37 °C. One infected tsetse fly per universal bottle with a wire gauze underneath 
to allow probing, was then placed on the ear of the mice for approximately 20 
mins or tsetse fly removed once a blood spot was observed on the ear of the 
mouse (see Figure 2.5 and 2.6).  
 
 
Figure 2-5 Tsetse probe on mouse ear. 
Infected tsetse fly separated into single universal tubes was used to probe on a C57Bl/6 mouse 
anesthetised with hypnorm/hypnovel. Tsetse fly was exposed to mouse ear for approximately 20 
mins in a hot box pre-heated to 37 °C. Following tsetse exposure, mice were recovered in 
conventional cages and kept till the time point needed. 
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Figure 2-6 Mouse ear post tsetse exposure.  
Once tsetse exposure described in figure 2.5 was over, visible blood spots were observed in the 
ear of C57Bl/6 mouse as indicated by the black arrow. 
 
2.8.2 Ear tissue preparation  
The ear samples for flow cytometry were collected by euthanising the mice by a 
schedule 1 procedure, and ears removed using scissors (FST, Foster city, USA) at 
the required time points and immersed in PBS. Ears were then transferred to 
microcentrifuge tubes (Eppendorf, Stevenage, UK) containing 500 µl, 4 mg/ml 
collagenase IV (Sigma-Aldrich, Dorset, UK), 2 mg/ml hyaluronidase (Sigma-
Aldrich, Dorset, UK)) and DNaseI (Sigma-Aldrich, Dorset, UK) in a 37 °C 
incubator, 1 hr. The digestion was stopped after an hour by the addition of 1 ml 
Iscove’s modified Dulbecco’s medium (Sigma-Aldrich, Dorset, UK) to the 
samples. Samples were then digested using the program B (2 x 30 s spin) of the 
MACS dissociator (Miltenyi, Surrey, UK). The tissue suspension was then passed 
through 40 µm cell strainers (BD, Oxford, UK) and cells were processed for 
fluorescent activated cell sorting (FACS) antibody staining as described in 
section 2.8.4.  
 
2.8.3 Flow cytometry analysis of samples 
Cell preparation for flow cytometry was performed in 12x75 mm, polystyrene 
tubes (BD Falcon, Oxford, UK). Cell suspensions were incubated in Fc-receptor 
blocking agent for 15 mins, at 4 °C cells, resuspended in FACS buffer at 400 g, 4 
°C for 5 mins, and washed twice. Cells were stained with viability dye e450 
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(eBioscience, Hatfield, UK), antibodies at 1/100 dilution except for MHCII FITC 
antibody (see Appendix II for list of antibodies), which was stained using a 1/300 
dilution. Cells were then resuspended in 200 µl volume FACS buffer containing 2 
mM EDTA. Data were acquired using a MACSQuant flow cytometer (Miltenyi) and 
analysed using FlowJo software (Tree Star Inc., Oregon, USA). 
 
2.9 Neutrophil depletion in vivo 
In order to deplete the neutrophils in mice, 1 mg of anti-Ly6G IA8 clone 
(BioXcell, West Lebanon, USA) was injected IP into mice 16 hrs before the mice 
were infected. IgG2a isotype controls (BioXcell, West Lebanon, USA) were 
injected IP into mice as control in all experiments carried out. 
 
2.10 Imaging the ear using the multiphoton microscope 
Multiphoton imaging was performed with a Zeiss LSM7 MP system equipped with 
both a 10X/0.3 NA air and 20X/1.0NA water-immersion objective lens (Zeiss) and 
a tunable titanium/ sapphire (Ti-S) solid-state 2-photon excitation source 
(Chameleon Ultra II; Coherent, Santa Clara, USA) from 700 nm to 1050 nm. To 
extend the wavelength, the output of the Ti-S laser passed through an optical 
parametric oscillator (OPO, Coherent). When pumped by the Ti-S laser at about 
800 nm, outputs up to 1200 nm were obtained. It was also possible to use part of 
the pump wavelength (800 nm) simultaneously with the OPO output. The 
intensity of the Ti-S beam bypassing the OPO was regulated by an acousto-
optical modulator controlled by an imaging software (Zen 2010, Zeiss). The scan 
head (Zeiss, LSM7 MP) had a maximum rate of 8 frames per second. The 
multiphoton had five detectors of non-descanned fluorescence available, three 
multialkali photodiodes and two GaAsP detectos. All imaging was carried out 
using the 20X/1.0NA water-immersion objective lens. Image files were analysed, 
and videos prepared using Volocity (Perkin-Elmer, Coventry, UK). 
  
2.10.1 Mouse preparation 
Mice to be used for imaging were anesthetised using freshly prepared 
hypnorm/hypnovel, injected IP at 10 µl/g of mice, and were anesthetised for a 
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maximum of 8 hrs and then euthanased using a schedule 1 procedure. The hair 
on the mouse ear to be imaged was then removed, by applying a hair removal 
cream (Nair ®) to the mouse hair for 2 mins, and then excess removed with a wet 
tissue. The mouse was then placed on a heat mat on a custom built imaging 
platform (Figure 2.7), and a rectal thermometer inserted to maintain the body 
temperature of the mouse following anaesthesia, and mice was monitored to 
ensure body temperature remained at 37 °C. The mouse ear was immobilised on 
the imaging platform using glue (3M Vetbond) and copious amounts of phosphate 
buffered saline was added to set the glue (see Figure 2.7 for set up 
requirements).  
 
 
Figure 2-7 Setup required for imaging mouse ears. 
The figure shows the hair cream, vetbond glue, stage with the rectal thermometer, grease and wet 
tissue required in setting up the mouse. 
 
 
2.10.2  Injection of mCherry T. b. brucei 
Prior to setting the mice under the microscope, mouse ear was exposed to 
infected tsetses as described in section 2.8.1 or 10 µl microvolumes of blood 
stream form T. b. brucei injected intradermally into the ear skin of anesthetised 
mice. Mice were anesthetised, ears rolled and adhered on to the bottle top 
cover of their water bottle, using a double-sided adhesive tape, in order to have 
a good surface area for precise injections. Intradermal injections were carried 
out using a 0.3 ml insulin syringe (BD, Oxford, UK) containing 106 bloodstream 
form trypanosomes in 10 µl volume which express mCherry. When infected 
tsetse was used to inoculate trypanosomes, the tsetse was left on anesthetised 
mouse ear for approximately 30 mins, with the mouse lying on a heat mat to 
keep its body warm. 
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2.10.3 Exogenous fluorescent labels 
For imaging trypanosome interactions in C57Bl/6 wild type mice i.e. metacyclic 
T. b. brucei in the ear skin following tsetse bites, or via inoculation of blood 
stream parasites intradermally into the ear skin, mice were prepared as 
described in section 2.10.1, post tsetse inoculation/injection of 1 x 106 blood 
stream form parasites in the ear skin (section 2.10.2). Blood plasma was labelled 
by intravenous injection of dextran 70 kD, 50-70 µl of 100 mg.ml-1 conjugated 
with fluorescein isothiocyanate (Sigma-Aldrich, Dorset, UK), or with quantum 
dots (QTracker, Invitrogen, Paisley, UK) in 30 µl volume using 0.3 ml insulin 
syringes (BD, Oxford, UK). Mice were then imaged under the multiphoton 
microscope within 30 mins post intravenous labelling of blood plasma. Exogenous 
labelling of blood plasma was not carried out on transgenic mice used in this 
study. 
 
2.10.4  Placing the mouse under the microscope 
Following injection of trypanosomes into the ear of mice, a ring of vacuum 
grease was made using a syringe around the edge of the ear. The ring was then 
filled with PBS for imaging under the dipping lens of the multiphoton microscope 
(Figure 2.8). 
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Figure 2-8 A mouse already prepared for imaging. 
This is an example of a mouse set up for imaging under the microscope, with a ring of grease 
made around the ear (red arrow), which served as a well filled with PBS when the dipping lens of 
the multiphoton laser scanning microscope was used for imaging. 
 
2.11 Hematoxylin and Eosin staining 
Whole ears from infected/uninfected mice were removed and fixed in 10% 
formalin for 24-48 hrs. The samples were then placed into metal moulds and 
embedded in paraffin wax blocks for sectioning. Tissue sections were cut at 8 
µm thick and mounted on Super Frost® Plus slides (VWR, Lutherworth, UK)). 
Hematoxylin and eosin (H&E) staining was then performed on the slides. 
Hematoxylin is a dye that forms complexes with metal cations, while eosin is an 
acidic dye. So when the sections are stained, the there is a reaction between 
the positively and negatively charged components, resulting in the staining of 
basophilic cell components such as nucleic acid blue by haematoxylin. While, 
eosin reacts negatively with the positively charged components acidophilic 
components of the cell such as the cytoplasm, to give a pink coloration. Prior to 
H&E staining, sections are deparaffinised and then rehydrated in decreasing 
ethanol concentrations. The sections were then rinsed in water for 3 min and 
stained in haematoxylin (Cell Path, Newton, UK) for 5 min. Excess stain was 
removed under running tap water. Then the slides were immersed in 1% acid 
alcohol, for few seconds, rinsed in water and placed in Scott’s tap water for 30s, 
followed by another round of rinsing in tap water. Sections were then counter 
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stained with 1% Eosin Y (Cell Path, Newton, UK) for 2 mins. Excess stain was 
washed off under running tap water. The stained sections were then dehydrated 
in a series of increasing ethanol concentrations, and cleared using xylene. 
 
2.12 Transmigration assay 
The Bare filter transmigration assay [278] was used to assess the chemotaxis of 
T. b. brucei towards the chemokine CCL21 (R&D, Abingdon, UK)). Transwell 
transmigration plate (Corning® 3 µm) was pre-incubated for 10 mins, 37 °C with 
600 µl CCL 21 (50-500 ng) diluted in chemotaxis buffer (0.5% Bovine serum 
albumin in Iscove’s modified Dulbecco’s medium). Following incubation with 
CCL21, the polycarbonate wells of the transwells were then loaded with 100 µl 1 
x 105 T. b. brucei resuspended in chemotaxis buffer, incubated at 37 °C, 5% CO2, 
7 hrs. After 7 hrs, incubation, cells at the bottom of the well were then counted 
using a haemocytometer under a light microscope. 
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3 Development of an experimental tsetse fly 
infection system 
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3.1 Introduction 
Tsetse flies (male and female) are obligate haematophagous arthropods, and are 
the only cyclical vector of many trypanosome species in Africa, with both sexes 
capable of transmitting infection [279]. Sites of maturation of trypanosomes in 
the tsetse fly vary depending on trypanosome species (Table 3.1). For example, 
T. vivax develops exclusively in the mouthparts, T. brucei has its initial 
establishment in the midgut, matures in the tsetse fly salivary gland, and T. 
congolense also has an initial establishment in the midgut, with further 
maturation in the mouthparts [280, 281]. Development of trypanosomes within 
tsetse flies involves a switch from a glycolytic pathway in its mammalian host to 
a Krebs cycle pathway in the tsetse fly [18, 23, 282]. T. brucei when taken up by 
the tsetse fly are freely motile, and those that survive the immune assault of the 
tsetse fly, and the new milieu in which they find themselves eventually migrate 
to the salivary gland. Following migration, the parasites in the salivary gland 
attach to the microvilli, and multiply as attached epimastigotes. Attachment to 
the microvilli by the epimastigotes is no longer maintained during differentiation 
to the mammalian-infective metacyclic trypomastigote, which undergo further 
metabolic changes and a reacquisition of the metacyclic VSG coat (MVSG) as a 
pre-adaptation for life in the mammal, before inoculation during a blood feed 
[18, 20, 283].  
 
Table 3-1 Developmental sites of African trypanosomes in Glossina spp. 
Species Trypomastigotes Epimastigotes Metacyclics 
T. brucei spp. Midgut Salivary gland Salivary 
glands 
T. congolense Midgut Proboscis Proboscis 
T. vivax Proboscis Proboscis Proboscis 
 
The duration of trypanosome development in the tsetse fly to achieve mature 
infections is approximately 27 days in T. brucei, 5 days in T. vivax and 15 days in 
T. congolense [281]. However, recently it has been shown using fluorescent 
trypanosomes in a study investigating mating in tsetse flies, that T. brucei could 
appear early in the salivary glands, as early as 13 days post infected feed [284]. 
Once trypanosomes arrive in the salivary glands, a tsetse fly is capable of 
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producing hundreds of metacyclic parasites per day and remains infective 
throughout its life span ~ 3 months [285]. 
 
Table 3-2 Factors reported to affect successful trypanosome infection rates 
in the laboratory using experimentally infected tsetse flies. 
Tsetse Trypanosome 
Species/laboratory colony [279] Species/strain [286] 
Fly sex [287-289] Stage of infection in host [290, 291] 
Fly age during first infected feed [292-
294] 
 
Degree of starvation [295]  
Temperature of incubation of pupae 
[296] 
 
Temperature of incubation of adult 
flies [297] 
 
Host blood for infective 
feed/maintenance [281, 298, 299]  
 
Midgut haemolymph lectin activity 
[286, 300, 301] 
 
Midgut haemolymph lectin activity 
[286, 300, 301] 
 
  
 
Natural Infections of tsetse flies with trypanosomes in the field have been 
investigated. This has been achieved by trapping tsetse flies with nets, 
dissecting, and examining the gut and mouthparts for parasites. Though this 
approach is crude and cannot discriminate between trypanosome subspecies e.g. 
in T. brucei, data collected suggests that mature infection in the tsetse salivary 
gland was generally less than 1% in the field [281, 302]. Various reasons have 
been attributed for low infection rates of tsetse flies both in the field, and in 
the laboratory. The factors listed in table 3.2 give a summary of the main 
challenges encountered in initiating successful experimental trypanosome 
infections in tsetse flies. These factors influencing transmissibility can 
collectively be expressed as transmission index (TI) [303, 304]. However, for the 
purpose of this project, it will be necessary to expand on three key factors that 
were optimised for successful experimental infections.  
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The first two are the tsetse fly species, and trypanosome combination. Tsetse fly 
species and trypanosome combination are important factors that determine the 
success rate of obtaining mature tsetse fly infections in the laboratory. Taking 
the tsetse fly species for instance, G. m. morsitans has been demonstrated to be 
susceptible to T. b. brucei J10, with 11.3% of flies becoming infected. In 
contrast, other tsetse fly species, G. austeni, G. pallidipes and G. brevipalpis 
were more refractory to infection with the same strain of T. b. brucei, with only 
1.3% of flies developing mid gut infections [305]. Also, with T. congolense stock 
1/148, G. m. morsitans produced 100% midgut infections, while in G. p. palpalis, 
mature infections where rarely obtained with the same stock [306]. The sex of 
the tsetse species has also been described to contribute to increase in successful 
transmission, with male tsetses producing higher infections than females [287-
289]. Inherent strain effects also affect maturation in the salivary gland of tsetse 
flies. For example, there are significant differences in infection between stocks 
of T. b. rhodesiense, which gave much lower infection rates, than T. b. brucei in 
G. m. morsitans. Maturation of T. b. gambiense is also very rare in any tsetse 
species, and there could also be great variation between stocks of T. congolense 
in the same tsetse species [286], highlighting that the species of the tsetse fly 
and the trypanosome strain combination are crucial for successful infections in 
the laboratory. 
  
Thirdly, the time of feeding the tsetse flies post eclosion with infected blood 
meal is crucial for obtaining mature infections. This has been described as the 
teneral phenomenom. Tsetse flies have been demonstrated in various studies to 
show increased susceptibility to infection when fed within the first 24 hrs post 
eclosion with an infected blood meal [292, 293, 296, 307, 308], although some 
workers have argued that this makes little difference to infection rates [295]. 
The teneral phenomenom has been argued to enhance infections in tsetse flies, 
because from time points 48 hrs onwards post eclosion age, trypanosome midgut 
susceptibility decreases due to increasing maturity of the peritrophic matrix, 
and disappearance of the milk gland protein a constituent of the larval meal 
remaining in the mid-gut upon eclosion [292].  
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The ability to achieve experimental infections of tsetse flies in the laboratory is 
a critical step in enabling investigation of previously uncharted areas in host-
trypanosome interactions, using T. b. brucei as a model. For the purpose of this 
project, two strains of T. b. brucei, STIB247 and GVR35 [271, 272] were selected 
because I had access to transgenic parasites for the two strains. Hence, this 
chapter aims to describe how an experimental tsetse fly infection was set up, 
used to demonstrate trypanosome kinetics from the skin to the draining lymph 
node, and establish patency via the ear pinna in mouse models. G. m. morsitans 
were used in combination with tsetse fly transmissible T. b. brucei STIB 247 and 
GVR35 strains. 
 
3.2 Experimental infections of Glossina spp. 
3.2.1 Tsetse Fly infections  
Blood meals for feeds to tsetses were prepared from mice infected with 
stabilates of T. b. brucei STIB247 WT and STIB247 mCherry. At a parasitemia of 
approximately 1 x 108 ml-1, when most (approximately 70%) of the parasites were 
short stumpy stage as identified by light microscopy, mice were euthanased and 
blood collected with CBSS/Heparin. The first teneral feed was carried out within 
24-48 hrs post eclosion, and repeated twice with an interval of one day between 
feeds, followed by maintenance on sterile defibrinated horse blood. Following 
27 days post exposure, screening was carried out by inducing tsetses to spit on 
warm glass slides, and examination of extruded saliva by light microscopy for the 
presence of trypanosomes. 
3.2.1.1 Glossina palpalis and G. pallidipes do not produce mature infections 
when supplemented with N-acetyl-D-glucosamine 
In order to obtain mature infections in the salivary glands of tsetse flies, I 
attempted to use two different species of tsetse flies combined with a 
nutritional supplement N-acetyl-D-glucosamine (NAG). NAG is an inhibitor of 
tsetse midgut lectin, and the decision to add NAG to infected blood was based 
on previous data indicating tripled infection rates [300, 309]. G. pallidipes, and 
G. palpalis were fed with T. b. brucei STIB247 WT infected blood meals as 
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described in section 3.2.1, and modified by addition of sterile 10 mM NAG in 
order to improve infection rates. Tsetses of each species were given at least two 
infective feeds through a silicone membrane 24-48 hrs post eclosion [310]. 
Following infective feeds, tsetse flies were maintained on defibrinated horse 
blood containing 10 mM NAG, while a batch of 50 flies in a cage for each species 
of flies were infected without the addition of 10 mM NAG. 200 tsetse 
flies/species were used for experimental infections with 10 mM NAG. 
3.2.1.2 Infection rates and fly survival 
After 27 days post infective blood feeds, tsetse flies were separated into single 
tubes for screening infected flies as described in section 3.2.1. Of the starting 
batch of tsetses, only 50% of G. pallidipes and 55% of G. palpalis survived till 
screening. For control tsetse flies fed with infected blood meals without addition 
of 10 mM NAG, mortality was at 35-40%. Of all the surviving tsetses, including 
controls not fed with 10 mM NAG, no positive tsetses with mature salivary gland 
infections were obtained following saliva screening. These experiments, which 
included repeated trials by myself and Dr. Marc Ciosi (unpublished), suggested 
that in our hands G. pallidipes and G. palpalis were refractory to infection with 
T. b. brucei strain STIB247 so further trials were stopped. This led to the 
conclusion that independent of NAG or with the addition of NAG I could not 
achieve mature salivary gland infections using these two species of tsetse flies.  
3.2.1.3 Combination of Glossina species and strain of T. b. brucei are crucial 
for infection in tsetse flies  
Following the unsuccessful attempts at infecting G. pallidipes and G. palpalis, 
which I thought would give better infections than G. m. morsitans, I switched 
back to G. m. morsitans - a species that has had previous success in the lab with 
tsetse fly infections, though at very low infection rates. Also, there was the 
inclusion of two extra strains of T. b. brucei (GVR35mCherry and GVR35WT). 
Blood feeds were prepared in the same manner as previously described, with the 
exclusion of NAG as a supplement in the infective blood meals. NAG was 
excluded because of unsuccessful fly infections when the supplement was 
added, and also previous success we had with G. m. morsitans was without the 
addition of NAG. Tsetse flies were fed within 24-48 hrs post eclosion, and 
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infected blood meals were repeated twice at one-day intervals, and screened 27 
days post feed. Tsetse flies were made to spit on to warm glass slides, and 
extruded saliva examined under the light microscope (Figure 3.1).  
 
Figure 3-1 Screening for metacyclic trypanosomes.  
Tsetse flies fed with infected blood meals, were screened 27 days post feed by probing on warm 
glass slides for approximately 10 mins on a hot plate pre-heated to 37 °C. Metacyclic 
trypanosomes can be visualised in (A) positive slide showed T. b. brucei in saliva, while (B) 
showed an example of the saliva of an uninfected tsetse probe lacking trypanosomes.  
 
Of the surviving tsetses, surprisingly a success rate (mature salivary gland 
infections) of 40% was recorded with G. m. morsitans infected with STIB247 WT, 
19 and 20% success with STIB247 mCherry and GVR35 mCherry, no success with 
GVR35 WT (Table 3.3). It is important to mention that in this study, I did not 
examine the percentage of flies that had mid gut infections of T. b. brucei.  
 
Table 3-3 Summary of tsetse fly infections using different strains of T. b. 
brucei 
T. b. brucei strain Number of G. m. 
morsitans 
Number of 
surviving tsetse 
flies 27 days post 
infected feed 
Percentage of 
salivary gland 
infection (%) 
247 wild type 200 148 40 
247 mCherry 200 145 20 
GVR35 mCherry 200 135 19 
GVR35 wild type 200 129 0 
 
The mortality rate of G. m. morsitans prior to screening for infected tsetse flies 
was between 25-30%. In subsequent experiments, I obtained similar mortality 
rates, except when there was a problem during dispatch of the pupae from the 
A B 
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suppliers. Using these approach I achieved mature salivary gland infections of at 
least 15% consistently during the project. Tsetse fly infections with T. b. brucei 
GVR35 WT was also discontinued. 
 
3.2.1.4 Metacyclic stage T. b. brucei express mCherry when passed through 
tsetse flies  
Once tsetses were established to have mature salivary gland infections of T. b. 
brucei, I then examined if the tsetses infected with mCherry expressing 
parasites maintained fluorescence expression. In order to test retention of 
fluorescence expression, tsetses were probed on warm slides, and extruded 
saliva examined by epifluorescence microscopy using a x63 oil immersion 
objective. I found that all the metacyclics of STIB247 mCherry seen under the 
bright field objective demonstrated mCherry fluorescence (Figure 3.2). On the 
other hand, it was observed that approximately 50% of the GVR35mCherry 
parasites retained fluorescence.  
 
Figure 3-2 mCherry expressing metacyclic T. b. brucei. 
Infected tsetse flies were made to probe on glass slides, containing 100 µl of warm HMI-9 medium 
without antibiotics. Immediately tsetses probed, a cover slip was placed on the glass slides and 
visualised under the microscope within 10-15 mins before the metacyclics die, hence losing 
mCherry expression. Metacyclic T. b. brucei expressing mCherry (STIB247) were visualised in 
HMI-9 using epi-fluorescence microscopy, excitation/emission at 450nm and 550 nm respectively. 
Pictures were taken using a x63 oil immersion objective. 
 
In all, the data here demonstrates that T. b. brucei STIB247 mCherry passed 
through tsetses and retained fluorescence expression, and would be suitable for 
intravital imaging studies. Further trials with GVR35 mCherry were also 
discontinued, because not all parasites retained fluorescence expression. 
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3.3 Does infected tsetse bites result in patency via the 
ear pinna of mice? 
In vivo studies in mouse models of African trypanosome infections have been 
mostly carried out through intraperitoneal and intravenous injections of known 
numbers of blood stage parasites in order to achieve parasitemia. Hence, it was 
essential to test the ear pinna if it would be appropriate for establishing patency 
in mice. For this study, tsetse flies with confirmed T. b. brucei 247 wild type 
infections were used to test if the ear pinna of mice would result in patency in 
mouse models for subsequent in vivo experiments. Anesthetised mice (C57Bl/6) 
were placed in a 37 °C incubator and the ventral ear pinna of each mouse was 
exposed to single tsetse fly probes using diferent tsetse flies per mouse for 
approximately 20 mins. Following tsetse probe on the ear pinna, confirmed by 
visible blood spots in the ear, mice were recovered, and blood parasitemia 
monitored over 25 days by counting using a haemocytometer. It was observed 
that within 4 days post tsetse exposure, parasites became apparent in the blood 
(Figure 3.3).  
 
 
Figure 3-3 Kinetics of parasitemia in C57Bl/6 mice infected with T. b. brucei post tsetse 
exposure to ear pinna of mice. 
Five Mice were anesthetised, and ear pinna exposed to infected tsetse probes, that is one tsetse 
fly per mouse using a separate tsetse fly for each mouse for approximately 20 mins. Following 
infected tsetse exposure, anesthetised mice were recovered and parasitemia monitored. T. b. 
brucei parasitemia was assessed over 25 days, using the tail prick method to collect 10 µl volume 
of blood with a Gilson pipette, lysed in equal volume of 0.8% NH4Cl and parasites counted using a 
haemocytometer. Lines represent individual mouse, and one mouse was uninfected out of the five 
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mice post infected tsetse fly exposure. Data shows four infected mice and the kinetics of 
parasitemia in each mouse. 
 
The data demonstrates that the ear skin is a valid route of infection to analyse 
early host-parasite interactions following vector-mediated transmission of 
infection. 
 
3.4 Quantifying T. b. brucei in mice 
Now that I had established a successful and reproducible model for experimental 
infection of tsetse flies in the laboratory, I next sought to quantify the number 
of T. b. brucei deposited in the skin and the kinetics of appearance in other 
tissues. Infected tsetse flies were exposed to the ear pinna of C57Bl/6 mice, ear 
and lymph node (LN) tissue samples collected at time points 0, 6, 24 and 48 hrs 
post exposure. Genomic DNA was extracted from tissue and Taqman quantitative 
PCR (qPCR) was performed on ear and cervical LN samples targeted at PFR2. Ear 
tissue from tsetse exposed mice for qPCR analysis was standardised by weighing 
the ears, so approximately 15 mg of ear tissue was used for extraction 
throughout the studies. For all qPCR analysis, 300 ng of DNA (ear or LN) was 
used, and copy numbers of PFR2 in total DNA extracted from ear/LN tissue was 
then computed. Copy numbers of PFR2 were calculated from qPCR values using a 
standard curve as described in materials and methods (Figure 3.4 & 3.5). Within 
0-6 hrs, parasites were already detected in the proximal draining lymph node 
(dLN) of mice, and the copy numbers of PFR2 in the dLN increased with time 
peaking at 48 hrs.  
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Figure 3-4 T. b. brucei kinetics in the ear. 
Infected tsetse flies (T. b. brucei 247 wild type) in universal bottles with a wire gauze for feeding, 
were exposed to mice ear pinna (one tsetse fly per mouse) for approximately 20 mins. Mice were 
euthanased and ears harvested with a scissors. Ear issue was weighed and approximately 15 mg 
of tissue was used for genomic DNA extraction throughout the studies. QPCR was then performed 
as described in the materials and methods. A taqman quantitative qPCR approach determined 
levels of PFR2 gene in tissue and copy number determined against a standard plasmid diluted 
from 106 to 101. Data represents 3 mice per group pooled for two independent experiments ± SEM.  
 
 
Figure 3-5 T. b. brucei kinetics in the draining lymph node. 
Infected tsetse flies (T. b. brucei 247 wild type) in universal bottles with a wire gauze for feeding, 
were exposed to mice ear pinna (one tsetse fly per mouse) for approximately 20 mins. Mice were 
euthanased and cervical LNs draining the inoculation site in the ear were harvested with forceps 
and placed in PBS prior to genomic DNA extraction. QPCR was then performed as described in the 
materials and methods. A taqman quantitative qPCR approach determined levels of PFR2 gene in 
tissue and copy number determined against a standard plasmid diluted from 106 to 101. Data 
represents 3 mice per group pooled for one independent experiment ± SEM.  
 
The numbers of T. b. brucei parasites detected in the skin within the first 48 hrs 
was variable across the time points. However 6 hrs post infection, the levels of 
parasites present in the dLN increased suggesting rapid metastasis of the 
parasites from the inoculation site. After this period, the level of infection in the 
dLN continued to increase up to 48 hrs. In all, the data describes the kinetics of 
egress of parasites from the skin to the dLN. 
 
3.5 General summary 
This chapter demonstrated the establishment of a protocol for experimental 
infections in the tsetse fly, validating the ear pinna of mice as a route of 
infection, and the use of qPCR to quantify parasites released via exposure of 
tsetse flies to mice ears. I show that the tsetse fly and trypanosome species, and 
optimisation of infected blood feeds was crucial for obtaining mature tsetse fly 
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salivary gland infections. The quantitation of parasites in the skin was a novel 
attempt describing when parasites appear in the dLN between 0-6 hrs. Also, this 
study demonstrates that some trypanosomes remain in the skin, and some 
drained rapidly to the LN. The detection of parasites in the dLN, suggests that 
the lymphatic vessels were involved in rapid drainage of the parasites from the 
skin to the blood via the dLN. The mechanisms involved in parasite drainage 
through the lymphatics, whether it is an active process through its flagella, 
chemotaxis or through the free flow of the lymph, remain yet unclear. These 
observations would serve as a good background to investigate the role of the 
lymphatics in dissemination of African trypanosomes from the skin, which I 
describe in chapter 5. 
3.6 Discussion 
3.6.1 Infection rates 
Maturation of African trypanosomes from ingestion in a blood meal into 
infectious stages in the salivary gland of tsetse flies is a tortuous journey for the 
parasite, both in the field and experimentally in the laboratory. Consequently, a 
significant outcome of this project was to establish a reliable and reproducible 
means of infecting tsetse flies experimentally. This experiment was carried out 
by testing the hypothesis that blocking the trypanocidal effects of the midgut 
lectins using NAG, could potentially improve the establishment of trypanosomes 
in the ecto-peritrophic space, and subsequently, maturation in the salivary gland 
of the tsetse fly [311]. In order to achieve this, I set out to establish infections 
of tsetse flies using different species (G. pallidipes, G. m. morsitans and G. 
palpalis) and the use of a supplement, NAG to enhance infections. The two 
species of tsetse flies (G. pallidipes and G. palpalis) previously reported to be 
permissive to infection [300, 309] were first applied in this study, however 
successful infections were not achieved.  
Previous reports have established that blocking the midgut lectin had resulted in 
dramatic increases in midgut establishment of T. brucei using different tsetse fly 
and trypanosome combinations [286, 311]. The tsetse species (G. pallidipes and 
G. palpalis) that were used, have previously been infected with T. brucei in 
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other studies so were clearly susceptible [312]. The results achieved suggests 
that in vivo blocking of the midgut lectin using NAG did not result in mature 
infections in G. pallidipes and G. palpalis. Another lectin found in the 
haemolymph when blocked by α-D-melibiose, in addition to inhibiting the midgut 
lectin by NAG has been demonstrated to enhance maturation rates in male 
tsetse flies [288]. However, addition of α-D-melibiose and NAG was not 
considered in this study due to time constraints for optimisation studies. Of note 
in this study was also the high mortality rate reported here when NAG was added 
to infected blood feeds. High mortality rates observed were consistent with 
what has been reported by other workers that have used NAG in optimising 
experimental infections in tsetse flies. Mortality of tsetses have been reported 
to begin from the first day post tsetse feed, and was not associated to the sex of 
the tsetse fly, similar to the observations here [300].  
Following the unsuccessful attempts at obtaining mature salivary gland 
infections using G. pallidipes and G. palpalis in combination with the addition of 
NAG to the infected blood meal, I switched to optimising a different tsetse 
species, G. m. morsitans as the host. Infected blood feeds were optimised to 
contain sufficient numbers of the stumpy stage of the parasite, which is pre-
adapted for life in the tsetse midgut and ready for transmission. Differentiation 
of the slender form parasites to stumpies is an irreversible cell cycle arrest 
involving morphological and metabolic changes to the life of the parasite [313]. 
Stumpy form parasites are more tolerant to stresses of the tsetse fly uptake, 
more sensitive to environmental cues such as cis-aconitate [314, 315], and it is 
thought that they are the only ones capable of differentiation to procyclic forms 
in the midgut of the tsetse fly [316], although other reports suggests that 
slender form parasites may be capable of doing same [317]. The tsetse fly strain 
used for optimisation, G. m. morsitans has been reported to have a weak barrier 
to infection with T. b. brucei strain J10 [279], and has previously been used 
successfully in the lab, albeit with a low rate of mature infection. Optimisation 
of infected blood feeds involved ensuring that at least 70% of the parasites in 
the blood were at the stumpy stage, which were identified visually based on 
their morphology and prepared the infected feed with warm defibrinated horse 
blood. To my surprise, the first attempt at achieving mature infections using the 
new strategy described gave over 40% infection success with T. b. brucei STIB247 
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and less mortality was observed compared to G. pallidipes or G. palpalis. This 
affirmed previous reports that the tsetse and trypanosome strain combination 
was essential for mature salivary gland infections. In addition to the tsetse 
species/trypanosome strain combination used for infection, some workers have 
used different blood meal sources e.g. goat and pig blood, and reported higher 
midgut infectivity, compared with tsetse flies fed on other mammalian blood 
[298, 299]. Although there has been a suggested link between blood source and 
tsetse infections, only defibrinated horse blood has been used throughout to 
prepare blood meals in this study. This produced comparable rates of infection 
in G. m. morsitans to those obtained using other blood meal sources for 
infections [298]. Host blood meal contains species-specific factors that could 
improve the chances of obtaining mature infections. For example, it has been 
demonstrated that blood from goats, pigs, and rats enhance infections in most 
tsetse-trypanosome combinations, whereas, blood from cattle and wild bovidae 
diminishes infections [299]. Goat blood in particular has been shown to 
consistently enhance infections better in tsetse flies than blood from other 
animals, and these results have been repeatable even at lower parasitaemias, 
and lower incubation temperatures [299]. 
Another important observation in this study was that not all T. b. brucei GVR35 
mCherry screened from infected tsetse flies retained expression of mCherry, 
compared to 100% transmission stability of the mCherry construct when T. b. 
brucei 247 mCherry was passed through tsetse flies. This raised the possibility 
that it was likely that some form of recombination event was occurring in the 
tsetse fly. Migration of T. brucei from the midgut to the salivary gland is a 
tortuous process in which the parasite encounters pronounced bottlenecks, 
which creates the opportunity for genetic exchange between parasites [318]. 
Mating or genetic exchange between the parasites has been demonstrated to 
occur in the salivary gland of the tsetse using fluorescent trypanosomes [284]. In 
T. brucei fly transmission, interclonal mating has been identified to occur, which 
makes it highly likely that the parasite has been genetically altered. Also, 
intraclonal mating in T. brucei and T. congolense has also been described to 
result in recombination events in the parasite [319]. The presence of 
recombination events in the fly suggests a likely reason why some of the T. b. 
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brucei GVR35mCherry parasites had lost the mCherry construct during 
development in the tsetse fly.  
 The data presented here did not attempt to investigate midgut infections, the 
role of tsetse fly sex in obtaining mature infections, although some studies have 
suggested there may be a sex bias in infections. These studies generally seem to 
suggest that male tsetse flies give higher salivary gland infections compared to 
females, although females survive longer [288, 300]. However, no differences 
were observed in midgut infections in the tsetse flies when different 
trypanosomes species (T. b. brucei, T. congolense and T. rhodesiense) were 
compared in both male and female tsetse flies [288]. These observations 
supported the view that midgut infection in the tsetse fly is a maternally 
inherited trait, while salivary gland infections is sex linked trait [320]. 
Susceptibility of G. m. morsitans to infection in this study was variable, and the 
success reported here for T. b. brucei is considerably higher to rates of infection 
observed in the closely related human pathogenic T. b. rhodesiense strains 
[286].  
3.6.2 The ear pinna is a valid route of infection 
Following the successful experimental infection of tsetse flies, I next sought to 
determine if infected tsetse fly feeds on the ear pinna of mice was sufficient to 
allow the establishment of blood parasitemia. The ear pinna was chosen as the 
site of inoculation because of its convenience for examining the behaviour of 
parasites [321-323], host immune cells in the skin [165, 324], and it is a well 
established technique within our group, that is an amenable site for intravital 
imaging studies [325]. In addition to its accessibility for intravital imaging 
studies, this would also serve as an accessible tissue site to investigate cellular 
recruitment to the skin post tsetse exposure, as already demonstrated in 
Leishmania following sand fly bites [166, 326].  
Previous reports on innate and adaptive immune responses during trypanosome 
infections in mice have been focussed on intravenous or intraperitoneal routes of 
infection with bloodstream form T. b. brucei [132, 327]. However, natural 
infections occur through the deposition of infective metacyclic stage 
trypanosomes into the dermis of the skin, after a tsetse fly feed. The feed by a 
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tsetse fly, injects the parasite along with the saliva. The saliva contains 
glycosylated proteins, which possess immunomodulatory and enzymatic functions 
[328-330]. The saliva of the tsetse fly has also been indicated to contribute to 
the onset of infections in mouse models, suggesting that they contain substances 
that could contribute to virulence in vivo [330]. These findings are not unique to 
the tsetse fly, as other vector delivered parasites such as Leishmania, have 
salivary components that modulate transmission dynamics [331, 332]. The 
outcome of the importance of using the vector for in vivo studies as 
demonstrated in other parasitic infections such as malaria and cutaneous 
leishmaniasis necessitated the use of the tsetse fly for this study.  
Most studies that have attempted to use tsetse flies for infection have focussed 
on the flank of mammals for feeds because of the preponderance of blood 
vessels, and a larger surface area [13, 191, 333, 334]. So the attempt here at 
using the ear pinna for trypanosome infections was novel, providing a limited 
surface area, fewer blood vessels, and needed to be tested to determine 
whether it was sufficient to result in patency in mice. When tsetse flies were 
exposed to the ear pinna, they were unable to obtain a blood feed as they would 
on other parts of the mice. Instead, most of the tsetse flies used in this study 
probed on ear pinna of mice making visible blood spots, or blood pools. The 
results here demonstrate that probing of the ear pinna post tsetse exposure was 
sufficient to cause patency, and this confirms previous observations that probing 
and not necessarily a blood feed was sufficient to establish trypanosome 
infection in mammals [335]. Mice lacking parasitemia following probes by 
infected tsetse flies were suspected to occur as a result of unsuccessful tsetse 
exposures. Both sexes of tsetse flies (male and female) were also established to 
be capable of transmitting T. b. brucei.  
The principal conclusion from this part of my study was that tsetse fly probes in 
the ear pinna of mice, was sufficient to initiate infection despite inability to 
achieve blood feeds. The findings here was important in order to determine if 
the ear pinna was a valid route of infection that could be used to characterise 
immune responses/parasite behaviour by conventional techniques and intravital 
imaging through the bite of the tsetse fly. The study demonstrates that the ear 
skin was suitable for establishment and dissemination of parasites into the 
blood. 
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3.6.3 T. b. brucei kinetics 
To my knowledge, the dose of T. brucei spp. delivered by tsetse fly vector to the 
mammalian skin has not been quantified. Interestingly, studies on African 
trypanosomes have generally focussed on injecting sufficient numbers of 
parasites to generate patency in their hosts, rather than the physiological 
relevance of this process. Therefore, in addition to the approximate numbers of 
trypanosomes used, the use of blood stages rather than transmission stages of 
parasite, the route of inoculation, as well as the loss of impact of the vector bite 
makes it difficult to fully appreciate the host/parasite response in infection. In 
particular, the earliest events that occur within the first few hours of 
inoculation into the skin by the tsetse fly, and parasite dissemination 
systemically has yet to be quantified in vivo.  
In order to quantify the parasites in vivo, the paraflaggellar rod 2 (PFR2) gene of 
T. b. brucei was an attractive target because it is highly conserved and 
expressed throughout the life cycle in T. brucei and T. cruzi [336]. Furthermore, 
PFR2 has been successfully applied to quantify trypanosomes in mouse models, 
for example in stage 2 HAT [252], and comparing chemotherapy of T. b. brucei 
GVR35 sensitive and drug resistant strains (Amy Jones, University of Glasgow 
thesis 2011). Therefore, I optimised a taqman qPCR approach targeting PFR2 
using an oligonucleotide probe designed to a section of PFR2 to estimate the 
copy numbers of parasites following a single tsetse fly probe per mouse over the 
course of 48 hrs at the bite site and the dLN. At the bite site there was 
variability within tissues in the copy numbers of parasites recovered back 
immediately after a tsetse probe. This is likely due to the different probing 
behaviour of tsetse flies, which would result in injection of different sizes of 
parasite inoculum. Also, the numbers of metacyclic T. b. brucei produced in the 
salivary glands of tsetse flies varies from one tsetse fly to another. In addition, 
PCR studies of parasites in the blood at the respective time points was not 
investigated, so there could be the likelihood of parasites entering the blood 
stream via routes excluding the LN. Within 0-6 hrs post infected tsetse exposure, 
parasites were detected in the dLN, and some were still detected at the bite 
site. The migration of parasites towards the dLN increases over the course of 
time, with more parasites detected in the dLN by 48 hrs. It was observed that 
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some of the parasites remained at the bite site and could have differentiated to 
long slender forms, which are capable of proliferation [14]. Although there is no 
direct evidence for differentiation of metacyclic T. b. brucei in this chapter, P. 
berghei and P. yoelii have been demonstrated to differentiate from sporozoites 
to exoerythrocytic forms in the skin, and may remain in the skin and serve as a 
secondary reservoir of infective merozoites [183, 184].  
Quantification of intracellular parasites such as Leishmania and Plasmodium has 
given us an understanding of how the inocula injected into the skin by the their 
vectors- sand fly and mosquito, contribute to pathogenesis [183, 337]. In 
Leishmania for instance, real time PCR approach has demonstrated that between 
10-100,000 parasites could be deposited in the skin following a sand fly probe 
[257]. The transmission efficiency of sand flies during a probe has been directly 
linked to the infection levels in the midgut. This simply means that a heavily 
infected sand fly would deposit large inocula during a feed into the skin of its 
host [257]. A direct correlation between infection burden in the tsetse fly 
salivary gland and numbers of metacyclic T. b. brucei deposited in the skin has 
not been established in this study. But it may be appropriate to speculate that 
variation in numbers of parasites deposited in the dermis through the probe of a 
tsetse fly could also be linked to the degree of parasitosis in the tsetse salivary 
gland. The variability in the numbers of parasites transmitted following tsetse 
fly bites further underscores the need to apply the natural route of infection in 
understanding the earliest events in pathogenesis.   
Here, I have also been able to provide direct evidence that parasites go into the 
LN via which they may enter into the bloodstream from the skin post tsetse 
exposure. In Plasmodium berghei sporozoites ~30% of the parasites take the 
lymphatic route and arrive at the first draining LN, where most of the parasites 
die [183]. In African trypanosomes, most of the parasites that find their way into 
the LN do not die and have been suggested to replicate in the paracortex of the 
LN based on intravital imaging studies within our group (unpublished). The 
detection of trypanosomes very early in the dLN post infected tsetse exposure 
strongly supports the idea that parasites enter the LN via the lymphatics as 
shown previously [13, 191]. These findings are fundamental for understanding 
the earliest events that occur following inoculation of metacyclic T. b. brucei in 
the skin, and might apply to other African trypanosomes. 
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4 Characterising the skin immune response to the 
bite of trypanosome infected tsetse fly 
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4.1 Introduction 
Many of the most serious parasitic infectious diseases in the world, ranging from 
malaria to more neglected tropical parasitic diseases such as filariasis, 
trypanosomiasis, leishmaniasis, and onchocerciasis, are transmitted by arthropod 
vector bites during blood feeds [338]. In as much as we know that the 
transmission of these parasites rely on the vector, most studies investigating the 
dynamics of parasite transmission and immunity in mammalian hosts have failed 
to consider the contribution of the vector. Most studies have assumed that 
parasites transmitted by injection through a syringe adequately reflect vector 
transmission. However, recent studies have made it very clear that these 
approaches do not mimic what happens in reality, raising doubts about the 
applicability of data obtained from such approaches in fully appreciating the 
host response to infection [165, 339].  
 
Arthropod saliva has been demonstrated to enhance infectivity for several 
pathogens in their mammalian hosts, for example, sand fly transmission of 
Leishmania, tick transmission of viruses, mosquito transmission of viruses and 
Plasmodium sporozoites [338, 340, 341]. The saliva of arthropod vectors such as 
mosquito, ticks, tsetse fly and sand fly, has been shown to contain a large 
number of substances that have pharmacologically important effects on the 
host, such as anti-haemostatic, vasodilatory, anti-coagulant and anti-
inflammatory or immunosuppressive activity [342-351]. Immunologically, the 
arthropod saliva also has profound consequences on the immune system of its 
host and on parasite dissemination from the bite site. In Leishmania spp, the 
sand fly vector has been used to demonstrate the early inflammatory processes 
that occur following inoculation in the ear of mice models. Through sand fly 
transmission of Leishmania it was revealed that the early recruitment of 
neutrophils to the inoculation site resulted in phagocytosis of parasites, which 
were still viable, hence transported into macrophages, promoting disease 
establishment [165, 352]. The saliva of sand flies has also been demonstrated to 
inhibit T cell activation, macrophage activation, IFN-γ, IL-12, and iNOS 
production [353-355]. Studies of Chikungunya virus transmission revealed that 
mosquito bites skewed the host immune response towards a Th2 phenotype 
through a significant upregulation of IL-4, possibly due to the contribution of 
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mosquito saliva. In contrast, needle injected Chikungunya virus induced a Th1 
immune response as evidenced by the significant upregulation of IFN-γ and IL-2, 
while Th2 cytokines such as IL-4 and IL-10 did not show significant changes in 
transcript levels [356]. These findings further emphasised differences in the 
immune responses elicited between mosquito and needle inoculations. In 
addition to the contribution of the arthropod saliva to the immune response, 
mechanical damage from the bite of arthropods or injection via a needle will 
induce a response from skin-resident immune cells such as Langerhans cells in 
the epidermis, αβ T cells, γδ T cells, mast cells, natural killer cells, 
macrophages and dendritic cells in the dermis. The mechanical damage in the 
skin produces endogenous signals that trigger an immune response in order to 
sterilise and also repair the damaged tissue [357].  
 
In studies carried out using mouse models of trypanosome transmission in the 
presence or absence of tsetse saliva via needle injections, it was demonstrated 
that the absence of saliva delayed the progress of parasites into the blood 
stream and that the saliva biases the host immune response towards a Th2 
phenotype, through the production of cytokines IL-4 and IL-5 [330]. What we 
know about how African trypanosomes interact with its host has been mostly 
based on intravenous or intraperitoneal injections of bloodstream form parasites 
into mammals [358-362], which clearly does not represent what happens in 
nature via the tsetse fly bite. A recent study has used modern analytical tools to 
analyse the events occurring in mammals in response to African trypanosome 
infection via the skin, and this was performed using intradermal needle injection 
of known numbers of bloodstream form parasites. The study demonstrated using 
B cell deficient mice, that low numbers of T. b. brucei and T. congolense 
parasites injected intradermally could be eliminated by the innate immune 
response [327]. The authors showed that B cell deficient mice exhibited the 
same degree of resistance when compared to wild type mice injected with the 
same number of parasites. In contrast, iNOS-/- and wild type mice treated with 
antibody to TNF-α were more susceptible to infection. This study clearly 
outlined a role for the innate immune response in controlling low parasite 
infections. As informative as the study was, it still missed a key part of the 
parasite’s life cycle, which is the metacyclic stage present in the salivary gland 
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of the tsetse, as well as the contribution of the tsetse fly bite and saliva to the 
host immune response, and parasite dissemination.  
 
Hence, this study arose out of a need to find answers to some of the questions 
unanswered regarding the earliest events post tsetse fly bite in the skin of 
mammals. These questions include, what are the kinetics of earliest events at 
the bite site following infected and uninfected tsetse fly exposure, does the 
presence of parasites have an effect on the magnitude of the immune response, 
what interactions occur between African trypanosomes and immune cells, and 
what functional role(s) do the cells recruited following inflammation play in 
pathogenesis. To address these questions, I hypothesised that infections using 
trypanosome infected tsetse fly would elicit the rapid infiltration of immune 
cells, and manipulating these immune cells would be important in limiting 
parasite establishment, and dissemination via the skin into the blood stream. 
Therefore, this chapter aims to fill in some significant gaps in our knowledge by 
incorporating the contribution of the tsetse fly in studying the earliest 
inflammatory processes and how this may relate to parasite dissemination into 
the bloodstream.  
 
4.2 Kinetics of cellular recruitment in the skin following 
tsetse fly bite 
In order to address the questions mentioned above, a flow cytometry analysis 
was undertaken of the cells recruited to the skin of T. b. brucei infected and 
uninfected tsetse exposed mice. Prior to characterising the immune cells by flow 
cytometry, I carried out histological analysis of mice ear samples that had been 
exposed to tsetse flies to assess whether host cells were recruited to the bite 
site post infected and uninfected tsetse exposure. For the study in this chapter, 
all infected tsetses refer to flies infected with T. b. brucei 247 wild type. 
4.2.1 Cells were recruited to the bite site following tsetse 
exposure 
Infected and uninfected tsetses were exposed to mice ears for 6 hrs, ears were 
collected and processed as described in materials and methods for Hematoxylin 
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and Eosin staining (H&E). H&E staining revealed the bite site, and the influx of 
cells post tsetse exposure. Cells were shown to infiltrate the lesion post-bite in 
both infected and uninfected ear samples, and appeared to congregate towards 
the dermal papillary lesion (Figure 4.1).  
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Figure 4-1 Infected and uninfected tsetse exposure caused recruitment of cells  
Mice were anesthetised, ears were exposed to feeding by infected and uninfected tsetses, ears 
harvested 6 hrs post tsetse exposure and stained with hematoxylin and eosin for morphological 
examination, as described in materials and methods. (A) Post exposure to infected tsetse, (B) post 
exposure to uninfected tsetse, (C) untreated ear control. Images were acquired using x40 
magnification on a Zeiss Axiostar Plus microscope fitted with AxioVision software; arrow points to 
the dermal papillary lesion (DPL) in response to tsetse fly bites, DE = dermis, EP = epidermis.  
 
4.2.2 Flow cytometry for identification of recruited leukocytes 
Once it was established by H&E that cells were indeed recruited to the tsetse 
bite site, I next sought to characterise the phenotype of cells that were 
recruited. In order to characterise the cells recruited, a flow cytometry 
approach was applied. This was carried out by processing tissues to isolate 
single-cell suspensions, by digestion of ear tissue, and staining with fluorescent 
antibodies. Once the process of isolation of cells from tissues was optimised for 
concentration of enzymes (Hyaluronidase and collagenase IV) with minimal 
damage to isolated cells, a gating strategy for identification of leukocytes was 
set up. The approach used here first involved drawing a gate on all cells using 
the forward scatter and side scatter plot, followed by the use of a live dead 
stain for exclusion of dead cells. For standardisation of total cell numbers in 
tissue samples, isolated cell suspensions were resuspended in 200 µl FACS buffer, 
and 100 µl volume taken up and analysed by the Miltenyi seven colour flow 
cytometry machine (MACSQuant analyzer) with automatic calibration features. 
The MACSQuant has an automated cell counter software, so by drawing a gate on 
viable cells as described below (Figure 4.2), the absolute number of cells was 
automatically calculated by the flow cytometry software. The number of cells 
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counted in 100 µl volume by the MACSQuant was then multiplied by two to get 
the total number of viable cells per ear tissue. For analysis of cell numbers in 
the refined populations of cells analysed, the same approach was applied by 
drawing a gate on the subset of cells I was interested in using the MACSQuant 
analyser. Leukocytes were gated by use of the CD45 marker. The CD45+ cell 
population was subsequently refined into leukocytes such as neutrophils, 
macrophages and monocytes using the appropriate lineage markers as described 
in Figure 4.2. Figure 4.2 shows that after tsetse exposure to a single mouse, 
approximately 3.73% of the viable cells expressed the CD45 marker. Further 
refinement of the CD45+ viable cells revealed that neutrophils constituted 27.4% 
of the cell type present in the skin post tsetse exposure. The gating strategy 
described in figure 4.2 was then applied throughout this study for 
characterisation of leukocytes post tsetse exposure in all cases. The percentage 
of CD45hi cells observed here was lower than what I expected following tsetse 
exposure. I anticipated a much more significant recruitment of cells to the bite 
site, this observation suggested that the tsetse bites did not induce excessive 
inflammation to the inoculation site.  
For this analysis and others, it should be noted that untreated controls refer to 
ear or lymph node samples not exposed to tsetses (naïve controls), while 
infected tsetse samples refers to mice tissues exposed to tsetses carrying T. b. 
brucei 247 wild type strain infections, and uninfected tsetse samples refers to 
mice tissue exposed to tsetses not infected with T. b. brucei 247. 
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Figure 4-2 Example plots of the flow cytometry-gating strategy for identification of 
leukocytes in the ear skin.  
Following tsetse exposure to mice ears, ears were harvested and samples were processed for 
isolation of single-cells and then stained with appropriate antibodies as described in the materials 
and methods. (A) Intact cells were identified based on size and granularity, (B) followed by 
selecting viable cells with a viability dye, and then identification of leukocytes based on CD45hi 
expression. (C) Identification of the different leukocyte populations was performed using CD11b+ 
and Ly6C+ expression to distinguish the three populations: neutrophils (CD11b+Ly6Chi), 
macrophages (CD11b+Ly6Cint) and monocytes (CD11b+Ly6Clo). (D) The expression levels of 
different populations could also be distinguished using a histogram to show Ly6G purity levels. 
Data is representative of 3 mice exposed to tsetse bites. 
 
4.2.3 CD45+ cells were identified post tsetse exposure by flow 
cytometry 
Inflammation is a fundamental process in mammals for removal of substances 
that are foreign or injurious to its host. A key event in the inflammatory 
response is the localised recruitment of leukocyte subsets. CD45 is a pan-
leukocyte marker expressed by all bone marrow derived cells except 
erythrocytes and platelets [363]. Hence, to allow for identification and 
quantification of leukocytes by flow cytometry, CD45 expression was used for 
phenotypic analysis. There was recruitment of cells to the inoculation site post 
tsetse exposure (Figure 4.3). However, no significant differences in CD45+ cells 
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recruited between infected and uninfected tsetse exposed samples (P>0.05; One 
way ANOVA with Tukey’s test). Tsetse exposed samples showed that there was 
recruitment of cells to the bite site.  
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Figure 4-3 Total leukocyte populations in the ear skin post tsetse exposure.  
Mice were anesthetised and ears exposed to infected/uninfected tsetse bites, and ears harvested 
at the respective time points. Following ear sample processing to isolate single-cell suspensions 
post tsetse exposure, processed samples were resuspended in 200 µl volumes FACS buffer. For 
flow cytometry analysis, 100 µl of cell suspension was analysed on the MACSQuant analyser, and 
the total number of cells present in the sample tube was estimated by Miltenyi software, and 
number obtained multiplied by two to calculate the total number of cells in the ear tissue. Total 
absolute numbers of CD45+ cells present over 48 hrs were quantified and plotted. Example plots at 
the time points analysed for infected and uninfected tsetse samples are presented: infected and 
uninfected tsetse ears at 2 hrs (A), 6 hrs (B), 12 hrs (C), 24 hrs (D), 48 hrs (E), and untreated naïve 
ear control (F), respectively. (G) Line graph depicts the absolute numbers of CD45+ cells in the skin 
post tsetse exposure, ± SEM. Data represents pooled data from 3 mice per group from 3 
independent experiments. No difference was observed between uninfected and infected tsetse 
samples (P>0.05; not significant, ns) carried out using a One-way ANOVA with Tukey’s post test. 
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Leukocyte subtypes accumulating post tsetse exposure were further refined 
based on expression of neutrophil, macrophage, and monocyte markers in the 
subsequent sections. 
4.2.4 Neutrophils were recruited within the first 24 hrs post tsetse 
exposure 
Neutrophils are rapidly recruited through blood vessels to sites of inflammation 
or sterile injury, through a series of steps tightly regulated by integrins [364]. 
They are usually the first immune cells that extravasate from the blood to tissue 
sites in inflammation. Hence, the kinetics of neutrophil influx post infected and 
uninfected tsetse exposure to mice ears was characterised. Following the 
identification of CD45+ cells in the skin, neutrophils were analysed through their 
combined expression of CD11b+ and Ly6Ghi. Consistent with their role as early 
responders at sites of tissue damage, neutrophils were detected in the ear pinna 
within the first 2 hrs in both infected and uninfected tsetse samples. Neutrophil 
recruitment at the time points analysed (2, 6, 12 and 24 hrs) was compared 
between infected and uninfected tsetse samples, and was found to be 
statistically insignificant (P>0.05; One way ANOVA with Tukey’s post test). 
However, comparison of either infected or uninfected tsetse exposed samples 
with untreated controls gave statistically significant results (P<0.05; One way 
ANOVA with Tukey’s post test) for the time points analysed in all samples, 
except for uninfected tsetse sample at 24 hrs, which showed no difference 
(Figure 4.4).  
Overall the data suggests that there was transient recruitment of neutrophils, 
with peak influx into the bite site occurring within the first 2 hrs, and there was 
no significant difference between infected and uninfected tsetse samples 
Chapter 4  114 
 
 
 
 
 
 
Chapter 4  115 
 
           
  
Figure 4-4 Estimation of the kinetics of neutrophil recruitment in the ear post tsetse 
exposure 
Mice were anesthetised and ears exposed to infected/uninfected tsetse bites, and ears harvested 
at the respective time points. Following ear sample processing to isolate single-cell suspensions 
post tsetse exposure, processed samples were resuspended in 200 µl volumes FACS buffer. For 
standardisation of absolute cell numbers, 100 µl of cell suspension was analysed on the flow 
cytometry machine, and the total number of cells present in the sample tube was estimated by 
Miltenyi software, and number obtained multiplied by two to calculate the total number of cells in 
the ear tissue. Neutrophils were gated as described in Figure 4.2. Neutrophils (CD11b+Ly6G+) are 
present in the top right hand quadrant of the live CD45+ cells gate. Representative dot plots of an 
infected and uninfected tsetse sample at 2 hrs (A), 6 hrs (B), 12 hrs (C) 24 hrs (D), and (E) 
untreated ear controls from naïve mice. (F) Bar graph summarised the mean neutrophil numbers, 
and (G) the proportion of neutrophils in infected, uninfected tsetse and untreated ears. Statistical 
test was estimated by comparing either infected or uninfected samples with untreated (UT) ear 
controls (*P<0.05, **P<0.01), and between infected and uninfected tsetse samples (P>0.05; not 
significant, ns) using One way ANOVA with Tukey’s post test. Data represents the mean ± SEM, 
pooled together from 3 mice per group for three independent experiments. 
 
4.2.5 Macrophage numbers in the ear skin do not change 
following tsetse exposure 
Macrophages belong to the professional phagocyte pool comprising monocytes, 
DCs, mast cells and neutrophils, due to their efficiency at phagocytosis. They are 
described as professional phagocytes due to the expression of receptors such as 
scavenger receptors or TLRs that can detect signals not normally found in 
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healthy tissues, non-self or damage responses [365]. During tissue injury, 
macrophages develop a pro-inflammatory phenotype and secrete inflammatory 
mediators such as TNF-α, NO and IL-1, which participate in the activation of 
antimicrobial mechanisms that contribute to the killing of microorganisms in vivo 
[366]. The significance of macrophages during inflammation led to the analysis 
of macrophages in ear skin post tsetse exposure, to ask if there were changes in 
numbers during inflammation in tsetse exposed samples. Macrophages were 
gated on live CD45+ CD11bint, and examined for the combined expression of 
F4/80+ and CD11b+ (Figure 4.5). Comparison of macrophage numbers in the skin 
of infected and uninfected tsetse exposed samples clearly shows that there was 
no statistically significant difference (P>0.05; One way ANOVA with Tukey’s post 
test). Further comparison of tsetse exposed samples with untreated controls also 
revealed no statistically significant changes in macrophage numbers (P>0.05; 
One way ANOVA with Tukey’s posttest). Overall, the data suggests no 
differences in macrophage numbers in the skin post tsetse bites at the time 
points analysed. 
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Figure 4-5 Kinetics of macrophage numbers following tsetse exposure.  
Following ear sample processing to isolate single-cell suspensions, processed samples were 
resuspended in 200 µl volumes FACS buffer. For flow cytometry analysis, 100 µl of cell suspension 
was analysed on the MACSQuant analyser, and the total number of cells present in the sample 
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tube was estimated by Miltenyi software by drawing gates on cells phenotyped to be macrophages. 
Identification of macrophages was carried out on live CD45+ cells that were double positives for 
CD11b and F4/80. Example dot plots for macrophages at the time points in infected and uninfected 
tsetse samples at 2 hrs (A), 6 hrs (B), 12 hrs (C) and 24 hrs (D), respectively. (E) Example plot of 
macrophages in untreated ear skin of naïve mice. (F) Bar graph represents mean macrophage 
numbers ± SEM, and (G) the proportion of macrophages in tissue. Statistical analyses were carried 
out by comparing either infected or uninfected samples to untreated controls, also between infected 
and uninfected tsetse samples (P>0.05; not significant, ns), using One way ANOVA with Tukey’s 
post test. Data represents the mean ± SEM, pooled together from 3 mice per group for three 
independent experiments. 
 
4.2.6 Inflammatory monocytes do not appear within 24 hrs post 
tsetse exposure.  
At sites of inflammation, inflammatory monocytes may be recruited from the 
blood, characterised by the expression of CD11b+ and Ly6Chi cells. Recruitment 
of inflammatory monocytes to the skin following tsetse exposure was therefore 
examined, and it was demonstrated that inflammatory monocytes were not 
recruited in the first 24 hrs post tsetse exposure (Figure 4.6). Rather, monocytes 
resident in the skin characterised by the expression of CD11b+, Ly6Clo, and Ly6G- 
were identified. Statistical comparisons of infected and uninfected tsetse 
exposed samples at each time point, suggests no significant difference (P>0.05; 
One way ANOVA with Tukey’s post test), and there was also no difference when 
infected and uninfected tsetse exposed samples were compared to untreated 
controls. 
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Figure 4-6 Kinetics of resident monocytes in the skin post tsetse bites.   
Following ear sample processing to isolate single-cell suspensions, processed samples were 
resuspended in 200 µl volumes FACS buffer. For flow cytometry analysis, 100 µl of cell suspension 
was analysed on the MACSQuant analyser, and the total number of monocytes present in the 
sample tube was estimated by Miltenyi software, by drawing gates on monocytes and number of 
cells counted multiplied by two. Identification of monocytes was carried out on live CD45+ cells that 
were double positives for CD11b+ and Ly6Clo. Example dot plots for monocytes at the time points in 
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infected/uninfected tsetse samples at 2 hrs (A), 6 hrs (B), 12 hrs (C) and 24 hrs (D), respectively. 
(E) Absolute cell counts were carried out and mean cell numbers depicted, and (F) the proportion 
of monocytes in tissue, were summarised in the bar graph. Statistical analyses was carried out by 
comparing infected/uninfected samples to untreated controls (UT), and between infected and 
uninfected tsetse samples. No statistically significant (ns) result was obtained using One way 
ANOVA with Tukey’s post test. Data represents the mean ± SEM, pooled together from 3 mice per 
group for three independent experiments.  
 
Together, the monocyte data here suggests that only skin resident monocytes 
were still present in the skin very early post tsetse exposure to mice ears. 
 
4.2.7 Activation of macrophages in the skin post tsetse exposure 
In African trypanosome infections, a type I cytokine environment typically 
predominates which fuels the generation of classically activated macrophages 
[131, 367-371]. Classically activated macrophages are developed in response to 
IFN-γ and exposure to microbes or microbial products such as LPS [372]. 
Classically activated macrophages secrete nitric oxide as well as costimulatory 
molecules such as CD86, upregulate MHCII, possess an enhanced antigen 
presenting capability and intracellular pathogen destruction [373]. MHCII is 
expressed on antigen presenting cells (APCs) such as macrophages and helps 
APCs in presenting antigens on their surface to cognate cells following processing 
in the lysosomal compartment of the cell [374]. Since the markers I used in 
phenotypic characterisation of macrophages post tsetse exposure consisted of 
anti-MHCII antibody, I measured the upregulation of MHCII on macrophages 
following tsetse exposure to determine its activation status. The data here was 
analysed using the mean fluorescent intensity (MFI) numbers to plot the 
expression levels of MHCII on macrophages in infected, uninfected tsetse 
samples, and untreated controls (Figure 4.7). At 2, 6, and 12 hrs MHCII MFI 
values on macrophages was significantly different compared to untreated 
controls (P<0.05; One way ANOVA with Tukey’s post test) in infected and 
uninfected tsetse samples with the exception of infected tsetse samples at 2 and 
12 hrs (P>0.05; One way ANOVA with Tukey’s post test). At 24 hrs infected and 
uninfected tsetse samples, were not significantly different from untreated 
controls (P>0.05; One way ANOVA with Tukey’s post test).  
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Figure 4-7 Upregulation of MHCII on macrophages in the ear skin post tsetse exposure.  
Following the processing of tissue and identification of macrophages (gated as described in Figure 
4.2), expression levels of MHCII was investigated. (A) Bar graph depicting MFI values of MHCII 
expression on macrophages. Histogram plots for macrophage expression of MHCII at the time 
points in infected and uninfected tsetse exposed samples at 2 hrs (B), 6 hrs (C), 12 hrs (D) and 24 
hrs (E), respectively. Statistical analysis was carried out using One-way ANOVA with Tukey’s post 
test (*P<0.05, **P<0.01). No significant (ns) difference was observed between infected and 
uninfected tsetse samples. Data represents the mean ± SEM, pooled together from 3 mice per 
group for three independent experiments. Green, yellow, red and grey lines represent a single 
mouse. 
 
4.2.8 Characterisation of the inflammatory profile in the ear  
4.2.8.1 Assessment of RNA quality from ear and draining lymph node of 
mice exposed to tsetse  
Following the identification and characterisation of the kinetics of cells 
recruited post tsetse exposure to ear samples, I next sought to characterise the 
expression profile of inflammation-associated genes in the skin and draining 
lymph node of C57Bl/6 mice. Two and twelve hours were identified as 
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appropriate time points based on the kinetics of neutrophil recruitment to the 
skin post tsetse exposure. Characterisation of inflammation associated genes was 
carried out by exposing infected and uninfected tsetses to mice ears, sampling 
tissues at 2 and 12 hours post exposure, extracting total RNA, and analysing the 
RNA obtained on a custom Taqman Low-Density Array (TLDA) microfluidic card. 
Prior to the TLDA analysis, the quality of RNA obtained from tissues was analysed 
using the Agilent 2100 Bioanalyser platform. The Agilent 2100 Bioanalyser 
provides the RNA integrity number (RIN), a ratio of 28S/18S, as well as an 
electrophoregram that gives information on the degree of noise and low 
molecular weight contamination [277], as shown in Figure 4.8. The 
electrophoregram also showed distinct and clear 18S and 28S bands, which was 
also an indicator of RNA quality. Only samples with RIN > 8.0 were used for 
downstream TLDA analysis. After confirmation of the quality of RNA to be used 
for analysis in the TLDA assay, approximately 1500 ng of total RNA was used for 
complementary DNA (cDNA) synthesis and downstream TLDA analysis.  
TLDA is a customised 384-well microfluidic card (Applied Biosystems) containing 
primers and probes for pre-selected chemokines and inflammatory cytokines. In 
all, the format selected was able to allow profiling for 32 genes for total RNA 
from skin, and 64 genes for total RNA from lymph node implicated in 
inflammatory responses. All gene expression levels were firstly normalised to 
18S, and then calibrated to untreated controls to obtain fold changes (ΔΔCT, 
where CT is the threshold cycle). Therefore for these studies, a fold change of ≥1 
or ≤1, meant that exposure to tsetse (infected and uninfected) induced 
upregulation or downregulation in that gene’s expression compared to untreated 
controls respectively. To allow a direct comparison of the modulation of gene 
expression in response to infected and uninfected tsetse exposure, fold changes 
were plotted on a logarithmic scale. Statistical significance for differences in 
fold change in expression of each gene was calculated using a 2-tailed Mann 
Whitney U test. 
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Figure 4-8 Assessment of RNA quality isolated from mouse ear skin and draining lymph 
node tissues isolated post tsetse exposure.  
Total RNA was isolated from mouse ears, and draining lymph nodes (dLN) exposed to tsetses or 
untreated control tissues as described in materials and methods. RNA quality was assessed using 
the Agilent 2100 Bioanalyser. (A) Representative gel image of total RNA isolated from ears of 
infected tsetse exposed ear samples (lanes 1-3, 6-7), uninfected tsetse exposed ears (lanes 4-5, 8-
9) isolated 12 hrs post probes, untreated controls (UT) (lanes 10-11), lane 12 is the internal control 
for the assay, Lane L: size marker (nucleotides, nt). (B) Electrophoregrams for each sample in the 
gel (A) is shown. The x-axis represents amplicons size (nt), while the y-axis represents the 
fluorescence units (FU). The electrophoregrams shows two peaks, 18S and 28S.  
 
Chapter 4  125 
 
4.2.8.2 Inflammatory profile in the ear at 2 and 12 hrs post tsetse exposure 
To better understand the mechanisms guiding leukocyte recruitment to the skin 
post tsetse exposure, an assessment of inflammation-associated genes in the skin 
was carried out by TLDA. The TLDA microfluidic card consisted of 32 genes, and 
the genes analysed were cytokines: TNF-α, IL-6, IL-10, IL-13, CD45, GM-CSF, CC 
chemokines: CCL2, 3, 4, 6, 7, 19, 27, CXC chemokines: CXCL1, 2, 3, 5, 10, 11, 
12, 13, CC receptors: CCR2, 3, 4, 5, 7, 10, CXC receptors: CXCR2, 4, 5 and 
Fractalkine receptor, comprising wells preloaded with reagents for qPCR to 
detect the cDNA, therefore expression level of an array of 32 genes. Samples 
were analysed as described in section 4.2.8.1. 
4.2.8.3 CC chemokine upregulation in mice ears at 2 and 12 hrs post tsetse 
exposure 
The CC chemokines that were upregulated at 2 hrs were CCL2, CCL4 and CCL7 
(Figure 4.9A). For CCL2 gene expression in the skin following tsetse exposure, 
there was a <10-fold increase in infected and uninfected tsetse samples. For 
CCL4, there was a 10-fold change in gene expression in both infected and 
uninfected tsetse samples. Lastly, at 2 hrs CCL7 gave a fold change in expression 
of <10 in both infected and uninfected tsetse samples. In all, the CC chemokines 
upregulated at 2 hrs were not statistically different between infected and 
uninfected tsetse exposed samples (P>0.05; 2-tailed Mann Whitney U test).  
Next, I investigated infected and uninfected tsetse samples post exposure at 12 
hrs. CCL2, CCL5 and CCL7 were the three CC chemokines upregulated (Figure 
4.9B). At 12 hrs, CCL2 and CCL7 gave fold change in gene expression ≥1≤10 in 
both infected and uninfected tsetse samples, while CCL5 fold change in gene 
expression was only observed in uninfected tsetse samples (Figure 4.9B). Fold 
changes in gene expression of CCL2, CCL5 and CCL7 post tsetse exposure were 
not significant (P>0.05; 2-tailed Mann Whitney U test).  
In summary, the presence or absence of T. b. brucei in the tsetse fly made no 
significant impact on inflammatory CC chemokines upregulation. 
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Figure 4-9 CC-chemokine expression did not differ at 2 and 12 hrs in infected and 
uninfected samples post tsetse exposure to the ear skin.  
Infected and Uninfected tsetses were exposed to ears of C57Bl/6 mice, and ears collected at 2 and 
12 hrs for total RNA isolation. 1500 ng of total RNA was used for cDNA synthesis diluted 1:5 and 
then used for chemokine gene analysis using Taqman Low Density Analysis. Gene expression was 
normalised with the housekeeping gene 18S, then RQ (relative quantification) values were set to 1 
using an untreated ear control to calibrate samples and work out gene expression levels to obtain 
fold changes (ΔΔCT). RQ values in the plots were depicted as fold changes. Each sample was 
tested in triplicate and data represents the mean ± SEM. (A) Bar graph show CC genes that gave 
fold changes ≥ 1 at 2 hrs were CCL2, CCL4, and CCL7. (B) CCL2, CCL5, and CCL7 gave fold 
changes ≥ 1 at 12 hrs. Statistical analysis to compare fold changes in gene expression induced 
following tsetse exposure was carried out using 2-tailed Mann-Whitney U test. No significant (ns) 
differences (P>0.05) were observed between infected and uninfected tsetse samples with the 
exception of CCL5 at 12 hrs (*P<0.05). Data depicts fold changes of pooled values from 3 mice per 
group. 
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4.2.8.4 CXC chemokine upregulation in mice ears at 2 and 12 hrs post tsetse 
exposure 
The CXC chemokine signatures followed a similar differential regulation pattern 
to the CC chemokines. At 2 & 12 hrs, CXCL1 and CXCL2 were the CXC 
chemokines that were upregulated post tsetse exposure. At 2 hrs, CXCL1 in 
uninfected tsetse exposed samples gave fold change values >10 fold in both 
infected and uninfected tsetse samples with no statistically significant 
difference (P>0.05; 2-tailed Mann Whitney U test) between infected and 
uninfected tsetse samples. At 12 hrs post tsetse exposure, CXCL1 expression was 
at base line level (similar to untreated controls i.e. gave a value of 1) in infected 
and uninfected tsetse exposed samples.  
For CXCL2 expression in infected tsetse samples at both time points (2 and 12 
hrs), fold changes were at base line level. While uninfected tsetse gave fold 
change values of ~1.5 and 6.5 respectively at 2 and 12 hrs (Figure 4.10). 
 
Figure 4-10 CXC-chemokine expression did not differ at 2 and 12 hrs in infected and 
uninfected samples post tsetse exposure to the ear skin. 
Infected and Uninfected tsetses were exposed to ears of C57Bl/6 mice, and ears collected at 2 and 
12 hrs for total RNA isolation. 1500 ng of total RNA was used for cDNA synthesis diluted 1:5 and 
then used for chemokine gene analysis using Taqman Low Density Analysis. Gene expression was 
normalised with the housekeeping gene 18S, then RQ (relative quantification) values were set to 1 
using an untreated ear control to calibrate samples and work out gene expression levels to obtain 
fold changes (ΔΔCT). RQ values in the plots were depicted as fold changes. Each sample was 
tested in triplicate and data represents the mean ± SEM. (A) Bar graph show fold changes ~12 at 2 
hrs for both CXCL1 and CXCL2. (B) At 12 hrs, CXCL2 expression was detected only in uninfected 
tsetse samples with fold change of ~6.5. Statistical analysis to compare fold change in gene 
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expression induced following tsetse exposure was carried out using 2-tailed Mann-Whitney U test. 
No significant (ns) differences were observed between infected and uninfected tsetse samples 
(P>0.05) with the exception of CXCL2 (*P<0.05) in both infected samples at 2 and 12 hrs. Data 
depicts fold changes of pooled values from 3 mice per group. 
 
4.2.8.5 CX3CL1 expression in mice ears at 12 hrs post tsetse exposure 
CX3CL1 a potent chemoattractant of T cells and monocytes was investigated at 2 
and 12 hrs. At 2 hrs, in infected and uninfected tsetse exposed samples, CX3CL1 
was expressed at levels similar to naïve controls, while at 12 hrs fold changes 
were ~ 1.5 in both infected and uninfected tsetse samples (Figure 4.11). Hence 
at 12 hrs, CX3CL1 expression was not significantly different between infected 
and uninfected tsetse samples (P>0.05; 2-tailed, Mann Whitney U test).  
 
Figure 4-11 CX3CL1 expression in the ear skin at 12 hrs post tsetse exposure. 
Infected and Uninfected tsetses were exposed to ears of C57Bl/6 mice, and ears collected at 12 
hrs for total RNA isolation. 1500 ng of total RNA was used for cDNA synthesis diluted 1:5 and then 
used for chemokine and cytokine gene analysis using Taqman Low Density Analysis. Gene 
expression was normalised with the housekeeping gene 18S, then RQ (relative quantification) 
values were set to 1 using an untreated ear control to calibrate samples and work out gene 
expression levels to obtain fold changes (ΔΔCT). RQ values in the plots were depicted as fold 
changes. Each sample was tested in triplicate and data represents the mean ± SEM. Bar graph 
shows CX3CL1 gene expression, fold changes ~ 1.5 at 12 hrs in both infected and uninfected 
samples. No significant (ns) difference (P>0.05) was observed between infected and uninfected 
tsetse samples, 2-tailed Mann-Whitney U test. Data depicts fold changes of pooled values from 3 
mice per group. 
 
 
4.2.8.6 Inflammatory cytokine expression post tsetse exposure at 2 and 12 
hrs 
The cytokine genes upregulated at 2 hrs in response to infected and uninfected 
tsetse exposure were IL-1β, macrophage colony stimulating factor (M-CSF) and 
IL-6 (Figure 4.12A). IL-1β gave fold change expression of <10 fold in both tsetse 
exposed samples, while IL-6 gave ~100 fold increase in infected and uninfected 
tsetse samples. M-CSF fold change values of <10 was also observed in infected 
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and uninfected tsetse exposed samples at 2 hrs, with no statistically significant 
difference in cytokine fold changes between infected and uninfected tsetse 
exposed samples at 2 hrs (P>0.05; 2-tailed, Mann Whitney U test). 
At 12 hrs only IL-1β was upregulated (Figure 4.12B), following infected and 
uninfected tsetse exposure. IL-1β gave fold changes ~8 and 12 fold in infected 
and uninfected tsetse samples respectively. No statistically significant difference 
was observed when both tsetse-exposed groups were compared (P>0.05; 2-
tailed, Mann Whitney U test). Unexpectedly, I observed a 30-fold change in the 
anti-inflammatory cytokine IL-10 in infected tsetse sample at 2 hrs, which was 
completely undetected in uninfected tsetse samples. Further analysis to 
investigate the upregulation of IL-10 at 12 hrs, or absolute quantification by 
qPCR did not detect its expression. 
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Figure 4-12 Inflammatory cytokine expression at 2 and 12 hrs in the ear skin post tsetse 
exposure.  
Infected and Uninfected tsetses were exposed to ears of C57Bl/6 mice, and ears collected at 2 and 
12 hrs for total RNA isolation. 1500 ng of total RNA was used for cDNA synthesis diluted 1:5 and 
then used for chemokine and cytokine gene analysis using Taqman Low Density Analysis. Gene 
expression was normalised with the housekeeping gene 18S, then RQ (relative quantification) 
values were set to 1 using an untreated ear control to calibrate samples and work out gene 
expression levels to obtain fold changes (ΔΔCT). RQ values in the plots were depicted as fold 
changes. Each sample was tested in triplicate and data represents the mean ± SEM. (A) Bar graph 
showing IL-1β, IL-6, IL-10 and M-CSF fold changes at 2 hrs. (B) At 12 hrs, bar graph shows IL-1β 
fold change. No significant (ns) difference was observed using 2-tailed Mann-Whitney U test, 
P>0.05, with the exception of IL-10 (*P<0.05). Data depicts fold changes of pooled values from 3 
mice per group. 
 
A summary of the results of all the genes analysed is given in Table 4.1 below. 
Table 4-1. Summary of the results of bar graphs presented for genes analysed 
at 2 and 12 hrs. 
Genes analysed at 
2 and 12 hrs 
Infected tsetse 
Upregulated/downregulated 
(+/-) 
Uninfected tsetse 
Upregulated/downregulated 
(+/-) 
CCL2 + + 
CCL4 + + 
CCL5 - + 
CCL7 + + 
CXCL1 + + 
CXCL2 - + 
CXC3CL1 + + 
IL-1β + + 
IL-6 + + 
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IL-10 + - 
MCSF + + 
+ = upregulated, - = downregulated 
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4.2.9 Summary of gene upregulation in the skin post tsetse 
exposure 
The aim of this section was to characterise the inflammatory profile in the skin 
following T. b. brucei infected and uninfected tsetse exposure, and also 
investigate whether there were differences between infected and uninfected 
tsetse samples. There were no statistically significant differences in 
inflammatory chemokine and cytokine genes upregulated between infected and 
uninfected tsetse exposed samples at the time points analysed.  
 
Figure 4-13 Summary of total genes analysed by Taqman Low Density Arrays at 2 and 12 
hrs in the ear skin post tsetse exposure.  
Infected and Uninfected tsetses were exposed to ears of C57Bl/6 mice, and ears collected at 2 and 
12 hrs for total RNA isolation. 1.5 µg of total RNA was used for cDNA synthesis diluted 1:5 and 
then used for chemokine and cytokine gene analysis using Taqman Low Density Analysis. Gene 
expression was normalised with the housekeeping gene 18S, then RQ (relative quantification) 
values were set to 1 using an untreated ear control to normalise samples and work out gene 
expression levels to obtain fold changes (ΔΔCT). Fold change values were computed as an 
increment over untreated controls. The expression data obtained from all the genes analysed at 2 
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and 12 hrs post tsetse bites are summarised above. The scoring system for classifying the colours 
is also indicated above. Genes that were undetectable on the TLDA microfluidic card are coloured 
black.  
 
Chemokines are important for leukocyte trafficking to sites of inflammation, and 
perform immunosurveillance roles in the skin. In this study, it has been shown 
that the CXC chemokines CXCL1, CXCL2, and CXCL5 were in the skin post tsetse 
bites. The pro-inflammatory chemokines CXCL1, CXCL2, and CXCL5 are 
associated with neutrophil extravasation from blood and bind the receptor 
CXCR1/CXCR2 during infection. CXCL1 and CXCL2 together with other 
proinflammatory CC chemokines upregulated in this study, such as CCL2, CCL4, 
CCL5 and CCL7 are important for neutrophil, macrophage and monocyte 
recruitment during inflammation. The presence of neutrophils in my model post 
tsetse exposure as confirmed by flow cytometry lends credence to the role of 
these pro-inflammatory chemokines in neutrophil extravasation [375]. Also, the 
fractalkine receptor CX3CL1 was upregulated at 12 hrs, and has been indicated 
to induce the accumulation of mature mast cells in the skin during inflammation. 
In the course of the transcript analysis from the skin post tsetse bites, I also 
identified the upregulation of pro-inflammatory cytokines IL-6 and IL-1β. IL-1β 
which can be produced by activated cells such as monocytes and macrophages, 
or non-immune cells such as fibroblasts and endothelial cells during injury, 
infection or inflammation, was consistently secreted at the two time points (2 
and 12 hrs) used for TLDA studies. The production of IL-1β, which was present in 
both infected and uninfected tsetse samples, may be likely due to the damage 
from the tsetse proboscis to the skin. IL-6 a pleiotropic cytokine was 
upregulated, albeit only at 2 hrs. The role of IL-6 has described to be essential in 
the differentiation of Th17 cells and it is involved in a wide range of biological 
activities such as immune regulation, hematopoiesis, inflammation and 
oncogenesis. Interestingly, there was also the upregulation of an anti-
inflammatory cytokine IL-10 in the infected tsetse sample at 2 hrs, which was 
significant when compared with the uninfected tsetse sample, which showed no 
upregulation. Anti-inflammatory cytokines dampen the expression of pro-
inflammatory cytokines. In the context of this infection model, IL-10 may 
dampen the production of pro-inflammatory cytokines in order to allow for 
parasite establishment in the skin, prior to dissemination into the blood stream 
[122]. Other chemokines such as CCL5 and CXCL2 were also downregulated in 
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the infected tsetse samples only. This might suggest that the presence of 
parasites in the tsetse was contributing to some form of anti-inflammatory role 
following tsetse bites. The upregulation of an anti-inflammatory cytokine IL-10 
and the downregulation of monocyte/neutrophil chemokines CCL5 and CXCL2 in 
infected tsetse samples, suggests that T. b. brucei may possess an anti-
inflammatory role. 
Taken together, the gene expression data here agrees with the flow cytometry 
data that there were no significant differences between infected and uninfected 
samples post tsetse exposure. The data here aso suggests a significant 
downregulation of chemokines involved in leukocyte chemotaxis (CCL5 and 
CXCL2) and a significant upregulation of an anti-inflammatory cytokine (IL-10) in 
infected tsetse samples. This suggests that inflammation events very early in the 
skin may be triggered by the tsetse damage and the presence of parasites in the 
skin might contribute to an anti-inflammatory role in vivo.  
4.2.10 Inflammatory profile of the lymph node post tsetse 
 exposure  
Following the analysis of the inflammatory genes triggered post tsetse exposure 
to mice ears, the inflammatory profile of the draining lymph node (LN) of mice 
was also analysed using TLDA. This was carried out using a customised TLDA 
microfluidic card that consisted of 64 customised genes, and was kindly supplied 
as a gift by Dr. Clive McKimme. The TLDA microfluidic card contained CC ligands 
(CCL) 1-28, CXC ligands (CXCL) 1-17, CX3CL1, XCL1, innate immunity genes TNF-
α, IL-6, IL-1α, IFN-α, IFN-β, IL-1β, adaptive immune genes and pathogen 
recognition receptors, comprising wells preloaded with reagents for qPCR to 
detect the cDNA, therefore expression level of an array of 64 genes. The 
housekeeping gene, 18S that was constitutively expressed in the LN was used to 
normalise gene expression levels prior to determining fold expression changes by 
calibrating with untreated control samples. Analysis was carried out in a similar 
manner to TLDA analysis of skin data as described in section 4.2.8.1. 
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4.2.10.1 Expression of chemokines in the draining lymph node at 2 and 
 12 hrs post tsetse exposure 
At 2 hrs, the chemokines and cytokines analysed suggested that there were no 
fold changes in gene expression above base line levels (i.e. untreated controls) 
in the lymph node.  
At 12 hrs, only 7 of the 64 genes analysed on the TLDA microfluidic cards were 
upregulated following exposure to infected and uninfected tsetses. Those genes 
upregulated were CC ligands; CCL7, CCL20, CCL28, and CXC ligands; CXCL2, 
CXCL5, CXCL10, and CXCL17. For CCL7 and CCL20, fold changes of <10 were 
observed in infected and uninfected tsetse exposed samples (Figure 4.14A). For 
CCL28, infected and uninfected tsetse exposed samples gave fold change values 
>500 at 12 hrs. No statistically significant difference between infected and 
uninfected tsetse samples was observed in the CC chemokines that were 
upregulated (P>0.05; 2-tailed, Mann Whitney U test). 
The CXC chemokines that were upregulated following infected and uninfected 
tsetse exposure at 12 hrs were CXCL2, CXCL5, CXCL10, and CXCL13 (Figure 
4.14B). CXCL2, CXCL5 and CXCL10 gave fold changes ≥10<100 in infected and 
uninfected tsetse samples. CXCL17 gave fold change values of >10<100 in 
infected and uninfected tsetse samples. No statistically significant difference 
(P>0.05; 2-tailed, Mann Whitney U test) was observed for CXC chemokine fold 
change gene expression between infected and uninfected tsetse samples in the 
draining LN at 12 hrs.  
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Figure 4-14 CC and CXC-chemokine upregulation at 12 hrs in the draining lymph node post 
tsetse exposure  
Infected and Uninfected tsetses were exposed to ears of C57Bl/6 mice, and ears collected at 12 
hrs for total RNA isolation. 1500 ng of total RNA was used for cDNA synthesis diluted 1:5 and then 
used for chemokine and cytokine gene analysis using Taqman Low Density Analysis. Gene 
expression was normalised with the housekeeping gene 18S, then RQ (relative quantification) 
values were set to 1 using an untreated lymph node control to calibrate samples and work out gene 
expression levels to obtain fold changes (ΔΔCT). RQ values in the plots were depicted as fold 
changes. Each sample was tested in triplicate and data represents the mean ± SEM. (A) Bar 
graphs show CCL7, CCL20 and CCL28 fold changes, (B) CXCL2, CXCL5, CXCL10 and CXCL17. 
No significant (ns) difference (P>0.05) was observed between infected and uninfected tsetse 
samples using 2-tailed Mann-Whitney U test. Data depicts fold changes of pooled values from 3 
mice per group. 
. 
 
In summary, the chemokine genes that were upregulated in the draining LN at 12 
hrs post tsetse exposure were not significantly different between infected and 
uninfected tsetse samples.  
4.2.11 Summary of gene upregulation in the draining LN post 
 tsetse exposure 
At 12 hrs, it was demonstrated that only inflammatory CC chemokines CCL7, 
CCL20 and CCL28 were upregulated, while CXC chemokines, CXCL2, CXCL5, 
CXCL10 and CXCL17 were upregulated in both infected and uninfected tsetse 
exposed samples.  
CXCL10, which was upregulated in the LN at 12 hrs, is an agonist for CXCR3, 
which is expressed on Th1 cells, and also antagonizes CCR3 expressed on Th2 
cells. This suggests that the upregulation of CXCL10 in the lymph node post 
tsetse exposure could contribute to the polarisation of the immune response to a 
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Th1 type [376]. CXCL5 an LPS-induced CXC chemokine could have been 
upregulated in the lymph node as a result of the bacteria released from the 
saliva components of the tsetse fly. CXCL5, similar to CXCL2 binds CXCR2 a 
neutrophil receptor, and has a role in neutrophil recruitment, as it has been 
described to be involved in neutrophil recruitment in lungs of mice infected with 
M. tuberculosis [377]. 
 In all, temporal upregulation of inflammation-associated genes in the draining 
LN was < 100 fold in almost all the genes analysed, and there was no difference 
between infected and uninfected tsetse exposed LN samples, similar to the 
findings reported in tsetse exposed mice ears.  
4.2.12 Depletion of neutrophils  
4.2.12.1 Establishing the protocol for neutrophil depletion 
From section 4.2.4, it was established that neutrophils were the first cells that 
were recruited very early to the bite site, either in infected or uninfected tsetse 
exposed samples. The aim of this section was to investigate the depletion of 
neutrophils and the functional consequence of depletion in parasite 
dissemination from the bite site to the blood stream. In order to deplete 
neutrophils from C57Bl/6 mice, a well-established model for neutrophil 
depletion was applied [378, 379]. Following administration of anti-Ly6G or 
isotype control antibodies, mice were kept for 16 hrs prior to infections. The 
first experiment was to test that depletion of neutrophils using anti-Ly6G was 
successful. Sixteen hours post administration of anti-Ly6G and setting up the 
appropriate controls, mice were treated with 10 µg/ml LPS to observe the 
recruitment of neutrophils for 6 hrs, when neutrophils were previously reported 
to be observed in the skin in our lab. LPS was used as a model to test the success 
of neutrophil depletions in mice, because it is a well-established model of 
inflammation in tissues [380-382]. As shown in Figure 4.15 neutrophils were 
successfully depleted in anti-Ly6G treated mice post LPS treatment. 
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Figure 4-15 Setting up the neutrophil depletion study.  
C57Bl/6 mice were injected intraperitoneally with 1 mg anti-Ly6G or isotype control antibodies and 
left for 16 hrs. Sixteen hours post injection of mice with antibodies, ear pinna of anti-Ly6G (1A8) 
and isotype treated mice were injected subcutaneously with 10 µg/ml of LPS. Six hours later, ear 
skin was collected and digested using hyaluronidase and collagenase type IV, and ground in a 
tissue-lysing machine. Cell suspension was spun down and passed through a 40- µm cell strainer 
to collect cells. Cells were then prepared for leukocyte staining as described in the materials and 
methods. The gating strategy described in figure 4.2 was applied, and neutrophils identified by the 
markers CD11b and Ly6G. Representative plots of neutrophils in the top right hand quadrant in (A) 
naïve control, (B) isotype control, and (C) anti-Ly6G treated mice. Data representative of 3 mice 
per group. 
 
4.2.12.2 Impact of Neutrophil depletion on African trypanosome 
 infection via tsetse transmission 
Once it was established that depletion of neutrophils was successful, it was then 
applied to T. b. brucei infection model. One mg anti-ly6G or isotype antibody 
was administered 16 hrs prior to T. b. brucei infected tsetse exposure to mice 
ear skin. Parasitemia was observed on a daily basis for the first 9 days. Mice 
treated with anti-ly6G showed parasitemia, as early as 2 days post infected 
tsetse exposure compared with isotype control antibody treated and naive 
controls. Isotype and untreated controls gave parasitemia from 3 and 4 days post 
infection in C57Bl/6 mice. Statistical analyses to compare the parasitemia in 
mice from the three groups revealed no statistically significant difference across 
the time points analysed (P>0.05; One way ANOVA with Bonferroni multiple 
test). Together, the data suggests that neutrophil depletion resulted in a minor 
increase in the appearance of parasites with no further impact on parasite 
dissemination. 
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Figure 4-16 Depletion of neutrophils causes an early appearance of parasitemia.  
Mice were administered anti-Ly6G or isotype control 2A3 antibodies for 16 hrs prior to infection via 
tsetse flies. Untreated control mice were also included in the infections. Parasitemia was monitored 
over 9 days with neutrophil depleted mice producing an earlier appearance of parasites from day 2 
compared with isotype controls and untreated mice. Statistical analyses to compare differences in 
parasitemia between the three groups were carried out using one-way ANOVA (Bonferroni multiple 
test) [(Data pooled from 4 mice per group for 2 independent experiments)]. No significant 
differences were observed (P>0.05).  
 
4.3 General summary 
At the start of this study, it was hypothesised that tsetse exposure to the skin 
would cause a rapid influx of inflammatory cells to the bite site, which would 
differ significantly between infected and uninfected tsetse exposed samples. To 
test the hypothesis, I set out to carry out flow cytometry to characterise the 
kinetics, and identity of cells that were recruited to the bite site, followed by a 
transcript analysis to identify inflammatory mediators. The findings here suggest 
that the presence or absence of infection in the tsetse did not impact on the 
recruitment of cells to the bite site when infected and uninfected tsetse 
exposed samples were compared statistically. However, in both groups (infected 
and uninfected tsetse exposed), there were statistically significant differences 
in cellular recruitment compared to untreated controls. This suggested that 
mechanical trauma from probing, and the saliva of the tsetse fly may be 
responsible for the influx of neutrophils into tissue. Transcript analysis of 
inflammatory mediators revealed the fold changes of chemokines and cytokines 
during tsetse induced inflammation. Overall, the TLDA data here followed a 
similar pattern with the flow cytometry data indicating no significant difference 
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between infected and uninfected tsetse exposed samples in most of the 
chemokines and cytokines analysed. However, I observed the downregulation of 
leukocyte attracting chemokines such as CCL5 and CXCL2, and an upregulation of 
IL-10 in infected tsetse samples. CXCL1/CXCL2, chemokines associated with 
neutrophil extravasation were also upregulated. The transcript data agree with 
the findings from my flow cytometry data that it was the impact of the vector, 
and not the parasites that mediated inflammation in the skin. A summary of the 
earliest events in the skin and draining lymph node post tsetse exposure is 
described in figure 4.17. 
The identification of neutrophils as the main immune cell type recruited within 
the first 24 hrs, led to further investigation of its role in pathogenesis. Hence the 
need to ask how mechanical trauma caused by tsetse probing would have an 
impact on parasite dissemination from the skin into the blood via the 
lymphatics. To address this, infections were carried out via the tsetse fly in 
neutrophil depleted mice. Depleting neutrophils from mice prior to infection 
gave similar parasitemia in neutrophil replete and deficient mice. A general 
discussion of the key findings of the results section and how it relates to 
pathogenesis are discussed below. 
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Figure 4-17 Summary of the earliest events in the skin and draining lymph node at the 
molecular and cellular level post tsetse exposure.  
Disruption of mice skin barrier by infected or uninfected tsetse exposure triggers a coordinated 
immune response to maintain skin homeostasis. Keratinocytes, which are normally present in the 
epidermis, can respond through production of pro-inflammatory cytokines such as IL-1β, and IL-6, 
that were upregulated within the first 12 hrs as shown by TLDA. Langerhans cells (not 
characterised by flow cytometry) present in the epidermis also act as key immunological sentinels. 
Macrophages and monocytes in the skin were activated and released pro-inflammatory 
chemokines such as CCL2, CCL4, CCL5, CCL7 and the fractalkine receptor (CX3CL1), which are 
involved in the recruitment of cells to sites of inflammation or infection post tsetse exposure. 
Dermal DCs which express CCR7 and have migratory capabilities can are also present in the skin 
(not characterised by flow cytometry). Neutrophils were recruited from the blood within the first 2 
hrs post tsetse exposure (as shown by flow cytometry) through the blood vessels to the site of 
tissue damage- most likely in a CXCL1/CXCL2 dependent manner based on the upregulation of 
these chemokines by TLDA. Metacyclic T. b. brucei injected into the dermis can also navigate 
through the anatomy and migrate into the lymphatics (see chapter 5 for further details) and access 
the draining LN within the first 6 hrs. In the LN, the molecular events within the first 12 hrs involved 
upregulation of pro-inflammatory chemokines such as CXCL2, CXCL5, CXCL10, CCL7, CCL20 
and CCL28. The chemokines upregulated in the draining lymph node can promote recruitment of 
neutrophils and monocytes. Green arrow= upregulated, red arrow= downregulated chemokines/ 
cytokines in the skin/LN. 
 
4.4 Discussion of the molecular and cellular events in the 
skin post tsetse bites 
To my knowledge, no study has been carried out to investigate the very earliest 
events (within 24 hrs) at the inoculation site using the tsetse, and 
characterisation of the kinetics of these events. Most studies on the immune 
response in African trypanosomes have been based on intravenous or 
intraperitoneal routes of infection, which investigated the downstream immune 
events [359, 361, 362, 383, 384]. Other studies have focussed on events in the 
stage 2 of the disease in mouse models, especially invasion of the central 
nervous system [237, 385-387]. As important as these studies are, most have 
neglected the skin stage of disease, which is the first step in parasite entry into 
mammals, where parasites encounter cells and interact with host anatomy prior 
to dissemination into the blood.  
This study identified the leukocytes recruited to the skin, and the kinetics of 
recruitment within the first 24 hrs in response to tsetse exposure. Temporal 
analysis of the events in the skin revealed that neutrophils were the 
predominant responders post tsetse exposure. As early as 2 hrs following tsetse 
exposure, neutrophils rapidly influxed the bite site, with maximum neutrophil 
numbers at that time point. Neutrophil recruitment appeared to be initiated by 
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damage caused by the tsetse fly probe rather than parasite entry into the skin, 
as demonstrated by lack of any statistically significant difference between 
infected and uninfected tsetse exposed samples. The early influx of neutrophils 
at the bite site is in agreement with the role of neutrophils as the first 
responders during wound healing, and clearance of pathogenic substances from 
tissues [388]. Neutrophils as key players of innate immunity carry out their 
primary function, which is to protect against bacteria or parasitic infections 
through their ability to recognize, phagocytose, and destroy pathogenic 
organisms via the release of proteases and reactive oxygen species [389-392]. 
Neutrophils also regulate the immune response through the release of IL-1, IL-3, 
IL-6, IL-12 and TNF-α, as well as chemokines such as CCL2, CCL3, CCL19 and 
CCL20. Neutrophil recruitment to sites of inflammation could be in response to 
endogenous factors released from the site of tissue damage, as demonstrated in 
the influx of neutrophils to laser induced brain injury [393]. This suggests that 
the initial influx of neutrophils to the bite site may be in response to endogenous 
factors released following mechanical trauma to the skin by the tsetse fly, the 
presence of tsetse derived factors in the saliva which could mimic a tissue 
damage signal, or possibly activate chemokine/chemokine receptor pathway to 
cause neutrophil recruitment [394].  
In cutaneous leishmaniasis delivered by the bite of the sand fly vector, 
neutrophils recruited to the site of tissue damage have been implicated in two 
roles in vivo- in protecting the host during infection, and also promoting disease 
following transmission of parasites [395-400]. The use of sand fly in initiating 
Leishmania spp. infection also demonstrated the persistence of neutrophils at 
the inoculation site when infected and uninfected sand flies were used for 
pathogen delivery [165, 339]. In this study however, using infected and 
uninfected tsetse flies, I do not observe a persistence of neutrophils following 
tsetse exposure, as observed in cutaneous leishmaniasis. However, the findings 
here were consistent with the Leishmania model, where the vector bite was 
sufficient to drive in a rapid and robust neutrophil influx irrespective of the 
infection status of the vector [166].  
The saliva of the tsetse fly is made up of a number of substances capable of 
initiating cellular recruitment, aiding tsetse fly feed, and parasite establishment 
in the skin of mammals. The tsetse fly saliva constituents include tsetse 
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thrombin initiator which facilitates blood feeding [401], putative endonucleases 
such as tsetse salivary gland proteins 1 and 2 [402], and an antigen5 related 
allergen [403]. The tsetse fly saliva also contains a number of proteins with 
unknown functions which are essential for the haematophagous behaviour of the 
tsetse fly by antagonising mammalian host responses such as vasoconstriction, 
platelet aggregation and coagulation reactions [329, 401, 404]. In the tsetse fly, 
an anti inflammatory role for the saliva has been described where it biases the 
host immune response towards a Th2 associated cytokine response, and also 
enhanced an early onset of infection in mouse models, when blood stage T. b. 
brucei were coinjected with tsetse saliva, compared to wild-type control mice 
infected without tsetse saliva [186, 188]. The occurrence of a Th2 associated 
cytokine response due to the saliva components of the vector has also been 
described in ticks [405, 406]. Similar observations of host immune modulation 
have been made with the saliva of sand flies in promoting parasite 
establishment. For example, salivary gland homogenates of Lutzomyia 
longipalpis induced the expression of CCL2, which led to the recruitment of 
macrophages, while saliva from Phlebotomus papatasi also attracted 
macrophages with increased parasite loads in order to aid parasite dissemination 
[394, 407]. In general, the saliva of vectors seems to produce an anti-
inflammatory response, inhibiting pro-inflammatory responses that help to 
promote parasite establishment. 
T. b. brucei being extracellular parasites, which release a number of proteases, 
and with rapid motility in vivo was hypothesised to trigger the innate immune 
response generated by the host post tsetse exposure. To my surprise this was not 
the case, it appeared that the presence of these extracellular free-living 
parasites in the skin, which are highly motile did not influence the outcome of 
the innate immune response within the time points analysed. The findings here 
are similar to observations in cutaneous leishmaniasis studies using the sand fly, 
suggesting there is no significant impact of T. b. brucei parasites in modulating 
the early inflammatory response [388, 408]. Although I report in this part of my 
study that there was no significant difference between infected and uninfected 
tsetse samples, there is the likelihood that the sample sizes used in this study 
was not sufficient enough to produce statistically significant difference between 
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the two groups. Hence, it is important to note this limitation in sample size 
when considering the findings in this part of the study. 
The functional role of neutrophils in pathogenesis, has been described in 
Leishmania spp. infections, where the use of neutrophil replete and deficient 
mice have been used to describe the Trojan horse hypothesis for Leishmania 
pathogenesis [166, 395]. Depleting neutrophils in our model suggests that the 
absence of neutrophils at the bite site was not sufficient to impair parasite 
dissemination or promote host resistance contrary to reports in Leishmania 
major sand fly transmitted infections [166]. T. b. brucei parasites did not 
demonstrate any difference in neutrophil deficient mice compared to neutrophil 
replete mice, with parasitemia in both groups adopting a similar pattern later on 
in infection. Neutrophil depletion in cutaneous leishmaniasis promotes host 
resistance to infection, hence restricting pathogenesis [166]. However, 
dissemination of T. b. brucei from the skin post tsetse exposure appears to be 
independent of the presence or absence of neutrophils. However, this neutrophil 
response when present in mice appears to be ineffective in limiting pathogenesis 
or could potentially suggest that T. b. brucei have efficient mechanisms of 
evading the early neutrophil response [409, 410]. Neutrophils despite possessing 
a potent arsenal against pathogens, quite a few pathogens have evolved 
mechanisms to avoid direct killing. These pathogens include Helicobacter pylori, 
Francisella tularensis, and Anaplasma phagocytophilum [411, 412]. The 
possibility of such mechanisms in T. b. brucei is yet to be investigated.  
African trypanosomes being parasites with a digenetic lifecycle, have adapted to 
surviving in harsh environmental conditions of its hosts i.e. in both the tsetse fly 
and mammals. A well-defined mechanism for evading the host immune response 
is the expression of VSGs [9, 15, 16, 205], however, this is only one of several 
mechanisms employed by African trypanosomes in evading the host immune 
system. In addition to the switching of the VSG coat, bloodstream form 
trypanosomes are known to evade host complement activity through the 
expression of a protein GP63 on its surface, and its rapid motility through its 
flagellum [220, 233, 237, 240, 413]. The rapid motility of T. b. brucei 
characteristic of the metacyclic and bloodstream stages, which is crucial for 
infection in the tsetse fly [230], and possibly pathogenesis in mammals, has been 
described as an immune evasion strategy employed by the parasite to wade off 
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immune cells [414]. T. b. brucei being an extracellular parasite is in constant 
contact with host tissues, and moves in an ordered sequence in the tsetse fly- 
travelling from the midgut to the salivary gland, and in mammals travelling from 
the skin to the bloodstream via the lymphatics [13, 191, 334]. This motility 
process is an active one, and motility mutants were unable to proceed beyond 
the midgut of the tsetse fly [230]. In the context of this work, rapid motility by 
T. brucei has been hypothesised to thwart phagocytic processes, in a manner 
similar to what happens in the bloodstream, where the flagellum removes host 
immunoglobulin bound to surface VSGs through hydrodynamic forces generated 
by its rapid movement [240]. Furthermore, in blood stream form T. b. brucei 
there is high-level expression of GP63. GP63 has been identified and extensively 
studied in Leishmania [415, 416] and Crithidia [417], prior to the identification 
of a homologue in T. b. brucei [418]. In Leishmania spp., GP63 has been 
described to play a role in the interaction between infective promastigotes and 
macrophages. GP63 contributes to the entry and survival of Leishmania 
promastigotes in macrophages [413]. This suggests that metacyclic T. b. brucei, 
like blood stages may also have high expression levels of GP63. Hence, GP63 may 
likely have a potential role in parasite evasion of host neutrophil response in the 
mammalian skin, in order for metacyclic T. b. brucei to establish itself. 
Other recruited cells such as inflammatory monocytes and DCs, which have been 
observed very early in other parasitic infections such as Leishmania [166] and 
Plasmodium spp., [379] following vector bites were absent in this model at the 
time points analysed. Intradermal injection of Plasmodium sporozoites into the 
skin, describes a two wave inflammatory response, characterised first by the 
appearance of neutrophils, followed by the onset of Ly6Chi cells (inflammatory 
monocytes) from 24 hrs [379, 419]. Inflammatory monocytes were not detected 
in this study within the first 24 hrs, but might likely appear at latter time points.  
In order to understand the inflammatory events occurring at the molecular level, 
this study identified two chemokine ligands, CXCL1 and CXCL2 that were 
differentially upregulated in the skin following transcript analysis, and act 
selectively on neutrophil recruitment [420, 421]. CXCL1 and CXCL2 bind the 
CXCR2 receptor, which is abundantly expressed on natural killer cells and 
granulocytes [422, 423]. CXCL1 and CXCL2 are both constitutively expressed in 
the epithelia and on endothelial cells [424, 425]. The transcript analysis in this 
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study demonstrated the upregulation of CXCL1 and CXCL2 in the skin post tsetse 
exposure, suggesting they have a role in neutrophil recruitment, although CXCL2 
was downregulated in infected tsetse samples. Pro-inflammatory cytokines such 
as IL-1 and TNF-α were also upregulated, and have been demonstrated in vitro 
to induce CXCL2 expression in murine endothelial cells [426]. IL-1 has also been 
demonstrated in vivo to be an important inducer of CXCL2 expression and 
subsequently hepatic neutrophil recruitment [427]. CXCL1 and CXCL2 can also 
act locally to mobilize neutrophils from the bone marrow. This has been 
demonstrated in a study where CXCL2 was injected into the blood, and resulted 
in a response that was similar to acute peritonitis when the peripheral 
neutrophil blood count was analysed [428]. So in the model described in this 
study, it is most likely that there could be a release of CXCL1 and CXCL2 in the 
skin through activation of the endothelia, which drives in neutrophils post tsetse 
exposure to the bite site. It would be interesting to investigate if the absolute 
copy numbers of the transcripts upregulated in tissues samples, and protein 
expression levels in tissues would be different between infected and uninfected 
tsetse samples. This would further define the molecular events occurring in the 
skin post tsetse bites. It is also important to note that a major limitation of using 
mouse models is the absent of the chancre at the bite site post inoculation by 
tsetse flies. However, how the absence of the chancre would impact on the 
outcome of immune responses when compared to that of cattle/humans is yet 
unclear. 
Taken together, the data here suggests there is no difference in the very earliest 
immune events in the skin between infected and uninfected tsetse exposed 
samples. This led me to propose that the very earliest immune events in the skin 
are driven by mechanical damage caused by the tsetse fly rather than the 
presence of metacyclic T. b. brucei. The findings here using flow cytometry, and 
transcript analysis of inflammatory mediators support this view. The data here 
also suggests that neutrophil depletion does not have a significant impact on 
pathogenesis in mice models. Further studies to identify the components of the 
tsetse saliva involved in neutrophil recruitment would shed more light on the 
temporal events occurring in the skin, and how this could be manipulated to 
further understand the earliest events in African trypanosome pathogenesis in 
vivo. 
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5 Imaging African trypanosomes and host 
interactions 
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5.1 Introduction 
In order to investigate the dynamics of what happens in vivo in the skin during 
the infection process, it is necessary to have transgenic parasites, and 
genetically modified mice, which can be used for visualisation of the events 
[266, 429-432]. The first demonstration of the applicability of imaging infection 
dynamics in mouse models was in the malaria parasite [322, 433-435]. Using 
fluorescent sporozoites injected by infected mosquitoes into the skin of 
anesthetised mice and imaged using a wide field fluorescent microscope, the 
authors were able to follow the fate of injected sporozoites in vivo [434]. 
Further studies have also shown the egress of the sporozoites from the skin into 
blood vessels or the LN via the lymphatics where sporozoites were degraded 
[183]. In vivo imaging approaches have also helped in understanding the motility 
behaviour of sporozoites, and how sporozoites invade the liver through Kupffer 
cells [322, 337, 436]. These observations have provided new insights about our 
understanding of the infection process in the malaria parasite. 
 
In Leishmania spp., a sand fly delivered pathogen that is the cause of cutaneous 
and visceral leishmaniasis, which has been studied in detail to provide insights 
into the events in the skin, direct entry of Leishmania into macrophages was 
thought to occur following deposition by the sand fly [437]. However, through 
intravital imaging, it has been revealed that neutrophils were recruited to the 
skin in both infected/uninfected sand fly bites. The neutrophils that were 
recruited to the skin were found to be infected by Leishmania, and these 
parasites remained viable [165]. Intravital imaging studies revealed that when 
Leishmania infected neutrophils were taken up by macrophages, they could 
potentially serve as a means of dissemination [165].  
 
In addition to understanding the events that occur in relation to parasite 
dissemination, intravital imaging has also revealed how the hosts’ innate and 
adaptive immunity is activated. The draining of pathogens from the bite site to 
the LN has been suggested to initiate an innate immune response, analogous to 
that seen in non-lymphoid tissues in the LN following the arrival of lymph borne 
parasites [438]. In Toxoplasma gondii infection, neutrophils recruited form 
dynamic swarms around the foci of infection in the subcapsular sinus of the LN. 
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This was then followed by the appearance of larger number of neutrophils later, 
which also formed swarms, suggesting a chemoattractant effect was in operation 
[152]. Intravital imaging has also helped assess how antigen specific T cells 
interact with APCs [439-441]. CD4+ T cell effector responses have been visualised 
in the skin of L. major infected animals, which defined two physiologic modes of 
antigen recognition by activated CD4+ T cells. In the first instance, there was a 
stable interaction in which T cells were completely arrested, and secondly, the 
interactions were dynamic during which T cells maintained a scanning behaviour 
[439]. The study also highlighted the limitations in CD4+ T cell responses to L. 
major, by demonstrating that antigen specific T cell responses in the skin was 
highly variable, suggesting lack of T cell accessibility in some areas [439]. 
Together, these studies have demonstrated through intravital imaging important 
immunological information that would otherwise have been near impossible 
using conventional techniques. 
 
The life cycle of African trypanosomes begins with an infected tsetse fly 
injecting metacyclic trypanosomes into the skin. African trypanosomes have 
been described to be established in the skin, egress from the skin to the 
lymphatics, and into the blood [189, 191, 442]. T. b. brucei were observed to 
appear in the lymph in goats that were cannulated within 24-48 hrs prior to 
detection of blood parasites, and prior to the onset of the chancre [191]. A 
similar observation has also been made in T. vivax, suggesting that the lymph is 
the principal route of dissemination [334]. The damage or wounding to the skin 
by the tsetse fly also generates the first wave of immune cells that infiltrate the 
bite site, similar to observations in sterile inflammation and in the sand fly [165, 
357, 443].  
 
The Multiphoton Laser Scanning Microscope (MPLSM) can been applied to provide 
further optical resolution of parasites, and also complement information about 
the precise location, behaviour, and interactions that occur within host tissues 
[444, 445]. MPLSM also provides deep tissue imaging, superior spatiotemporal 
resolution [446], and has been used to reveal that T. b. brucei GVR35 invade the 
meninges as early as day 5 post infection [252].  
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As already mentioned T. b. brucei enter the lymphatics from the skin following 
tsetse fly bite, but the exact mechanisms of entry and possibility of tropism for 
lymphatics have not been investigated to date. The detection of parasites in the 
LN before appearance in the blood by qPCR in chapter 3, and also the detection 
of T. b. brucei in the lymph prior to blood through the cannulation of goats 
[191], led us to hypothesise that African trypanosomes may exhibit tropism for 
lymphatics. Here, I used MPLSM to visualise the motility of mCherry tagged T. b. 
brucei in the skin, trafficking of neutrophils to the bite site in response to tsetse 
fly bites, and egress of T. b. brucei from the skin to the lymphatic vessels. All 
image files were then analysed and movies prepared using Volocity. This was 
possible through the use of the tsetse fly infection model set up in chapter 3, 
C57Bl/6 mice, transgenic mice (Prox-1 mOrange and LysM-GFP) and reporter 
dyes.  
 
5.2 Metacyclic stage T. b. brucei can be visualised in the 
skin 
In order to visualise metacyclic stage T. b. brucei in the skin of C57Bl/6 mice 
following successful infection of tsetse flies, anesthetised mice ears were probed 
using one infected tsetse fly per mouse ear. Mice were placed on a heat mat to 
keep the body temperature warm, or the microscope stage was pre-heated to 37 
°C and used as the base for tsetse fly probes. Tsetse flies were allowed to probe 
on mice ears until a blood spot/obvious puncture in the skin was visible – for 
approximately 30 mins. Mice were then prepared and imaged as described in 
materials and methods.  
Once the infected tsetse flies had probed mouse ears, mice were placed under 
the MPLSM for imaging. T. b. brucei were found to be injected into the 
extracellular matrix, and metacyclic T. b. brucei detected using the dermal 
puncture in the skin as a landmark. Metacyclic T. b. brucei were readily found 
near areas in the skin were the tsetse fly probe was carried out and was 
visualised approximately 30 mins post tsetse bite. Approximately 5-10 
metacyclic T. b. brucei were visualised at the bite site, and parasites were 
spread over the different areas of the skin were tsetse fly probes had taken 
place. Metacyclic T. b. brucei were located in the dermis of the skin and 
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exhibited vigorous cell motility (Figure 5.1A). T. b. brucei motility might be 
driven by the flagella from the tip to the base, and the cells moved for extended 
periods in one direction, tumbled or occasional spinning as previously described 
[447].  
                      
            
      
 
Figure 5-1 Visualising metacyclic T. b. brucei in the skin 
Following infected tsetse fly bites in the ear pinna of anesthetised C57Bl/6 mice, mouse ear was 
prepared for imaging immediately after tsetse fly probe. T. b. brucei were imaged in the skin within 
30 mins post tsetse fly bite. Image acquisition under the MPLSM was carried out for ≥ 20 mins. 
Laser generation of the second harmonic signal shows collagen as green. (A) Representative 
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image of metacyclic T. b. brucei, (B) volocity software was used to track metacyclic T. b. brucei to 
allow calculation of, (C) velocity, (D) displacement rate, and (E) meandering index. Values 
represent data showing the median as indicated using the horizontal bar. Data represents tracks 
pooled from 2 independent animals, scale bar denotes 14 µm. No significant differences were 
observed between the two independent animals (P>0.05; 2 tailed Mann Whitney U test). 
 
In vitro experiments on blood stream form African trypanosomes have reported 
high swimming velocities of 20 µm/s, and that trypanosomes are capable of 
highly directional cell motility [447]. The tracking of T. b. brucei in the skin 
(Figure 5.1B) enabled the calculation of motility parameters related to 
metacyclic T. b. brucei in the skin, such as the meandering index, displacement 
and velocity using Volocity software (Improvision). Motility of T. b. brucei in the 
skin gave median velocity of 57.42 µm/min (Figure 5.1C), and median 
displacement rate (shortest distance between two positions at two time points) 
of 13.56 µ/min (Figure 5.1D). The meandering index (the total 
displacement/path length of a cell track) allowed for a more detailed analysis of 
the straightness of T. b. brucei with a value of 1 representing a completely 
linear track. As shown in Figure 5.1E, metacyclic T. b. brucei had a median 
meandering index of 0.25.  
Entry of malaria sporozoites into blood vessels following Anopheles mosquito 
injection into the dermis in P. yoelii and P. berghei has been reported [321]. 
Given the previous data indicating that trypanosomes migrate via lymphatics, I 
speculated that I would not be able to detect T. b. brucei entering skin blood 
vessels following tsetse fly bite. To test this, blood vessels of C57Bl/6 mice were 
labelled intravenously (i.v.) using a vascular tracer dye, by injection of 70 Kda 
dextran conjugated with fluorescein isothiocyanate (FITC). I report here that 
metacyclic T. b. brucei imaged were highly motile, and no parasites were 
detected inside blood vessels (Figure 5.2A).  
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Figure 5-2 Metacyclic T. b. brucei parasites do not enter skin blood vessels 
Following infected tsetse fly bites in the ear pinna of anesthetised C57Bl/6 mice, mouse ear was 
prepared for imaging immediately after tsetse fly probe. C57Bl/6 mice were injected i.v. with FITC 
dextran to label blood vessels. Blood vessels (green) and laser induced second harmonic signal 
appears green for collagen. T. b. brucei were imaged in the skin within 30 mins of tsetse fly bite. 
Image acquisition under the MPLSM microscope was carried out for ≥ 20 mins. (A) Metacyclic T. b. 
brucei in the skin with labelled blood vessels, (B) velocity, (C) displacement rate, and (D) 
meandering index. Horizontal bar shows the mean. Data represents tracks pooled from 2 
independent animals, scale bar denotes 50 µm. 
From the movies acquired, blood flow was still apparent indicating that the 
mouse was alive. Also in the movies of the mice acquired, I could visualised cells 
moving through the blood vessls potentially leukocytes. Metacyclic T. b. brucei 
had mean velocity of 59.46 ± 30.41 µm/min (Figure 5.2B), and displacement rate 
of 21.33 ± 20.08 µm/min (Figure 5.2C) respectively. Meandering index of 
metacyclic T. b. brucei was 0.33 ± 0.19 (Figure 5.2D). 
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Figure 5-3 Bloodstream form T. b. brucei parasites do not enter skin blood vessels 
Following injection of bloodstream form T. b. brucei intradermally into the ear pinna of anesthetised 
C57Bl/6 mice, mouse ear was prepared for imaging. C57Bl/6 mice were injected i.v. with FITC 
dextran to label blood vessels. Blood vessels (green) and laser induced second harmonic signal 
appears green for collagen. T. b. brucei were imaged in the skin within 10 mins of intradermal 
injection. Image acquisition under the MPLSM microscope was carried out for ≥ 30 mins. (A) T. b. 
brucei in the skin with labelled blood vessels, (B) tracked T. b. brucei to allow for calculation of, (C) 
velocity, (D) displacement rate, and (E) meandering index. Horizontal bar shows the mean. Data 
represents tracks pooled from 2 independent animals, scale bar denotes 50 µm. 
 As a control in this study, I also injected 1 x 106 blood stream form parasites 
into the skin, and no blood stage T. b. brucei were detected in blood vessels in 
the skin (Figure 5.3A). Blood stream form T. b. brucei had a mean velocity and 
mean displacement rate of 34.94 ± 16.04 (Figure 5.3C) and 18.19 ± 15.32 
µm/min (Figure 5.3D), respectively, and mean meandering index of 0.46 ± 0.32 
(Figure 5.3E). Mean velocity of metacyclic T. b. brucei was significantly different 
from blood stream form T. b. brucei (Figure 5.4A; P<0.0001), while the 
displacement rate and meandering index were not significantly different (Figure 
5.4B & 5.4C). 
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Figure 5-4 Metacyclic T. b. brucei migrate faster than blood stream forms.          
 Statistical analysis was carried out on velocity, displacement rate and meandering index of 
Metacyclic and blood stream form T. b. brucei injected into mice ears. (A) velocity (***p<0.0001), 
(B) displacement rate (not significant) & (C) meandering index (not significant). Data were pooled 
from 3 independent animals, and a 2 tailed unpaired t-test used for statistical analysis. 
 
These results suggested that rapid motility might be a crucial step for metacyclic 
T. b. brucei dissemination from the skin. Furthermore, the absence of T. b. 
brucei metacyclics or bloodstream forms in skin blood vessels suggested that 
lack of penetration of blood vessels might not be dependent on the life cycle 
stage of T. b. brucei injected into the skin, and that T. b. brucei may not 
disseminate via skin blood vessels, consistent with previous studies. A few 
parasites were also observed in the dermis near hair follicles (data not shown), 
which are immune privileged sites. 
It is also important to mention that metacyclic T. b. brucei could still be 
visualised in the skin for at least 2 hrs post tsetse transmission. In summary, T. 
b. brucei was not detected in the blood vessels of C57Bl/6 mice when both 
metacyclic and blood stream stages were injected via the tsetse fly and needle. 
T. b. brucei exhibited tumbling motion with significantly higher velocity in 
metacyclic T. b. brucei than blood stream stages in the skin. MPLSM imaging was 
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carried out using 800 nm and 1200 nm excitation wavelengths for imaging 
parasites and blood vessels in vivo.  
5.3 Neutrophils can be imaged in the skin following 
infected tsetse fly bites and do not form dynamic 
clusters 
In chapters 3 & 4, it was established that T. b. brucei remained in the skin and 
neutrophils were recruited to the bite site following tsetse fly probe in the skin.  
My findings were in agreement with previous work that skin wounding was 
sufficient to cause recruitment of phagocytes to site of injury [448]. It was also 
shown that there were no significant differences in neutrophil absolute numbers 
between ears exposed to infected and uninfected tsetse flies. Through intravital 
imaging, the previous section has also established that indeed, T. b. brucei were 
present in the skin and could differentiate into long slender forms in the skin 
based on preliminary experiments carried out in the lab. So I sought to ask if I 
could visualise the trafficking of neutrophils to the bite site, investigate the 
behaviour of neutrophils, and possibly image the interactions between T. b. 
brucei and neutrophils using LysM-GFP reporter mice. Although I had previously 
established that neutrophil recruitment was independent of the presence of 
trypanosomes, I carried out further investigations with neutrophils to examine if 
there was formation of NETs, which is found in other intracellular parasites and 
bacteria infections. 
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Figure 5-5 Neutrophils do not swarm following inoculation of metacyclic T. b. brucei.  
Following infected tsetse fly bites in the ear pinna of anesthetised LysM-GFP reporter mouse, 
mouse ear was prepared for imaging 3 hrs post tsetse fly probe. Laser generation of second 
harmonic signals was used to visualise collagen (blue). Neutrophils were imaged for ≥ 20 mins. (A) 
Neutrophils migration to the bite site, hair follicle (HF), (B) neutrophil tracks to allow calculation of, 
(C) velocity, (D) displacement rate, and (E) meandering index. Data represents tracks from 2 
independent animals, horizontal bar shows the mean. Scale bar denotes 28 µm. 
 
LysM-GFP mouse expressed a green fluorescent protein under the control of the 
lysozyme M (LysM) promoter [267]. LysM is expressed specifically by 
macrophages and neutrophils [449], and the LysM-GFP mouse is well established 
in investigating neutrophil recruitment. In this mouse, endogenous neutrophils 
are brightly labelled, while macrophages and monocytes are labelled to a lesser 
extent [267, 450]. LysM-Gfp mice has been used in investigating leukocyte 
trafficking in pulmonary inflammation, where the neutrophils recruited formed 
dynamic clusters [451], in intracellular infections such as Toxoplasma gondii, 
where the parasites invade neutrophils recruited to the small intestine and use 
as a potential mechanism for spreading infection [452], and also in Leishmania 
infections for investigating the behaviour of neutrophils following sand fly bites 
[326]. 
Within 3 hrs of tsetse fly probe to the ear, neutrophils were rapidly recruited to 
the site of tissue damage, visualised and movies acquired. As shown in Figure 
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5.5A, there was migration of neutrophils in a directed manner, with a mean 
velocity of 5.45 ± 4.08 µm/min (Figure 5.5C) and displacement rate of 3.75 ± 
3.90 µm/min (Figure 5.5D). Migrating cells exhibited very little deviation from 
their path, indicated by the meandering index as a measure of directionality: 
0.64 ± 0.38 (Figure 5.5E), and recruited cells remained around the site of injury. 
In other models of inflammation, neutrophil swarms have been reported [431]. I 
observed that there was no formation of neutrophil swarms at the site of tissue 
injury. I was however unable to visualise T. b. brucei and neutrophils together 
simultaneously, due to spectral overlap. However, neutrophils were detected in 
the same plane as T. b. brucei. 
In summary, these results reveal a notable behaviour of neutrophils in African 
trypanosome infections, which is absence of neutrophil swarms and rapid 
recruitment of neutrophils to the site of tsetse fly probe.  
5.4 African trypanosomes migrate towards lymphatic 
vessels 
To date no study has demonstrated whether T. b. brucei have preference for 
lymphatics in mammalian hosts. From my data in chapter 3 where T. b. brucei 
were detected in the LN within 6 hrs, I postulated that African trypanosomes 
might have tropism for lymphatic vessels. To test this hypothesis, I began by 
injecting lymphatic vessel endothelial hyaluronan receptor-1 (Lyve-1) antibodies 
to label lymphatics. This was unsuccessful, and I subsequently switched to the 
use of Prox-1 mOrange mice to investigate interactions of T. b. brucei with 
lymphatic vessels.  
5.4.1.1 Imaging lymphatic vessels using Prox-1 mOrange 
Following the unsuccessful application of lyve-1 antibody in imaging lymphatic 
vessels and fluorescent trypanosomes, a transgenic reporter mouse, Prox-1 
mOrange was then used. These transgenic mice have a lymphatic endothelial 
cell specific Prox1 promoter-driven fluorescent reporter, and Prox1 is faithfully 
expressed on lymphatic endothelial cells [268, 269]. In Prox-1 knockout mice, 
lymphatics do not develop, whereas blood vessels appear normal [453]. The use 
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of transgenic constructs under Prox1 transcripional control has been used in 
studies of dendritic cell migration, lymphatic vessel morphology during the early 
phases of cutaneous inflammation and in lymphangiogenesis [454]. In this study, 
the first set of experiments performed was to visualise lymphatic vessels under 
the MPLSM prior to infection studies.  
 
Figure 5-6 Visualising lymphatic vessels in Prox-1 mOrange mice. 
 Prox-1 mOrange mice was anesthetised and prepared for ear imaging as previously described in 
the materials and methods. Lymphatics in the ear of Prox-1 mOrange mice were imaged at 800nm 
and 1200 nm excitation wavelengths. The distinctive oak leaf patterning of lymphatic endothelial 
cells in the lymphatic vessels was detected shown in white, lymphatic vessels reveal blind endings 
and lymphatic vessels in the skin have irregular sizes compared to blood vessels (e.g. Figure 
5.2A), Scale bar: 120 µm. Representative image of several images collected. 
 
Lymphatic vessels were visualised in the ear skin of Prox-1 mOrange mouse. 
Lymphatic vessels appeared wider and more irregular shaped than blood vessels 
(Figure 5.2A), and formed a network of vessels (Figure 5.6). Lymphatic vessels 
displayed lack of uniformity in size compared to blood vessels, and possessed 
blind endings.  
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In summary the ear skin of Prox-1 mOrange mouse has irregular anastomoses of 
lymphatic vessels with blind endings in the dermis of the skin, and were wider 
than blood vessels.  
5.4.1.2 T. b. brucei penetrate skin lymphatic vessels 
In the previous section, it was established that Prox-1 mOrange mice lymphatic 
vessels were sufficiently bright for MPLSM imaging and the settings optimised.  
           
       
 
Figure 5-7 T. b. brucei migrates into lymphatic vessels.  
1x106 bloodstream T. b. brucei were injected intradermally into the ear pinna of mice and imaged 
after 1 hr. Mouse ear was prepared for imaging as described in the materials and methods. 
Chapter 5  161 
 
Collagen was visualised using second harmonic signal from the laser, indicated as green (A) Intra 
and Extra lymphatic T. b. brucei (B) dotted lines indicate the outline of the lymphatics, tracked to 
calculate (C) velocity, (D) displacement rate, and (E) meandering index for intra/extra lymphatic T. 
b. brucei respectively. Data presented in the plots show mean as indicated with the horizontal bar, 
[(***P<0.0001; not significantly different (ns), statistical analysis was calculated using 2-tailed, 
unpaired t-test)]. 
 
The next approach was to ask if I could image the lymphatic vessels and mCherry 
T. b. brucei simultaneously, and possibly visualise trypanosomes entering 
lymphatics. To answer this question, Prox1-mOrange mice were intradermally 
injected with 1 x 106 blood stream form T. b. brucei in the ear pinna. Following 
injection, mice were left for approximately 1 hr, before MPLSM imaging. Once 
the mice ears were prepared and imaged, I observed that most of the parasites 
injected into the skin remained extra lymphatic, residing in the extracellular 
matrix of the skin. However, to my surprise, I observed that a few parasites 
were intra lymphatic, and all parasites imaged were in the same plane with the 
lymphatic vessels. 
Hence, through intravital imaging and single cell tracking it was revealed that T. 
b. brucei parasites were both intra and extra lymphatic, and were highly motile 
in the lymphatic vessels (Figure 5.7A&B). It was surprising to detect intra 
lymphatic T. b. brucei, because previous imaging experiments carried out using 
infected tsetse flies and intradermal injection of blood stream form T. b. brucei 
had not shown the presence of parasites in the lymphatics. T. b. brucei were 
tracked (Figure 5.7B), and the following motility parameters computed: velocity, 
displacement rate and meandering indices. Following extrapolation of the 
parameters, and relating each parameter to parasites individually tracked, I 
found that T. b. brucei within the lymphatics had a significant increase in 
velocity than those that were extra lymphatic (24.25 ± 1.3 and 11.01 ± 1.32 
µm/min; P<0.001, Figure 5.7C). The mean displacement rate (6.29 ± 0.81 and 
4.51 ±1.52 µm/min; Figure 5.7D), and mean meandering index (0.28 ± 0.03 and 
0.35 ± 0.06; Figure 5.7E) for both intra and extra lymphatic T. b. brucei were 
not significantly different. 
The detection of T. b. brucei in the lymphatics in this study is novel, and 
demonstrated that there may be a tropism for lymphatics by T. b. brucei due to 
the movement of some of the parasites towards the lymphatic vessels. Hence, 
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these observations led to further investigate whether the entry into lymphatics 
was chemokine mediated, specifically CCL21. 
5.4.1.3 T. b. brucei do not migrate towards CCL21 in vitro 
Following the detection of intra lymphatic T. b. brucei within 2 hrs of 
intradermal ear injections, I then attempted to decipher how these 
trypanosomes gain access to lymphatic vessels. To address this question, I 
investigated the role of a chemokine, CCL21, in chemotaxis of T. b. brucei 
towards lymphatic vessels. CCL21 is a chemokine involved in lymphocyte 
recruitment and is highly expressed on high endothelial venules (HEVs) and 
lymphatics [455, 456]. CCL21 was chosen as the chemokine to be tested because 
of the role it plays in lymphocyte recruitment to LNs via HEVs, and in DC 
transmigration through lymphatic vessels. This was tested in vitro using a 
transmigration assay (see materials and methods) that was set up to include 
different concentrations of recombinant CCL21, and 1 x 105 T. b. brucei added 
to the wells to assess chemotaxis.  
 
Figure 5-8 There is no chemotaxis of T. b. brucei towards CCL21.  
Chemokine concentrations of 0, 100, 300 and 900 ng of CCL21 were added to media, and 
incubated with the transmembrane for 10 mins at 37 °C, 5% CO2 for equilibration to occur.  105 T. b. 
brucei was added to the different chemokine concentration gradients and incubated for 7 hrs. Using 
a haemocytometer to count parasites, 10 µl of media containing transmigrated parasites was 
added and counted under a compound microscope. There were no statistically significant (ns) 
differences when compared to untreated controls (0 ng), statistical analyses was carried out using 
2-tailed unpaired t test. Data presented in the bar graphs were mean ± SEM, n=3, for 3 
independent experiments.  
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Following incubation for 7 hrs, the data suggests no statistically significant 
difference between T. b. brucei that were incubated in at the different CCL21 
concentrations (Figure 5.8). Seven hours incubation was chosen because at later 
time points, T. b. brucei began to die and exhibit reduced motility, while at earlier 
time points only few parasites had migrated across the membrane. In the absence 
of CCL21, T. b. brucei were still able to migrate across the membrane at a similar 
rate compared to when 300 ng CCL21 was added.  
Together, the data suggests that there is no chemotaxis of T. b. brucei towards 
CCL21.  
5.5 General summary 
In this chapter I started by stating that I had shown in chapter 3 that T. b. brucei 
was detected in the LN from 6 hrs, and in chapter 4, neutrophils trafficked to 
the bite site following tsetse fly bites (infected and uninfected). Here, I have 
gone a step further to visualise interactions of T. b. brucei and its host 
spatiotemporally using the MPLSM. Firstly, metacyclic T. b. brucei were 
visualised for the first time directly in the extracellular matrix of the skin after 
tsetse fly probes, and these parasites were very motile (significantly more so 
than bloodstream forms). I also demonstrated that T. b. brucei were not 
detected in blood vessels in the skin immediately after a tsetse fly probe or 
intradermal needle injection of blood stream stage T. b. brucei. In addition, it 
was shown using LysM-GFP reporter mice that the recruitment of neutrophils to 
the bite site was rapid and did not result in the formation of swarms.  
 
Lastly, using the Prox-1 mOrange mice, it was demonstrated that T. b. brucei 
that were intra lymphatic behaved differently from those that were extra 
lymphatic, and also present data suggesting CCL21 is not involved. The data here 
may also suggest the possibility of tropism for lymphatic vessels by T. b. brucei, 
when injected into the skin. Altogether, in this chapter I present novel data 
specifically shedding light on T. b. brucei dissemination from the skin to 
lymphatic vessels in Prox-1 reporter mice through intravital imaging studies. The 
key findings of this chapter are discussed below. 
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5.6 Discussion 
To evaluate interactions that occur between T. b. brucei and its host following 
tsetse fly bites, I used the 247 strain of T. b. brucei that was pleomorphic and 
had been successfully used to infect tsetse flies in chapter 3. This strain was also 
used in characterising the nature of the early immune events in the skin, which 
identified neutrophils as the main cells recruited. Once infected tsetse flies had 
probed into the skin, metacyclic T. b. brucei were imaged under the MPLSM. T. 
b. brucei metacyclics were actively motile and navigated rapidly through the 
skin. Motility in African trypanosomes has been a subject of interest, as parasite 
movement in specific host tissues are key events in pathogenesis, immune 
evasion and disease transmission. Motility in African trypanosomes is driven by a 
single flagella that runs across the cell, laterally connected to the cell body 
[220], and is important for the establishment of infection in the tsetse fly and 
possibly in mammalian hosts.  
In the blood stream, rapid motility of T. b. brucei helps to evade antibody 
clearance. Antibodies that bind the VSGs expressed on T. b. brucei were sorted 
from the surface to the flagellar pocket where they are internalized and 
endocytosed [240]. The hydrodynamic forces required for sorting antibodies from 
the surface of trypanosomes are produced by forward motility of T. b. brucei. 
This was described through RNAi mediated transcript depletion of genes to 
inactivate trypanosome endocytosis (by targeting clathrin) [457], cell 
directionality (by targeting flagellum adhesion glycoprotein, fla1) [458], or 
plasma membrane recycling (by targeting actin) [230]. Of significance was that 
the removal of fla1 resulted in a loss of antibody-VSG complex sorting to the 
posterior, consequently blocking the first step of antibody clearance [240]. 
Hence besides antigenic variation as the well known mechanism applied by 
trypanosomes to evade immune responses [9], directional cell motility and 
plasma membrane recycling functions cooperate in removing host antibodies 
[240]. The findings established that physical flow forces generated by the beat 
of the flagella while swimming were essential not only for motility but also 
survival in the blood stream of mammals. This further suggested that high 
cellular motility might be essential for parasite survival [219, 223, 224].  
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In the tsetse fly, motility is important for infection of the salivary glands to 
occur. T. b. brucei forward motility is essential for migration in the tsetse fly 
[230]. Inducible RNAi silencing of the dynein intermediate chain (DNAI1) of the 
flagella axoneme led to a loss of trypanosomes ability for propulsive wave and 
forward motility [217]. Motility impaired trypomastigote parasites were unable 
to complete the first crucial step in infection, which was migrating from the 
foregut to the midgut, although they could still proliferate, albeit at half the 
normal duplication rates [230]. This observation of the importance of motility in 
the tsetse fly has led to investigations of the potential impact of motility 
mutants in pathogenesis in mammals [232]. In order for African trypanosomes to 
migrate from the skin into the lymphatics and then the draining LN, motility is 
most likely essential. My data suggests that metacyclic T. b. brucei have a 
significantly higher velocity than bloodstream form T. b. brucei, which may 
serve an advantage in establishing and migrating rapidly to the skin lymphatics.  
In addition, intra lymphatic T. b. brucei showed a significant increase in 
velocity, compared to extra lymphatic T. b. brucei, which is a key step in 
systemic dissemination [191, 334]. However, it was also observed that the mean 
velocity of blood stage parasites in the extravascular matrix of Prox-1 mOrange 
was slightly more than those on C57Bl/6 mice. This difference though not 
significant, could be due to the differences associated with the use of transgenic 
mice in this study, or possibly suggests the need for more replicates to further 
verify my findings. Data here shows that T. b. brucei may need to navigate 
quickly through the skin in order to survive the immune assault of the host, 
thrive in its new environment, and disseminate into the blood, via the 
lymphatics. In stage 2 of HAT, penetration of the vascular endothelium or the 
CNS by blood stream form T. b. brucei requires actively motile parasites [252]. 
In a study to decipher the role of motility mutants in vivo with blood stream 
form T. brucei 427 (monomorphic parasites), it was shown that T. b. brucei 
propulsive motility was dispensable for blood stream form infections [232]. The 
authors concluded that motility made no difference in their model through 
intraperitoneal injections. However their study has some drawbacks, which 
include; the use of an acute infection T. b. brucei model, so migration of T. b. 
brucei into the brain could not be monitored. Secondly, the route of infection 
was intraperitoneal, hence neglecting the skin stage as well as lacking the 
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appropriate parasite life cycle stages (i.e. metayclics), resulting in a model that 
does not accurately mimic establishment of infection and parasite dissemination 
[191]. So in the context of my work, I would argue that motility mutants of T. b. 
brucei transmitted through the tsetse fly into the skin might be unable to 
establish parasitemia in mammalian hosts. Motility mutants of metacyclic T. b. 
brucei may become trapped in the skin, allowing the immune system to clear 
the infection.  
The data in this study also did not detect T. b. brucei in blood vessels following 
tsetse fly. This is in contrast to what has been seen in Plasmodium spp 
sporozoites injected by the mosquito bites. Sporozoites were shown to rapidly 
migrate into both blood and lymphatic vessels [183, 434]. Most of the 
sporozoites released by the mosquito enter into the dermis of the skin and glide 
into blood vessels, while the few that migrate into lymphatics, remain in the LN 
where they were killed [183]. The lymphatic route of sporozoite dissemination 
for malaria parasites appeared to be a dead end. In contrast, in this study, I 
report the presence of T. b. brucei into only the lymphatics; T. b. brucei were 
not detected in blood vessels (either metacyclic or blood stream forms of T. b. 
brucei), despite repeated trials using both tsetse fly inoculation and needle 
injection of blood stream form T. b. brucei. The absence of T. b. brucei in blood 
vessels post tsetse fly bite reflects the importance of the intravital imaging tools 
in understanding T. b. brucei pathogenesis in vivo. It also agrees with previous 
reports that the lymphatics is a route of dissemination of parasites [191, 334].  
 In mammals, apart from laboratory rodents that have been used for 
experimental T. brucei infection studies via the tsetse fly, there is the 
development of a chancre (skin lesion) in the skin within 4-5 days [333]. In the 
chancre, T. b. brucei were observed to proliferate, and neutrophils detected at 
day 11-post infection [13, 191, 333, 459]. Although there was no chancre 
observed in our mouse model, which might suggest a difference in immune 
response in humans or cattle. This difference is a limitation of the study in using 
mice models for analysing the earliest interactions in the skin. T. b. brucei also 
remain in the skin as detected by MPLSM imaging for at least 24 hrs post tsetse 
fly bites and qPCR data in chapter 3, suggesting that the skin may be a 
‘reservoir’ for T. b. brucei. In Plasmodium spp., sporozoites have been shown to 
remain and differentiate into merozoites in the skin, and serve as a potential 
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source of parasitemia in relapsing infections [337]. Though there is no direct 
evidence to prove a similar phenomenom happens in T. b. brucei, this possibility 
can’t be ruled out. Here, I observed that some T. b. brucei remain in the skin 
and differentiate into blood stages within 20 hrs post infected tsetse fly bites, 
though the fate of these parasites in the skin is yet unclear.  
Next, I investigated the recruitment of neutrophils to the bite site following 
tsetse fly bites, since they were already identified as the first cells recruited to 
the tsetse fly bite site. Neutrophil recruitment from the blood to infectious sites 
or in response to tissue damage is a key feature of the early innate immune 
response [460, 461]. Further investigation on neutrophil recruitment was to 
determine if the presence of neutrophils at the bite site resulted in NET 
formation, which is used in killing parasites or bacteria in vivo. In my model, the 
recruitment of neutrophils to the bite site did not result in swarm formation as 
observed in inflamed, infected or sterilely wounded tissues [326, 408, 450, 451, 
462-469]. In a model to demonstrate the formation of neutrophil swarms in 
extravascular spaces, and the molecular events guiding swarm formation, it was 
reported that neutrophil cell death initiated dramatic neutrophil swarm 
formation. Leukotriene B4 (LTB4) was shown to play a key role as a unique 
intercellular communication signal between neutrophils, allowing a rapid 
integrin-independent neutrophil recruitment through the tissue [470]. This 
suggests that the absence of neutrophil swarms in my model could possibly be 
due to the absence of LTB4 needed at sites of cell death in order to mediate 
neutrophil swarm formation [470]. Parasite infections such as T. gondii and L. 
major have been described to form dynamic neutrophil clusters in the LN and 
skin respectively [408, 471]. The absence of neutrophil swarms was a novel 
observation of the behaviour of recruited neutrophils during T. b. brucei 
infection in the skin. The recruitment of neutrophils to the bite site was rapid, 
and directed towards the site of injury, suggesting chemotactic factors such as 
CXCL1/CXCL2 were at play. In a model of liver injury, neutrophil migration was 
found to depend on an intravascular CXCL2 gradient for migration to sites of 
tissue necrosis [472]. The role of neutrophils in carrying out its phagocytic 
functions have been described in bacterial and parasitic infections, where 
antigens are transported through lymphatic vessels to the draining lymph node 
[473]. From the intravital data on neutrophils described here, this suggests that 
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at sites of T. b. brucei deposition/tsetse fly probe, neutrophils rapidly migrated 
from the blood to phagocytose parasites.  
The lymphatic vessels are responsible for draining excess fluid, soluble proteins, 
migratory DCs and antigens through lymphatic vessels into the LN. The draining 
function of lymphatic vessels is important for maintaining tissue homeostasis, 
and in inflammatory conditions there is increased fluid and cellular activity [194, 
195, 474]. Dissemination of T. b. brucei through the lymphatics has been 
described for over three decades [191, 333], but the likely mechanisms involved 
have yet to be described. Based on the observation of intra lymphatic T. b. 
brucei, and extra lymphatic parasites migrating towards the lymphatic vessel, it 
led me to propose that the mechanism of entry of T. b. brucei into lymphatic 
vessels may be similar to leukocyte transmigration into lymphatics, in particular 
DC entry into lymphatics. Transmigration of leukocytes through endothelial cell 
junctions occurs in a tightly regulated manner, requiring integrins such as 
PECAM, CD99 and other proteins [430, 475-477]. This process involves sequential 
interactions between adhesion molecules on the leukocytes and the endothelial 
cell, and during acute inflammation there is an increase in vascular permeability 
to fluid, without an alteration to the barrier functions which prevents the exit of 
solutes [475].  
Dendritic cells (DCs), described as professional APCs, unlike other leukocytes do 
not require an integrin mediated cell-cell and cell-matrix interactions to enter 
the lymphatics in mouse dermis [478]. DCs enter lymphatics through expression 
of chemokine receptor CCR7, while CCR7 non-expressors DCs are unable to 
migrate into the lymphatics [193, 479]. CCR7 is upregulated on migratory DCs 
and acts as a gatekeeper during their mobilization [480, 481]. CCR7 deficient 
DCs can crawl as fast as CCR7 sufficient DCs, but do not enter the lymphatics, 
and fail to gain access to LNs [203]. CCR7 recognizes the ligands CCL19 and 
CCL21, which together coordinate the trafficking of DCs and T cells to, and 
within secondary lymphoid organs under steady and inflammatory conditions 
[479]. CCL21 is a chemokine associated with lymphocyte ingress into LNs, and 
DCs have been described to migrate directionally along CCL21 gradients [482, 
483]. Two types of CCL21 are expressed (CCL21-ser and CCL21-Leu). CCL21-Leu 
is expressed on lymphatic endothelial cells and CCL21-Ser on fibroblastic 
reticular cells [484]. DCs gain access into lymphatics through perforations or 
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button like junctions that are present in the initial lymphatics. These button-like 
junctions are equipped with flap valves to allow entry but prevent exit of solutes 
and small particles [204]. Hence, to access the lymphatics, DCs seek out areas 
with sparse basement membrane on initial lymphatics, where they are able to 
squeeze in, at or near blind-ended tips of initial lymphatics [204], and localize in 
the subcapsular sinus of the LN [485-487].  
From my observation of intra lymphatic T. b. brucei, some of the extra 
lymphatic T. b. brucei were observed to migrate towards lymphatic vessels in a 
CCL21 independent manner as shown from the transwell assay. Hence, T. b. 
brucei may interact with lymphatic vessels through its rapid motility, seeking 
out perforations through which they may gain entry. The architecture of the 
lymphatics being a one-way drainage system may also favour the entry of T. b. 
brucei. DCs also interact with the endothelium using their lamellipodia, and are 
guided by lymph flow and other cues, which lead them to the LN [203]. T. b. 
brucei appear to behave similarly, traversing at significantly higher velocities 
compared to extra lymphatic parasites in a random manner, probably due to the 
weak current of the lymph flow and rapid flagella motility. Cells migrate in the 
direction of lymph possibly due to chemotactic cues produced by the lymphatics 
or endothelial cells [488]. In the intracellular parasite T. cruzi, a closely related 
parasite to T. b. brucei, it has been described to bind CCL2. Injection of CCL2 
into the air pouch of infected mice increased T. cruzi migration to different 
tissues and leukocyte recruitment in a concentration dependent manner [489]. 
The run and tumble behaviour of T. b. brucei in vivo which is characteristic of 
bacterial chemotaxis [490, 491], also raises the intriguing possibility of T. b. 
brucei migrating in a chemotactic manner both in the lymphatics and the skin.  
Although the data presented here is novel with respect to the observation of 
parasites in the extravascular matrix, intralymphatic parasites and neutrophil 
migration to the bite site post infected tsetse exposure. The experiments 
described in this study have some drawbacks. Firstly is the suggestion that I was 
unable to detect parasites in blood vessels using tsetse flies (metacyclics) and 
needle injections of blood stream form parasites. Inability to detect parasites in 
the blood vessels could possibly be due to direct injection of parasites into the 
blood vessels or rapid transit of the parasites into the blood stream of the mouse 
from the skin, hence making it undetectable. Although the injection of parasites 
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directly into blood vessels is atypical of dipteran vectors, hence it is highly 
unlikely this was the case. Secondly, the observation of intralymphatic parasites 
was carried out using blood stream form parasites without sufficient replicates. 
Parasites in the Prox1 mOrange mice also had higher velocities compared to 
their counterparts imaged in wild type mice. This suggests that the phenotype of 
the mouse used could be attributed to the difference in velocities, and the need 
to carry out more replicates to properly draw conclusions regarding the 
migration of parasites towards lymphatic vessels and also account for the 
difference in velocities. Furthermore, there is the need to carry out these 
studies using infected tsetse flies (i.e. with metacyclics injected into the skin), 
to decipher whether the results obtained with blood stream injections would be 
similar or different. The use of infected tsetses for inoculation during lymphatic 
imaging would however pose considerable challenges with imaging due to the 
low numbers of parasites injected with the strain used in this study. I was also 
unable to compare the behaviour of neutrophils in uninfected tsetse and 
infected tsetse exposed mice. This would also be necessary to account for the 
contribution of the parasite to neutrophil behaviour in vivo. It would be 
interesting to find out whether uninfected tsetse exposed mice would form 
neutrophil swarms which was absent in infected tsetse exposed mice. Hence 
further studies taking note of these limitations, need to be carried out, and also 
taking into account that these observations have been made in mice, which 
might be different in humans/cattle. So interpretations of data from mice 
models have to been done with caution when drawing conclusions on 
trypanosome host interactions occurring in the skin post tsetse exposure. The 
limitations outlined here, however does not diminish the novelty of the data 
presented in this chapter.  
  
Overall, my findings in this study outline the events observed following the 
injection of T. b. brucei into the dermis of the skin via the tsetse fly bite, and 
the host cellular recruitment that follows. Metacyclic T. b. brucei were highly 
motile in the skin, migrating rapidly in the dermis of the skin, and blood stream 
forms rapidly migrating towards lymphatics. Intravital imaging also revealed that 
the damage to the skin by the tsetse fly caused the recruitment of neutrophils, 
which do not form swarms and maintain directionality towards the site of injury. 
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A thorough understanding of the molecular mechanisms guiding this process 
would deepen our understanding of the pathogenesis of African trypanosomes in 
mammals.  
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6 General Discussion 
 
 
 
 
 
 
Chapter 6  173 
 
6.1 Introduction    
For arthropod delivered parasites, the skin represents the first contact the 
vector and parasites have with the mammalian host. This serves an opportunity 
for the parasite to establish itself, and also for the host to mount an innate 
immune response to clear or control infection [492]. In African trypanosomes, 
transmitted by the bite of the tsetse fly, the skin is needed for the parasites to 
establish and disseminate to other organs of the mammal [18, 23]. The skin also 
serves as a physical barrier to prevent the entry of parasites, and it is also host 
to a plethora of immune cells [82, 93]. The bite of the tsetse fly is capable of 
eliciting an immune response as observed in other arthropod delivered parasites 
such as Leishmania spp [166]. During infection, the first line of cellular defence 
is the recruitment of neutrophils within minutes, which is followed later by 
monocytes, which can differentiate into macrophages and DCs, and are recruited 
by chemotaxis through local production of CCL2, CCL3, CCL4 and CCL5 [488]. 
Once the parasites are established, next is dissemination from the bite site, 
which for some intracellular parasites such as Leishmania involves capture and 
dissemination by neutrophils [165, 166].  
 
In African trypanosomes infected cattle, cannulation of the flank of these 
animals indicates the presence of trypanosomes in the lymph prior to blood 
detection. This suggests that parasites may use the lymphatics as a principal 
route of dissemination [13, 191]. In mammals, leukocytes transmigration into 
lymphatics has been described extensively, especially that of DCs [430, 475]. 
Migratory DCs express CCR7, which recognize the ligands CCL19 and CCL21 that 
participate in trafficking DCs into the lymphatics along CCL21 gradients [193, 
479, 486]. This suggests that DC entry into lymphatics involves cells following a 
chemotactic gradient. In African trypanosomes, it has yet to be established 
whether chemokines, active parasite motility or events similar to leukocyte 
transmigration are involved in parasite ingress into lymphatics. Dissecting the 
events in the skin would help shape our understanding of parasite dissemination 
and interactions that may occur within host tissues. This present study has 
described some of those very early events in the host occurring in the skin post 
tsetse fly bites, at the molecular and cellular level, using conventional 
techniques and intravital imaging studies.  
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6.2 Tsetse fly infections and T. b. brucei egress from the 
skin to the lymph node 
In this study, I successfully established a method for experimental infections of 
mice via trypanosome infected tsetse flies in the laboratory. This was important 
in order to carry out studies in vivo that mimic the natural route of infection in 
the field through injection of the right dose and life cycle stage (metacyclics) of 
parasites via the tsetse fly. My method of infecting tsetse flies by optimising the 
blood meal, trypanosome and tsetse strain combination (T. b. brucei 247 and G. 
m. morsitans) was consistent with previous reports that optimising these 
parameters could enhance successful salivary gland infections in tsetse flies 
[298, 493]. This approach gave a consistently high level of mature infections in 
tsetse flies. Following tsetse infections, mice ear pinna was then exposed to 
infected tsetse flies, which demonstrated the successful establishment of T. b. 
brucei in mice. There was detection of parasitemia, and this validated that the 
route of infection (ear pinna) was appropriate for further in vivo studies. 
 
I also report here the establishment/proliferation of parasites in mouse skin by 
qPCR, which is consistent with what has been observed in goats [11, 13, 191, 
192]. Also, the presence of parasites in the LN suggested that the lymphatics 
were used to transit into the blood stream. The presence of parasites in the skin 
for up to 48 hrs suggests the importance of the skin stage in pathogenesis, and 
points to other critical roles it may play in infection yet to be identified. The 
lymphatics drain antigens and excess fluid from the skin and maintain normal 
tissue homeostasis. In relation to this study, this suggests lymphatics are 
important in trafficking T. b. brucei as observed for immune cells e.g. dendritic 
cells from tissues to the LN. Other vector-transmitted parasites such as 
Plasmodium sporozoites have also been demonstrated to transit to the LN 
through the lymphatics, although the LN is a dead end for these parasites [184]. 
In African trypanosomes following infections initiated by the bite of infected 
tsetse flies on the flanks of cattle, parasites multiply at the bite site, followed 
by the onset of a localised skin reaction (chancre). Lymph collected from the 
nodes of these mammals via the efferent lymphatics were shown to contain 
parasites, preceding the appearance of parasites in the blood, suggesting that 
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the LN also serves for proliferation of trypanosomes and a passage route for 
dissemination into the blood [11, 494].  
 
In all, the data presented shows that African trypanosomes migrates towards the 
lymphatics, and enters the lymphatics during infection as previously described 
[191], but further studies are needed to prove there is tropism for lymphatics. 
 
6.3 Identification of the molecular and cellular events in 
the skin post tsetse fly bites 
The very early events following the bite of infected/uninfected tsetse flies 
remained an area that was uncharted prior to this study. African trypanosomes 
inject metacyclic stage parasites into the skin, and as previously discussed, the 
damage to the skin itself from the probe caused the recruitment of cells to the 
bite site. The first cells identified to enter the skin from the blood post tsetse 
bite were neutrophils, which were CD11b+ and Ly6G+. The presence of 
neutrophils in the skin post tsetse fly bite was consistent with the recruitment of 
neutrophils in other arthropod transmission models such as Phlebotomous 
duboscqi [326, 396]. However, the presence of neutrophils was not different in 
infected or uninfected tsetse fly bites, suggesting that the break in the skin 
caused by the probe was responsible for the early influx of cells.  
 
Neutrophils are recruited to sites of inflammation or sterile injury to either clear 
invaders or participate in the tissue repair process in the skin [462, 495]. 
Neutrophils can become primed by chemokines and cytokines such as TNF-α, IL-
8, and become mobilized to sites of infection, releasing proteases and reactive 
oxygen species for clearing pathogens [496]. Neutrophil derived proteases could 
also be responsible for proteolytic activation of IL-1β and IL-6, and both 
cytokines were upregulated in the skin post tsetse fly exposure. Membrane-
associated proteinase 3 could cleave IL-1β, while neutrophil elastase could play 
a role in degradation of soluble IL-6 [497]. At sites of infection, neutrophils 
could also release cytokines, chemokines and anti-microbial peptides in order to 
carry out its phagocytic function [498]. The recruitment of neutrophils to the 
bite site during infection results in immunity against the invading pathogens, 
through phagocytosis [152].  
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TLDA analysis in the skin also revealed the upregulation of two chemokines 
associated with neutrophil recruitment, CXCL1 and CXCL2, which bind the 
chemokine receptors CXCR1/2 that are involved in neutrophil extravasation from 
the blood [499]. The saliva of Anopheles stephensi contains a 200 Kda neutrophil 
chemotactic factor, which serves as a chemoattractant for neutrophils [500]. 
The saliva of the tsetse fly is highly heterogeneous, with several proteins with 
hypothetical functions. These saliva components could contain substances that 
modulate the innate immune response, which is characteristic of the saliva of 
vectors [501, 502]. The tsetse fly saliva has been suggested to modulate the T 
helper response in African trypanosome infections towards a Th2 phenotype, 
when injected with or without trypanosomes intraperitoneally [186]. 
Furthermore, neutrophils have been effective in clearing Trypanosoma 
congolense in the chancre formed after a tsetse fly bite, confirming their 
phagocytic role in Trypanosoma infections [13]. The presence of neutrophils in 
the chancre at day 11-post infection suggests they are beneficial to the host 
during infection [503]. In contrast to the protective roles of neutrophils in 
infection, neutrophils have been demonstrated through depletion studies to 
facilitate the onset of parasitemia in Leishmania major [339]. Given the 
contrasting activity of neutrophils it was important to establish their role in 
tsetse mediated trypanosome infection. Using antibody mediated neutrophil 
depletion, there was no difference observed in parasitemia.  
 
Overall, the data here seems to suggest that the very earliest immune events 
post tsetse fly bite resulted in the influx of neutrophils to the skin, which may 
play a protective role in clearing parasites. However, sufficient parasites were 
able to evade neutrophil killing and successfully establish parasitemia. This 
study also shows that it is the impact of the vector probe and its saliva that 
drives and sustains the migration of neutrophils from the blood to the skin, 
rather than the presence of trypanosomes. 
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6.4 Proposed mechanism for T. b. brucei dissemination 
through the lymphatics 
The life cycle of African trypanosomes in mammals begins in the skin where 
parasites are deposited, gain access into the blood via the lymphatics, and 
continue through parasite uptake from the skin during a tsetse fly feed. At each 
stage of T. b. brucei infection, the parasites possess unique features for 
adapting to its new environment [18, 23]. The first stage during the tsetse bite is 
the release of metacyclic T. b. brucei, which then differentiate into long slender 
forms present in the blood stream, which then differentiate into short stumpy 
stages that are taken up in the skin during tsetse fly feeds. The very early events 
in parasite dissemination from the skin have yet to be investigated. This led me 
to investigate intravitally the spatiotemporal events in the skin stage of the 
lifecycle of T. b. brucei in mammals.  
 
Metacyclic T. b. brucei injected into the skin via tsetse bites were actively 
motile with a higher velocity than bloodstream forms, and moved randomly in 
the skin. Metacyclic parasites were not detected in blood vessels. I also observed 
the presence of T. b. brucei in the ear skin lymphatic vessels using Prox-1 
mOrange, lymphatic vessel reporter mice. Intralymphatic parasites were clearly 
motile and moved rapidly within the lymphatic vessel. During leukocyte 
trafficking, DCs enter the lymphatics through the initial lymphatic vessels 
present in the dermis, through the interaction of the chemokine receptor CCR7 
with the ligand CCL21 expressed on lymphatic vessels [482, 504]. However, CCR7 
deficient DCs have been found to still gain access into the T cell area of the LN 
though in lower numbers, possibly through other chemokine receptors CXCR4 
[505] or CCR8 [506] which partially overlap with CCR7 signalling. CCR7 and 
CCL21 have not been identified to be involved in migration towards lymphatics 
for T. b. brucei, but the use of host chemokine receptors by the parasite can’t 
be ruled out, and needs to be investigated further. 
 
Parasite derived chemokine homologues have also been described which could 
induce cell migration. For example parasite macrophage migratory inhibitory 
factor has been isolated from nematodes [507, 508], and protozoa [509, 510]. 
Also, Strongyloides stercoralis can interact with chemokine receptors to induce 
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eosinophil migration [511]. Through these homologues, parasites have evolved 
mechanisms to prolong survival and dissemination in their hosts. This suggests it 
is likely that T. b. brucei secrete molecules that could bind host factors in order 
to gain access to the lymphatics.  
 
I also observed T. b. brucei parasites migrating towards the lymphatic vessels in 
the skin, suggesting they might penetrate by seeking out perforations in the 
lymphatics. DCs actively crawl along the endothelium and their migration in the 
initial lymphatics was not due to lymph flow current alone [203]. My findings 
seem to mimic that, with parasites actively migrating in lymphatic vessels and 
not appearing to be pushed along by the weak lymph current. Here, I also report 
that the crawling movement along the endothelium reported for DCs is absent in 
our T. b. brucei model [203]. The study presented in this thesis is the very first 
intravital observation of the migrationof T. b. brucei towards lymphatic vessels 
and observation of intralymphatic parasites.  
 
I propose that African trypanosomes may gain access into the lymphatics using a 
mechanism similar to DCs, by seeking areas on the lymphatics with perforations. 
Once in the initial lymphatics, through a combination of active motility by their 
flagella and by sensing direction of lymph flow they migrate towards larger 
collecting vessels where they may now be sufficiently pushed by the shear force 
of the lymph [512, 513].  
 
6.5 Conclusions 
The aim of this thesis was to characterise the very early immune events in the 
skin post tsetse fly bites with infected/uninfected tsetse flies, and also visualise 
the events that occur in the skin using T. b. brucei as a model for African 
trypanosomes. The study presented here draws the following conclusions: 
 
1. The recruitment of cells to the bite skin post tsetse bite is independent of 
the presence or absence of parasites. The damage caused by the tsetse fly 
drives the influx of host cells, which were predominantly neutrophils. 
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2. T. b. brucei are detected in the LN prior to blood dissemination, and 
infection of tsetse flies is best achieved through optimisation of the 
infected blood feed, trypanosome strain and tsetse fly combinations. 
3. Metacyclic T. b. brucei are actively motile in the skin 
4. T. b. brucei migrates towards lymphatic vessels and gain entry.  
 
Overall the data presented in this thesis demonstrates that chemokines drive 
neutrophil influx to the skin, specifically CXCL1 and CXCL2. Also, neutrophil 
behaviour in the skin in African trypanosome infections was unique in that 
neutrophil swarms were absent during intravital imaging studies. T. b. brucei 
were also detected, and could possibly gain access to the initial lymphatics 
through gaps in the basement membrane where they could squeeze in. The data 
presented here also excludes the possibility of CCL21 contributing to T. b. brucei 
ingress into lymphatic vessels. 
 
6.6 Future work 
In the light of the findings from this thesis as outlined above, it would be 
interesting to carry out the following studies to provide more insights into the 
very early events in African trypanosome infections. Firstly, the characterisation 
of the factor(s) present in the tsetse fly salivary gland that could potentially 
drive neutrophil influx to the bite site - this would shed more light on the 
neutrophil influx data I have presented in chapter 4 of my thesis. Secondly, it 
would also be interesting to dissect the molecular mechanisms underlying the 
entry of African trypanosomes into the lymphatics, first through in vitro 
chemotaxis assays using a broad range of chemokines, and followed by the use of 
mice deficient in skin lymphatics in order to define the impact this would have 
on pathogenesis.  
 
In summary, these studies together with the data from my thesis would 
undoubtedly provide further insights into African trypanosome dissemination 
through the skin, hence uncovering the ‘black box’ of the very earliest events in 
the skin. 
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Appendices 
I General solutions 
 
Complete medium: 500 mL IMDM [Iscove’s Modified Dulbecco’s Medium, 
(Invitrogen, Paisley, UK)] containing 4%v/v foetal calf serum (FCS), penicillin 
(100 units/mL), streptomycin (100 µg/mL), and 2 mM L-Glutamate. 
 
Hanks’ Balanced Salt Solution 1x with CaCl2 and MgCl2 (1x HBSS): 1x HBSS was 
purchased from Life Technologies (Paisley, UK). 
 
Chemotaxis buffer: 0.5% w/v Bovine Serum Albumin (BSA) in IMDM 
 
Fluorescence activated cell sorting (FACS) buffer: 500 ml of 1x DPBS 
containing 4% v/v FCS, 2 mM EDTA and 0.09% w/v Sodium Azide. 
 
Dulbecco’s Phosphate Buffered Saline, 1x (1x DPBS) without CaCl2 & MgCl2: 1x 
DPBS was purchased from Life Technologies (Paisley, UK). 
 
Modified HMI-9 for culturing Pleiomorphic T. b. brucei  
 
ßBCPT comprises of the components below: 
 
Bathocuproinedisulfonic acid disodium salt           14.1mg (5 mM) – final 0.5 mM 
Distilled water (d.H20)                                          5 ml 
 
Thymidine       19.5 mg (16 mM) – final 0.16 mM 
d.H20        5 ml 
 
Sodium Pyruvate      110 mg  
d.H20        5 ml 
 
ß-mercaptoethanol      7ul (200 mM) – final 2 mM 
d.H20        5 ml 
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L-cysteine C3H7NO2S     91.0 mg (100 mM) – final 1mM 
d.H20        5 ml 
 
Filter sterilise and add to medium as directed below, or store at -20oC until 
needed. 
 
For 500 ml HM19 add in the following order: 
 
Iscoves modified Dulbecco’s medium  + glutamax     365 ml 
Hypoxanthine (stored at 40 oC)        5 ml 
Kanamycin (10mg/ml -20 oC)        1.5 ml 
Pen/Strep (5000 Units each -20 oC)  (or 2.5 ml of 10 000 U/ml)  5 ml 
ßBCPT (5 ml of each component mixed together as above)   25 ml 
Glucose           500 mg 
Adenosine           67 mg 
Guanosine           71 mg 
Methyl cellulose          0.55 g 
 
Leave overnight on stirrer in cold room 
 
Add 133 ml Serum Plus (20%) + 133 ml PAA Gold FCS (20%) to 400 ml Mod-HMI-9 
 
Filter sterilise and store at 4 oC  
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II List of antibodies 
 
Antibody Clone Company 
Ly6G Gr1 BD 
F4/80 BM8 eBioscience 
CD45 30-F11 BD 
CD11b M1/70 BD 
IA/IE (MHC II) 2G9 BD 
Ly6C RB-8C5 eBioscience 
Viability  eBioscience 
Ly6G IA8 BioXcell 
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